# EDGAR Filing Document

**Accession Number:** 0000819118
**File Stem:** 0000819118-23-000007
**Filing Date:** 2023-1
**Character Count:** 338243
**Document Hash:** 1d614b54c7a304630a8840c421078a30
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000819118-23-000007.hdr.sgml**: 20230119

**ACCESSION NUMBER**: 0000819118-23-000007

**CONFORMED SUBMISSION TYPE**: N-CSR

**PUBLIC DOCUMENT COUNT**: 8

**CONFORMED PERIOD OF REPORT**: 20221130

**FILED AS OF DATE**: 20230119

**DATE AS OF CHANGE**: 20230119

**EFFECTIVENESS DATE**: 20230119

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** FIDELITY CONCORD STREET TRUST
- **CENTRAL INDEX KEY:** 0000819118
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 0228

**FILING VALUES:**
- **FORM TYPE:** N-CSR
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-05251
- **FILM NUMBER:** 23536837

**BUSINESS ADDRESS:**
- **STREET 1:** 245 SUMMER STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210
- **BUSINESS PHONE:** 617-563-7000

**MAIL ADDRESS:**
- **STREET 1:** 245 SUMMER STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FIDELITY INSTITUTIONAL TRUST
- **DATE OF NAME CHANGE:** 19920703

## Series and Classes Contracts Data

### Fidelity Nasdaq Composite Index Fund (Series ID: S000055366)

| Class ID   | Class Name                           | Ticker Symbol   |
|:---|:---|:---|
| C000174185 | Fidelity Nasdaq Composite Index Fund | FNCMX           |

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UNITED STATES

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SECURITIES AND EXCHANGE COMMISSION

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Washington, D.C. 20549

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **FORM N-CSR** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **CERTIFIED SHAREHOLDER REPORT OF REGISTERED** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **MANAGEMENT INVESTMENT COMPANIES** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Investment Company Act file number <u>811-05251</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Fidelity Concord Street Trust</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Exact name of registrant as specified in charter)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>245 Summer St., Boston, Massachusetts 02210</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Address of principal executive offices) (Zip code)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cynthia Lo Bessette, Secretary

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 245 Summer St.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Boston, Massachusetts 02210</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Name and address of agent for service)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Registrant's telephone number, including area code:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>617-563-7000</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

---

| | |
|:---|:---|
|  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Date of fiscal year end:  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; November 30  |
|  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Date of reporting period:  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; November 30, 2022  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Item 1.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Reports to Stockholders</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

**Fidelity® Nasdaq Composite Index® Fund**

**Annual Report**

**November 30, 2022**

![](img87682_1.jpg)

![](img87682_2.jpg)

**Contents**

---

| |
|:---|
| **[Performance](#Sec_Performance)** |
| **[Management's Discussion of Fund Performance](#Sec_Mgt Discussion of FundPerformance)** |
| **[Investment Summary](#Sec_InvestmentSummary1282)** |
| **[Schedule of Investments](#Sec_ScheduleOfInvestments1282)** |
| **[Financial Statements](#Sec_FinancialStatements1282)** |
| **[Notes to Financial Statements](#Sec_Notes to Financial Statements)** |
| **[Report of Independent Registered Public Accounting Firm](#Sec_Report of Independent Registered Public Accounting Firm)** |
| **[Trustees and Officers](#Sec_Trustee and Officers)** |
| **[Shareholder Expense Example](#Sec_Shareholder Expense Example)** |
| **[Distributions](#Sec_Distributions)** |
| **[Board Approval of Investment Advisory Contracts and Management Fees](#Sec_Board Approval of Investment Advisory Contracts and Management Fees)** |

---

To view a fund's proxy voting guidelines and proxy voting record for the 12-month period ended June 30, visit http://www.fidelity.com/proxyvotingresults or visit the Securities and Exchange Commission's (SEC) web site at http://www.sec.gov.

You may also call 1-800-544-8544 to request a free copy of the proxy voting guidelines.

The NASDAQ OMXGroup, Inc. (which with its Affiliates are the Corporations) and are licensed for use by Fidelity. The product has not been passed on by the Corporations as to its legality or suitability. The product is not issued, endorsed or sold by the Corporations. The Corporations make no warranties and bear no liability with respect to shares of the product.

Standard & Poor's, S&P and S&P 500 are registered service marks of The McGraw-Hill Companies, Inc. and have been licensed for use by Fidelity Distributors Corporation.

Other third-party marks appearing herein are the property of their respective owners.

All other marks appearing herein are registered or unregistered trademarks or service marks of FMR LLC or an affiliated company.© 2023 FMR LLC. All rights reserved.

*This report and the financial statements contained herein are submitted for the general information of the shareholders of the Fund. This report is not authorized for distribution to prospective investors in the Fund unless preceded or accompanied by an effective prospectus.*

*A fund files its complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Form N-PORT. Forms N-PORT are available on the SEC's web site at http://www.sec.gov. A fund's Forms N-PORT may be reviewed and copied at the SEC's Public Reference Room in Washington, DC. Information regarding the operation of the SEC's Public Reference Room may be obtained by calling 1-800-SEC-0330.*

*For a complete list of a fund's portfolio holdings, view the most recent holdings listing, semiannual report, or annual report on Fidelity's web site at http://www.fidelity.com, http://www.institutional.fidelity.com, or http://www.401k.com, as applicable.*

**NOT FDIC INSURED •MAY LOSE VALUE •NO BANK GUARANTEE**

*Neither the Fund nor Fidelity Distributors Corporation is a bank.*

**Performance: The Bottom Line**

Average annual total return reflects the change in the value of an investment, assuming reinvestment of distributions from dividend income and capital gains (the profits earned upon the sale of securities that have grown in value, if any) and assuming a constant rate of performance each year. The hypothetical investment and the average annual total returns do not reflect the deduction of taxes that a shareholder would pay on fund distributions or the redemption of fund shares. During periods of reimbursement by Fidelity, a fund's total return will be greater than it would be had the reimbursement not occurred. How a fund did yesterday is no guarantee of how it will do tomorrow.

&nbsp;&nbsp; **Average Annual Total Returns** <br>

---

| | | | |
|:---|:---|:---|:---|
| **Periods ended November 30, 2022** <br>| **Past 1** <br> **year**  | **Past 5** <br> **years**  | **Past 10** <br> **years**  |
| Fidelity® Nasdaq Composite Index® Fund  | &nbsp;&nbsp; -25.37%  | &nbsp;&nbsp; 11.69%  | &nbsp;&nbsp; 15.38%  |

---

---

| |
|:---|
| **$10,000 Over 10 Years**  |
| Let's say hypothetically that $10,000 was invested in Fidelity® Nasdaq Composite Index® Fund on November 30, 2012. <br>The chart shows how the value of your investment would have changed, and also shows how the Nasdaq Composite Index® performed over the same period.  |
| ![](img87682_5.jpg)  |

---

**Management's Discussion of Fund Performance**

**Market Recap:** 

U.S. equities returned -9.21% for the 12 months ending November 30, 2022, according to the S&P 500® index, as a multitude of risk factors challenged the global economy. Persistently high inflation prompted the Federal Reserve to aggressively tighten monetary policy, and market interest rates eclipsed their highest level in roughly a decade, stoking recession fears and sending stocks into bear market territory. In late 2021, the Fed shifted to a more restrictive policy stance and proceeded to hike its benchmark rate six times, by a total of 3.75%, between March and November - the fastest-ever pace of monetary tightening - while taking substantive steps to shrink its massive asset portfolio. Against this hostile backdrop for risk assets, the S&P 500® posted its worst year-to-date result (-23.87%) in 20 years through September, a seasonally weak month for stocks that stayed true to form, and then some, with volatility spiking due to growing certainty the Fed would persist in its effort to cool inflation, even at the expense of economic growth. Three of the index's worst monthly returns ever were recorded this period, with the S&P 500® shedding 8% to 9% in April, June and September. Gains of similar proportion were made in July and October, amid optimism on inflation and policy easing. November (+6%) began with another rate hike of 0.75% and ended on a high note as the Fed signaled its intent to slow its pace of rate rises. By sector for the 12 months, communication services (-33%) lagged most. In sharp contrast, energy (+76%) led the way.

**Comments from the Geode Capital Management, LLC, passive equity index team:**

For the fiscal year ending November 30, 2022, the fund returned -25.37%, roughly in line with the -25.59% result of the benchmark NASDAQ Composite Index. By sector, information technology returned -24% and detracted most, followed by consumer discretionary, which returned -40%. The communication services sector returned -36%, hampered by the media & entertainment industry (-39%), and health care (-18%) also hurt. Other notable detractors included the financials (-14%), industrials (-13%), and real estate (-17%) sectors. Conversely, consumer staples advanced roughly 8% and contributed most, driven by the food, beverage & tobacco industry (+15%). Energy stocks also helped, gaining approximately 49%. The utilities sector rose 22% and materials (+2%) also contributed. Turning to individual stocks, the biggest individual detractor was Amazon.com (-45%), from the retailing group. Tesla, within the automobiles & components segment, returned -49% and hindered the fund. In software & services, Microsoft (-22%) hurt. Other detractors were Alphabet (-29%) and Meta Platforms (-64%), from the media & entertainment category. Conversely, the biggest individual contributor was T-Mobile (+39%), from the telecommunication services industry. In pharmaceuticals, biotechnology & life sciences, Amgen (+48%) and Vertex Pharmaceuticals (+69%) helped. Another contributor was PepsiCo (+19%), a stock in the food, beverage & tobacco industry.

*The views expressed above reflect those of the portfolio manager(s) only through the end of the period as stated on the cover of this report and do not necessarily represent the views of Fidelity or any other person in the Fidelity organization. Any such views are subject to change at any time based upon market or other conditions and Fidelity disclaims any responsibility to update such views. These views may not be relied on as investment advice and, because investment decisions for a Fidelity fund are based on numerous factors, may not be relied on as an indication of trading intent on behalf of any Fidelity fund.*

**Investment Summary November 30, 2022 (Unaudited)**

---

| | |
|:---|:---|
| &nbsp;&nbsp; **Top Holdings (% of Fund's net assets)**  | &nbsp;&nbsp; **Top Holdings (% of Fund's net assets)**  |
| Apple, Inc.  | 12.7  |
| Microsoft Corp.  | 10.2  |
| Amazon.com, Inc.  | 5.3  |
| Alphabet, Inc. Class C  | 3.4  |
| Alphabet, Inc. Class A  | 3.2  |
| Tesla, Inc.  | 3.2  |
| NVIDIA Corp.  | 2.3  |
| Meta Platforms, Inc. Class A  | 1.5  |
| PepsiCo, Inc.  | 1.4  |
| Costco Wholesale Corp.  | 1.3  |
|  | 44.5  |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp; **Market Sectors (% of Fund's net assets)**  | &nbsp;&nbsp; **Market Sectors (% of Fund's net assets)**  |
| Information Technology  | 44.3  |
| Consumer Discretionary  | 14.4  |
| Communication Services  | 13.4  |
| Health Care  | 9.6  |
| Financials  | 5.1  |
| Consumer Staples  | 4.9  |
| Industrials  | 4.8  |
| Utilities  | 1.0  |
| Real Estate  | 1.0  |
| Energy  | 0.8  |
| Materials  | 0.4  |

---

---

| |
|:---|
| &nbsp;&nbsp; **Asset Allocation (% of Fund's net assets)**  |
| ![](img87682_6.jpg)  |
| *Foreign investments - 4.9%*  |

---

**Schedule of Investments November 30, 2022**

Showing Percentage of Net Assets

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp; **Common Stocks - 99.7%**  | &nbsp;&nbsp; **Common Stocks - 99.7%**  | &nbsp;&nbsp; **Common Stocks - 99.7%**  |
|  | Shares  | Value ($) <br>|
| COMMUNICATION SERVICES - 13.4%  |  |  |
| Diversified Telecommunication Services - 0.2%  |  |  |
|  Anterix, Inc. (a)  | 15055  | 511870  |
|  AST SpaceMobile, Inc. (a)(b)  | 27143  | 156615  |
|  ATN International, Inc.  | 9505  | 460137  |
|  Bandwidth, Inc. (a)  | 17024  | 389169  |
|  Charge Enterprises, Inc. (a)(b)  | 120637  | 255750  |
|  Cogent Communications Group, Inc.  | 25499  | 1480217  |
|  Consolidated Communications Holdings, Inc. (a)  | 76045  | 351328  |
|  Cuentas, Inc. (a)  | 6700  | 2006  |
|  EchoStar Holding Corp. Class A (a)(b)  | 23662  | 411719  |
|  Frontier Communications Parent, Inc. (a)(b)  | 136361  | 3514023  |
|  Iridium Communications, Inc. (a)  | 75205  | 3993386  |
|  Liberty Global PLC:  |  |  |
|  Class A (a)  | 38785  | 778803  |
|  Class B (a)  | 327  | 6668  |
|  Class C (a)  | 234108  | 4841353  |
|  Liberty Latin America Ltd.:  |  |  |
|  Class A (a)  | 1495  | 11571  |
|  Class C (a)  | 140421  | 1093880  |
|  Nextplat Corp. (a)  | 37686  | 59544  |
|  Radius Global Infrastructure, Inc. (a)  | 57547  | 728545  |
|  Sify Technologies Ltd. sponsored ADR (a)(b)  | 13702  | 18772  |
|  Telesat Corp. (a)(b)  | 5704  | 49054  |
|  |  | 19114410  |
| Entertainment - 1.7%  |  |  |
|  Activision Blizzard, Inc.  | 441897  | 32678283  |
|  Anghami, Inc. (a)(b)  | 17135  | 43095  |
|  Bilibili, Inc. ADR (a)(b)  | 74795  | 1298441  |
|  Blue Hat Interactive Entertainment Technology (a)(b)  | 1312  | 879  |
|  Chicken Soup For The Soul Entertainment, Inc. (a)(b)  | 3106  | 20375  |
|  Cinedigm Corp. (a)(b)  | 80948  | 38466  |
|  CuriosityStream, Inc. Class A (a)(b)  | 14288  | 19146  |
|  Dolphin Entertainment, Inc. (a)(b)  | 1963  | 4927  |
|  DoubleDown Interactive Co. Ltd. ADR (a)(b)  | 2770  | 24736  |
|  DouYu International Holdings Ltd. ADR (a)(b)  | 78060  | 102259  |
|  Electronic Arts, Inc.  | 156999  | 20532329  |
|  Engine Gaming & Media, Inc. (a)(b)  | 23558  | 13878  |
|  Gaia, Inc. Class A (a)  | 13031  | 33750  |
|  Genius Brands International, Inc. (a)(b)  | 160281  | 117165  |
|  GigaMedia Ltd. (a)(b)  | 1957  | 2427  |
|  Gravity Co. Ltd. ADR (a)(b)  | 3688  | 153126  |
|  Grom Social Enterprises, Inc. (a)  | 33010  | 5546  |
|  iQIYI, Inc. ADR (a)(b)  | 197902  | 587769  |
|  Liberty Media Corp. Liberty Braves:  |  |  |
|  Class A (a)(b)  | 14692  | 486599  |
|  Class C (a)  | 16026  | 522127  |
|  Liberty Media Corp. Liberty Formula One:  |  |  |
|  Class A (a)  | 14368  | 789809  |
|  Series C (a)  | 117797  | 7178549  |
|  Liquid Media Group Ltd. (a)(b)  | 14232  | 3137  |
|  LiveOne, Inc. (a)(b)  | 40255  | 27373  |
|  Lizhi, Inc. ADR (a)(b)  | 12605  | 9187  |
|  Lytus Technologies Holdings PTV Ltd. (a)(b)  | 40712  | 37455  |
|  Motorsport Games, Inc. Class A (a)(b)  | 564  | 2809  |
|  NetEase, Inc. ADR (b)  | 93943  | 6681226  |
|  Netflix, Inc. (a)  | 253442  | 77434134  |
|  Nexters, Inc. (a)(b)(c)  | 33010  | 38138  |
|  Playstudios, Inc. Class A (a)  | 64251  | 268569  |
|  Playtika Holding Corp. (a)(b)  | 230413  | 2177403  |
|  Reading International, Inc. Class A (a)  | 19966  | 64291  |
|  Reservoir Media, Inc. (a)(b)  | 28696  | 181359  |
|  Roku, Inc. Class A (a)  | 70436  | 4181785  |
|  Scienjoy Holding Corp. (a)(b)  | 17909  | 35281  |
|  Sciplay Corp. (A Shares) (a)  | 19299  | 309170  |
|  Take-Two Interactive Software, Inc. (a)  | 95292  | 10071411  |
|  The9 Ltd. sponsored ADR (a)(b)  | 8161  | 5956  |
|  Versus Systems, Inc. (a)(b)  | 1207  | 2450  |
|  Warner Bros Discovery, Inc. (a)  | 1385680  | 15796752  |
|  Warner Music Group Corp. Class A  | 77473  | 2655000  |
|  |  | 184636567  |
| Interactive Media & Services - 8.4%  |  |  |
|  36Kr Holdings, Inc. ADR (a)  | 1078  | 1197  |
|  9F, Inc. ADR (a)(b)  | 42546  | 8547  |
|  AcuityAds Holdings, Inc. (a)  | 23024  | 41213  |
|  Alphabet, Inc.:  |  |  |
|  Class A (a)  | 3413630  | 344742494  |
|  Class C (a)  | 3509361  | 356024673  |
|  Angi, Inc. (a)  | 45307  | 101035  |
|  Baidu, Inc. sponsored ADR (a)  | 103250  | 11212950  |
|  Bumble, Inc. (a)  | 70582  | 1719378  |
|  BuzzFeed, Inc. (a)(b)  | 60546  | 69628  |
|  CarGurus, Inc. Class A (a)  | 54988  | 719243  |
|  CF Acquisition Corp. VI (a)(b)  | 161686  | 1539251  |
|  Enthusiast Gaming Holdings, Inc. (a)(b)  | 110249  | 68564  |
|  EverQuote, Inc. Class A (a)  | 26593  | 287204  |
|  Fangdd Network Group Ltd. ADR (a)(b)  | 2821  | 3329  |
|  FaZe Holdings, Inc. Class A (a)(b)  | 63918  | 129754  |
|  Glory Star New Media Group Holdings Ltd. (a)(b)  | 45347  | 66660  |
|  Hello Group, Inc. ADR  | 108565  | 623163  |
|  IAC, Inc. (a)  | 48486  | 2515939  |
|  Izea Worldwide, Inc. (a)(b)  | 31302  | 20691  |
|  JOYY, Inc. ADR  | 35033  | 1067105  |
|  Kanzhun Ltd. ADR (a)  | 124587  | 2344727  |
|  Kubient, Inc. (a)(b)  | 6524  | 6460  |
|  Liberty TripAdvisor Holdings, Inc. (a)(b)  | 115325  | 101486  |
|  Luokung Technology Corp. (a)(b)  | 210130  | 35701  |
|  Match Group, Inc. (a)  | 159702  | 8074533  |
|  Meta Platforms, Inc. Class A (a)  | 1299321  | 153449810  |
|  Outbrain, Inc. (a)(b)  | 26490  | 102781  |
|  Professional Diversity Network, Inc. (a)(b)  | 1922  | 1749  |
|  QuinStreet, Inc. (a)  | 29776  | 423712  |
|  Qutoutiao, Inc. ADR (a)(b)  | 18176  | 8539  |
|  So-Young International, Inc. ADR (a)  | 62527  | 47821  |
|  Society Pass, Inc. (b)  | 9864  | 14993  |
|  Sohu.Com Ltd. ADR (a)  | 24154  | 356996  |
|  Spark Networks SE ADR (a)  | 5776  | 6700  |
|  Super League Gaming, Inc. (a)(b)  | 17381  | 11847  |
|  Taboola.com Ltd. (a)(b)  | 69454  | 193082  |
|  Travelzoo, Inc. (a)(b)  | 6862  | 36712  |
|  TripAdvisor, Inc. (a)(b)  | 69482  | 1416738  |
|  Trivago NV ADR (a)  | 43707  | 60753  |
|  TrueCar, Inc. (a)  | 56073  | 139622  |
|  Vimeo, Inc. (a)  | 92858  | 397432  |
|  Vinco Ventures, Inc. (a)(b)  | 126154  | 84599  |
|  Weibo Corp. sponsored ADR (a)  | 49991  | 796857  |
|  Wejo Group Ltd. (a)  | 49881  | 47053  |
|  Yandex NV Series A (a)(c)  | 178045  | 610666  |
|  Ziff Davis, Inc. (a)  | 26561  | 2450518  |
|  Zoominfo Technologies, Inc. (a)  | 230913  | 6604112  |
|  |  | 898788017  |
| Media - 2.0%  |  |  |
|  AdTheorent Holding Co., Inc. Class A (a)  | 47329  | 91345  |
|  Advantage Solutions, Inc. Class A (a)(b)  | 177154  | 439342  |
|  AirNet Technology, Inc. ADR (a)  | 5468  | 3396  |
|  AMC Networks, Inc. Class A (a)  | 16028  | 319919  |
|  Baosheng Media Group Holding Ltd. (a)(b)  | 976  | 868  |
|  Beasley Broadcast Group, Inc. Class A (a)(b)  | 282190  | 293478  |
|  Cardlytics, Inc. (a)(b)  | 36616  | 164406  |
|  Charter Communications, Inc. Class A (a)  | 91920  | 35967377  |
|  Comcast Corp. Class A  | 2506795  | 91848969  |
|  comScore, Inc. (a)(b)  | 21501  | 29026  |
|  Criteo SA sponsored ADR (a)  | 32862  | 889246  |
|  Cumulus Media, Inc. (a)  | 11565  | 84656  |
|  Daily Journal Corp. (a)  | 1070  | 294250  |
|  DISH Network Corp. Class A (a)  | 173264  | 2780887  |
|  E.W. Scripps Co. Class A (a)  | 39165  | 586692  |
|  Fluent, Inc. (a)  | 46702  | 60246  |
|  Fox Corp.:  |  |  |
|  Class A  | 187824  | 6094889  |
|  Class B  | 126638  | 3864992  |
|  Gambling.com Group Ltd. (a)(b)  | 13722  | 140651  |
|  Harte-Hanks, Inc. (a)  | 5634  | 56565  |
|  iClick Interactive Asia Group Ltd. (A Shares) ADR (a)(b)  | 3435  | 8484  |
|  iHeartMedia, Inc. (a)  | 66104  | 531476  |
|  Insignia Systems, Inc. (a)(b)  | 1817  | 16335  |
|  Integral Ad Science Holding Corp. (a)  | 86987  | 865521  |
|  Lee Enterprises, Inc. (a)  | 2469  | 44442  |
|  Liberty Broadband Corp.:  |  |  |
|  Class A (a)  | 13861  | 1250262  |
|  Class C (a)  | 73860  | 6710920  |
|  Liberty Media Corp. Liberty SiriusXM:  |  |  |
|  Series A (a)(b)  | 56950  | 2495549  |
|  Series C (a)  | 129227  | 5664019  |
|  Loyalty Ventures, Inc. (a)  | 32234  | 77684  |
|  Magnite, Inc. (a)  | 62865  | 698430  |
|  Marchex, Inc. Class B (a)  | 34542  | 58721  |
|  Mediaco Holding, Inc. (a)  | 9137  | 9868  |
|  Mobiquity Technologies, Inc. (a)(b)  | 5950  | 5891  |
|  National CineMedia, Inc. (b)  | 42414  | 18056  |
|  News Corp.:  |  |  |
|  Class A  | 221960  | 4250534  |
|  Class B  | 111410  | 2166925  |
|  Nexstar Broadcasting Group, Inc. Class A  | 22260  | 4219606  |
|  Nextplay Technologies, Inc. (a)(b)  | 71369  | 11548  |
|  Paramount Global:  |  |  |
|  Class A (b)  | 10752  | 246006  |
|  Class B (b)  | 352157  | 7071313  |
|  Perion Network Ltd. (a)(b)  | 27171  | 745301  |
|  PubMatic, Inc. (a)(b)  | 20605  | 322880  |
|  Saga Communications, Inc. Class A  | 1013  | 26085  |
|  Salem Communications Corp. Class A (a)  | 18198  | 24203  |
|  Scholastic Corp.  | 19973  | 821290  |
|  Sinclair Broadcast Group, Inc. Class A (b)  | 29222  | 542360  |
|  Sirius XM Holdings, Inc. (b)  | 2187677  | 14198024  |
|  Stagwell, Inc. (a)(b)  | 74881  | 558612  |
|  Stran & Co., Inc. (a)(b)  | 1570  | 2104  |
|  TechTarget, Inc. (a)(b)  | 15882  | 725172  |
|  The Trade Desk, Inc. (a)  | 254529  | 13271142  |
|  Thryv Holdings, Inc. (a)(b)  | 18106  | 347273  |
|  Tremor International Ltd. ADR (a)(b)  | 5026  | 38801  |
|  Troika Media Group, Inc. (a)  | 26445  | 3364  |
|  TuanChe Ltd. ADR (A Shares) (a)(b)  | 5969  | 5790  |
|  Urban One, Inc.:  |  |  |
|  Class A (a)  | 4568  | 22794  |
|  Class D (non-vtg.) (a)  | 21932  | 96501  |
|  WiMi Hologram Cloud, Inc. ADR (a)(b)  | 28988  | 22019  |
|  Xcel Brands, Inc. (a)  | 4288  | 3601  |
|  ZW Data Action Technologies, Inc. (a)(b)  | 12732  | 7003  |
|  |  | 212217109  |
| Wireless Telecommunication Services - 1.1%  |  |  |
|  FingerMotion, Inc. (a)(b)  | 25594  | 108519  |
|  Gogo, Inc. (a)  | 75352  | 1182273  |
|  Millicom International Cellular SA (a)  | 90052  | 1222906  |
|  NII Holdings, Inc. (a)(c)  | 5182  | 1347  |
|  Partner Communications Co. Ltd. ADR (a)  | 5513  | 43553  |
|  Shenandoah Telecommunications Co. (b)  | 28888  | 562449  |
|  Spok Holdings, Inc.  | 20912  | 169805  |
|  SurgePays, Inc. (a)(b)  | 26205  | 172691  |
|  T-Mobile U.S., Inc. (a)  | 713355  | 108044748  |
|  uCloudlink Group, Inc. ADR (a)(b)  | 12409  | 47402  |
|  VEON Ltd. sponsored ADR (a)  | 970358  | 582215  |
|  Vodafone Group PLC sponsored ADR  | 231382  | 2598420  |
|  |  | 114736328  |
|  TOTAL COMMUNICATION SERVICES  |  | 1429492431  |
| CONSUMER DISCRETIONARY - 14.4%  |  |  |
| Auto Components - 0.2%  |  |  |
|  China Automotive Systems, Inc. (a)(b)  | 19314  | 139447  |
|  Dorman Products, Inc. (a)  | 17959  | 1609845  |
|  Foresight Autonomous Holdings Ltd. ADR (a)  | 2169  | 1432  |
|  Fox Factory Holding Corp. (a)  | 25531  | 2708839  |
|  Garrett Motion, Inc. (a)(b)  | 46318  | 327931  |
|  Gentex Corp.  | 129732  | 3749255  |
|  Gentherm, Inc. (a)  | 18245  | 1306160  |
|  Kandi Technologies Group, Inc. (a)(b)  | 39238  | 107120  |
|  Luminar Technologies, Inc. (a)(b)  | 141016  | 1080183  |
|  Mobileye Global, Inc.  | 27811  | 792892  |
|  Motorcar Parts of America, Inc. (a)  | 12691  | 143028  |
|  Patrick Industries, Inc.  | 13038  | 729215  |
|  REE Automotive Ltd. (a)(b)  | 118453  | 65872  |
|  Solid Power, Inc. (a)(b)  | 104800  | 384616  |
|  Strattec Security Corp. (a)  | 1858  | 46153  |
|  Sypris Solutions, Inc. (a)(b)  | 6622  | 15032  |
|  The Goodyear Tire & Rubber Co. (a)  | 155651  | 1746404  |
|  Visteon Corp. (a)  | 15401  | 2260867  |
|  XPEL, Inc. (a)(b)  | 15108  | 1035653  |
|  |  | 18249944  |
| Automobiles - 3.6%  |  |  |
|  Arcimoto, Inc. (a)(b)  | 1159  | 8635  |
|  Arrival SA (a)(b)  | 501750  | 159958  |
|  AYRO, Inc. (a)(b)  | 18733  | 10953  |
|  Canoo, Inc. (a)(b)  | 58429  | 78295  |
|  Cenntro Electric Group Ltd. (a)(b)  | 208899  | 130353  |
|  ElectraMeccanica Vehicles Corp. (a)(b)  | 157533  | 187464  |
|  Faraday Future Intelligent Electric, Inc. (a)(b)  | 158899  | 51022  |
|  Gogoro, Inc. (a)(b)  | 129471  | 475159  |
|  Li Auto, Inc. ADR (a)(b)  | 213964  | 4707208  |
|  Lordstown Motors Corp. Class A (a)(b)  | 112427  | 186629  |
|  Lucid Group, Inc. Class A (a)(b)  | 963086  | 9765692  |
|  Mullen Automotive, Inc. (a)(b)  | 385607  | 74075  |
|  Niu Technologies ADR (a)  | 20884  | 79986  |
|  Phoenix Motor, Inc. (b)  | 8319  | 13477  |
|  Polestar Automotive Holding UK PLC (a)(b)  | 1216768  | 9052754  |
|  Rivian Automotive, Inc.  | 519119  | 16632573  |
|  Tesla, Inc. (a)  | 1769822  | 344584343  |
|  Volcon, Inc. (a)(b)  | 14272  | 16984  |
|  Workhorse Group, Inc. (a)(b)  | 124046  | 285306  |
|  |  | 386500866  |
| Distributors - 0.2%  |  |  |
|  Educational Development Corp.  | 7081  | 21101  |
|  Funko, Inc. (a)(b)  | 24268  | 230546  |
|  Kaival Brands Innovations Group, Inc. (a)(b)  | 31106  | 33283  |
|  LKQ Corp.  | 154891  | 8415228  |
|  Pool Corp.  | 22246  | 7328055  |
|  Weyco Group, Inc. (b)  | 6799  | 174054  |
|  |  | 16202267  |
| Diversified Consumer Services - 0.1%  |  |  |
|  17 Education & Technology Group, Inc. ADR (a)(b)  | 24088  | 26256  |
|  2U, Inc. (a)  | 55243  | 443601  |
|  Afya Ltd. (a)  | 26135  | 392548  |
|  American Public Education, Inc. (a)  | 10578  | 135927  |
|  Amesite, Inc. (a)(b)  | 22120  | 6194  |
|  Arco Platform Ltd. Class A (a)(b)  | 16151  | 146005  |
|  Aspen Group, Inc. (a)(b)  | 21449  | 8003  |
|  ATA Creativity Global ADR (a)  | 4528  | 7743  |
|  China Liberal Education Holdings Ltd. (a)(b)  | 48266  | 55506  |
|  Duolingo, Inc. (a)  | 17400  | 1212258  |
|  E-Home Household Service Holdings Ltd. (a)  | 941  | 602  |
|  EpicQuest Education Group International Ltd. (a)(b)  | 1797  | 3199  |
|  European Wax Center, Inc. (b)  | 23118  | 335211  |
|  Frontdoor, Inc. (a)  | 47662  | 1113861  |
|  Golden Sun Education Group Ltd. (b)  | 6190  | 9656  |
|  Grand Canyon Education, Inc. (a)  | 18944  | 2141998  |
|  Laureate Education, Inc. Class A  | 102949  | 1078906  |
|  Lincoln Educational Services Corp. (a)(b)  | 24123  | 159453  |
|  Meten EdtechX Education Group Ltd. (a)(b)  | 7857  | 1914  |
|  NaaS Technology, Inc. ADR (a)(b)  | 17939  | 98485  |
|  OneSpaWorld Holdings Ltd. (a)(b)  | 45861  | 457234  |
|  Perdoceo Education Corp. (a)  | 46741  | 670733  |
|  Rover Group, Inc. Class A (a)  | 107567  | 518473  |
|  Skillful Craftsman Education Technology Ltd. (a)(b)  | 6452  | 5291  |
|  Strategic Education, Inc. (b)  | 14254  | 1165977  |
|  Tarena International, Inc. ADR (a)(b)  | 8570  | 47649  |
|  Udemy, Inc. (a)  | 81254  | 1152994  |
|  Vasta Platform Ltd. (a)(b)  | 9735  | 39329  |
|  Visionary Education Technology Holdings Group, Inc.  | 22075  | 13678  |
|  Vitru Ltd. (a)(b)  | 15786  | 370971  |
|  Wag! Group Co. (a)(b)  | 8539  | 22372  |
|  Wah Fu Education Group Ltd. (a)(b)  | 9305  | 19261  |
|  WW International, Inc. (a)(b)  | 10016  | 41366  |
|  Xwell, Inc. (a)(b)  | 121824  | 50557  |
|  Zhongchao, Inc. (a)(b)  | 5917  | 7189  |
|  |  | 11960400  |
| Hotels, Restaurants & Leisure - 2.3%  |  |  |
|  Airbnb, Inc. Class A (a)  | 227759  | 23263304  |
|  Allied Esports Entertainment, Inc. (a)(b)  | 17647  | 24353  |
|  BJ's Restaurants, Inc. (a)  | 13822  | 443410  |
|  Bloomin' Brands, Inc. (b)  | 47883  | 1078325  |
|  Booking Holdings, Inc. (a)  | 22606  | 47008047  |
|  Bragg Gaming Group, Inc. (a)(b)  | 6633  | 21756  |
|  BurgerFi International, Inc. (a)(b)  | 9417  | 13937  |
|  Caesars Entertainment, Inc. (a)  | 124392  | 6320358  |
|  Carrols Restaurant Group, Inc. (a)  | 24770  | 36907  |
|  Century Casinos, Inc. (a)  | 16194  | 120969  |
|  Churchill Downs, Inc.  | 21349  | 4738624  |
|  Chuy's Holdings, Inc. (a)  | 9648  | 305745  |
|  Codere Online Luxembourg SA (a)(b)  | 3157  | 8082  |
|  Cracker Barrel Old Country Store, Inc. (b)  | 13041  | 1497107  |
|  Dave & Buster's Entertainment, Inc. (a)(b)  | 26022  | 1032033  |
|  Denny's Corp. (a)  | 38087  | 477611  |
|  Draftkings Holdings, Inc. (a)(b)  | 259275  | 3972093  |
|  Ebet, Inc. (a)(b)  | 9638  | 6370  |
|  El Pollo Loco Holdings, Inc.  | 18467  | 201290  |
|  Elys Game Technology Corp. (a)  | 11486  | 1746  |
|  Esports Entertainment Group, Inc. (a)(b)  | 10135  | 1203  |
|  Expedia, Inc. (a)  | 87439  | 9341983  |
|  FAT Brands, Inc.:  |  |  |
|  Class A (b)  | 3129  | 21121  |
|  Class B (b)  | 53810  | 375594  |
|  Fiesta Restaurant Group, Inc. (a)  | 12322  | 80339  |
|  First Watch Restaurant Group, Inc. (a)  | 32731  | 513222  |
|  Full House Resorts, Inc. (a)  | 16206  | 123976  |
|  Golden Entertainment, Inc. (a)  | 16184  | 717113  |
|  Good Times Restaurants, Inc. (a)  | 9092  | 22003  |
|  H World Group Ltd. ADR  | 90804  | 3475977  |
|  Hall of Fame Resort & Entertainment Co. (a)(b)  | 57261  | 34334  |
|  Inspirato, Inc. (a)  | 67948  | 126383  |
|  Inspired Entertainment, Inc. (a)  | 15862  | 194151  |
|  Jack in the Box, Inc.  | 11357  | 821111  |
|  Krispy Kreme, Inc.  | 90430  | 1394431  |
|  Kura Sushi U.S.A., Inc. Class A (a)(b)  | 4711  | 309513  |
|  Light & Wonder, Inc. Class A (a)  | 53198  | 3445634  |
|  Lindblad Expeditions Holdings (a)  | 29723  | 269885  |
|  Lottery.Com, Inc. (a)(b)  | 18815  | 5385  |
|  MakeMyTrip Ltd. (a)  | 37977  | 1127537  |
|  Marriott International, Inc. Class A  | 183151  | 30284018  |
|  Melco Crown Entertainment Ltd. sponsored ADR (a)(b)  | 141538  | 1207319  |
|  Monarch Casino & Resort, Inc. (a)  | 10263  | 870816  |
|  Mondee Holdings, Inc. (a)(b)  | 44977  | 353069  |
|  Muscle Maker, Inc. (a)(b)  | 84646  | 52734  |
|  Nathan's Famous, Inc. (b)  | 3678  | 249736  |
|  NeoGames SA (a)  | 14676  | 202676  |
|  Noodles & Co. (a)  | 27889  | 153668  |
|  Papa John's International, Inc.  | 19976  | 1663202  |
|  Penn Entertainment, Inc. (a)  | 92636  | 3259861  |
|  Playa Hotels & Resorts NV (a)  | 89710  | 551717  |
|  Portillo's, Inc. (a)(b)  | 18790  | 379370  |
|  Potbelly Corp. (a)  | 12369  | 68895  |
|  Rave Restaurant Group, Inc. (a)(b)  | 5714  | 10228  |
|  RCI Hospitality Holdings, Inc. (b)  | 5507  | 501247  |
|  Red Robin Gourmet Burgers, Inc. (a)(b)  | 10497  | 87020  |
|  Red Rock Resorts, Inc.  | 34811  | 1568584  |
|  Ruth's Hospitality Group, Inc.  | 22375  | 391786  |
|  Selina Hospitality PLC (a)(b)  | 60296  | 197771  |
|  SharpLink Gaming Ltd. (a)(b)  | 20794  | 11647  |
|  Sonder Holdings, Inc. (a)(b)  | 146334  | 259011  |
|  Sportradar Holding AG (a)(b)  | 115671  | 1326746  |
|  Starbucks Corp.  | 652791  | 66715240  |
|  Target Hospitality Corp. (a)(b)  | 58530  | 846344  |
|  Texas Roadhouse, Inc. Class A (b)  | 38296  | 3803559  |
|  TH International Ltd. (a)(b)  | 22867  | 80035  |
|  The Cheesecake Factory, Inc. (b)  | 27723  | 971414  |
|  The ONE Group Hospitality, Inc. (a)(b)  | 15859  | 104511  |
|  Trip.com Group Ltd. ADR (a)  | 264789  | 8460009  |
|  Tuniu Corp. Class A sponsored ADR (a)(b)  | 16132  | 19197  |
|  Vacasa, Inc. Class A (a)(b)  | 142077  | 223061  |
|  Wendy's Co.  | 113229  | 2554446  |
|  Wingstop, Inc. (b)  | 16489  | 2729094  |
|  Wynn Resorts Ltd. (a)  | 64739  | 5416065  |
|  Yatra Online, Inc. (a)(b)  | 14712  | 37516  |
|  |  | 248584574  |
| Household Durables - 0.1%  |  |  |
|  Aterian, Inc. (a)(b)  | 9914  | 10707  |
|  Bassett Furniture Industries, Inc.  | 4416  | 83860  |
|  Cavco Industries, Inc. (a)  | 5108  | 1172950  |
|  Cricut, Inc. (a)(b)  | 23394  | 192299  |
|  Dixie Group, Inc. (a)  | 9905  | 9843  |
|  Flexsteel Industries, Inc.  | 3070  | 45436  |
|  GoPro, Inc. Class A (a)  | 68957  | 377884  |
|  Helen of Troy Ltd. (a)  | 13115  | 1292352  |
|  Hooker Furnishings Corp.  | 6220  | 105802  |
|  iRobot Corp. (a)(b)  | 15616  | 813437  |
|  Koss Corp. (a)(b)  | 4327  | 27693  |
|  Landsea Homes Corp. (a)  | 25172  | 138194  |
|  Legacy Housing Corp. (a)  | 13484  | 236240  |
|  LGI Homes, Inc. (a)(b)  | 13814  | 1372283  |
|  Lifetime Brands, Inc. (b)  | 13509  | 113611  |
|  Live Ventures, Inc. (a)(b)  | 1095  | 27709  |
|  Lovesac (a)(b)  | 8426  | 219497  |
|  Nephros, Inc. (a)  | 3085  | 3208  |
|  Newell Brands, Inc. (b)  | 230165  | 2985240  |
|  Nova LifeStyle, Inc. (a)(b)  | 6916  | 3526  |
|  Purple Innovation, Inc. (a)(b)  | 37566  | 189708  |
|  Singing Machine Co., Inc. (b)  | 2438  | 12604  |
|  Snap One Holdings Corp. (a)  | 40295  | 326792  |
|  Sonos, Inc. (a)  | 69375  | 1216144  |
|  Universal Electronics, Inc. (a)  | 7603  | 166278  |
|  Viomi Technology Co. Ltd. ADR Class A (a)  | 21467  | 19580  |
|  VOXX International Corp. (a)(b)  | 13480  | 148145  |
|  Vuzix Corp. (a)(b)  | 34442  | 143623  |
|  ZAGG, Inc. rights (a)(c)  | 14972  | 1347  |
|  |  | 11455992  |
| Internet & Direct Marketing Retail - 6.2%  |  |  |
|  1-800-FLOWERS.com, Inc. Class A (a)(b)  | 24871  | 210409  |
|  1stDibs.com, Inc. (a)(b)  | 17092  | 102894  |
|  Amazon.com, Inc. (a)  | 5800754  | 560004791  |
|  Baozun, Inc. sponsored ADR (a)  | 27489  | 119302  |
|  Betterware de Mexico SAPI de CV (b)  | 23570  | 160040  |
|  CarParts.com, Inc. (a)(b)  | 33968  | 184107  |
|  D-MARKET Electronic Services & Trading ADR (a)(b)  | 42209  | 29196  |
|  Dada Nexus Ltd. ADR (a)(b)  | 21030  | 131017  |
|  Digital Brands Group, Inc. (a)(b)  | 145  | 526  |
|  Duluth Holdings, Inc. (a)(b)  | 20657  | 180955  |
|  eBay, Inc.  | 318583  | 14476412  |
|  Etsy, Inc. (a)  | 72851  | 9622889  |
|  Future FinTech Group, Inc. (a)(b)  | 46446  | 16674  |
|  GigaCloud Technology, Inc. Class A (b)  | 17953  | 132314  |
|  Global-e Online Ltd. (a)(b)  | 88559  | 1910218  |
|  Groupon, Inc. (a)(b)  | 9986  | 83183  |
|  Hour Loop, Inc. (b)  | 19584  | 61102  |
|  iMedia Brands, Inc. (a)(b)  | 4159  | 2450  |
|  iPower, Inc. (a)(b)  | 20826  | 10119  |
|  JD.com, Inc. sponsored ADR  | 287954  | 16465210  |
|  Jowell Global Ltd. (a)(b)  | 14581  | 6270  |
|  Kidpik Corp. (b)  | 2938  | 2247  |
|  Lands' End, Inc. (a)  | 21391  | 247280  |
|  Liquidity Services, Inc. (a)  | 22490  | 375358  |
|  Lulu's Fashion Lounge Holdings, Inc. (b)  | 23329  | 89817  |
|  Lyft, Inc. (a)  | 201969  | 2266092  |
|  Meiwu Technology Co. Ltd. (a)(b)  | 41954  | 54540  |
|  MercadoLibre, Inc. (a)  | 28679  | 26699719  |
|  Moxian (BVI), Inc. (a)(b)  | 15637  | 13010  |
|  Newegg Commerce, Inc. (a)(b)  | 123193  | 224211  |
|  Nogin, Inc. (a)(b)  | 13833  | 11343  |
|  Oriental Culture Holding Ltd. (a)  | 19230  | 10807  |
|  Overstock.com, Inc. (a)(b)  | 23881  | 635712  |
|  Ozon Holdings PLC ADR (a)(b)(c)  | 50413  | 105900  |
|  PetMed Express, Inc. (b)  | 10954  | 216889  |
|  Pinduoduo, Inc. ADR (a)  | 266837  | 21891307  |
|  Poshmark, Inc. (a)  | 32903  | 586660  |
|  Qurate Retail, Inc. (b)  | 71062  | 584840  |
|  Qurate Retail, Inc. Series A  | 103153  | 242410  |
|  Remark Holdings, Inc. (a)(b)  | 77933  | 18704  |
|  Rent the Runway, Inc. Class A (a)(b)  | 5980  | 7953  |
|  RumbleON, Inc. Class B (a)  | 7222  | 55104  |
|  Secoo Holding Ltd. ADR (a)(b)  | 2632  | 4316  |
|  Stitch Fix, Inc. (a)(b)  | 68949  | 278554  |
|  The RealReal, Inc. (a)  | 93508  | 139327  |
|  Trxade Health, Inc. (a)(b)  | 15392  | 8696  |
|  Uxin Ltd. ADR (a)(b)  | 17215  | 46997  |
|  Vivid Seats, Inc. Class A (b)  | 51717  | 403393  |
|  Waitr Holdings, Inc. (a)(b)  | 7274  | 6043  |
|  Xometry, Inc. (a)(b)  | 26019  | 1098782  |
|  Yunji, Inc. ADR (a)  | 20622  | 17118  |
|  |  | 660253207  |
| Leisure Products - 0.1%  |  |  |
|  American Outdoor Brands, Inc. (a)(b)  | 7566  | 71574  |
|  AMMO, Inc. (a)(b)  | 66715  | 142770  |
|  BRP, Inc.  | 19963  | 1493831  |
|  Clarus Corp.  | 18975  | 157872  |
|  Escalade, Inc. (b)  | 7721  | 78059  |
|  Hasbro, Inc.  | 76308  | 4793669  |
|  JAKKS Pacific, Inc. (a)  | 7383  | 138948  |
|  Johnson Outdoors, Inc. Class A  | 5547  | 313738  |
|  Latham Group, Inc. (a)  | 35212  | 121481  |
|  Malibu Boats, Inc. Class A (a)  | 11640  | 671744  |
|  MasterCraft Boat Holdings, Inc. (a)  | 12347  | 317565  |
|  Mattel, Inc. (a)  | 196136  | 3575559  |
|  Peloton Interactive, Inc. Class A (a)(b)  | 169329  | 1926964  |
|  Smith & Wesson Brands, Inc. (b)  | 28528  | 335775  |
|  Vision Marine Technologies, Inc. (a)  | 5949  | 26830  |
|  |  | 14166379  |
| Multiline Retail - 0.2%  |  |  |
|  Dollar Tree, Inc. (a)  | 127258  | 19125605  |
|  Franchise Group, Inc. (b)  | 22084  | 575288  |
|  Ollie's Bargain Outlet Holdings, Inc. (a)  | 35458  | 2159392  |
|  Tuesday Morning Corp. (a)(b)  | 14694  | 1709  |
|  |  | 21861994  |
| Specialty Retail - 1.0%  |  |  |
|  Academy Sports & Outdoors, Inc.  | 46966  | 2370844  |
|  America's Car Mart, Inc. (a)(b)  | 3745  | 272486  |
|  Arhaus, Inc. (b)  | 40242  | 387530  |
|  Arko Corp. (b)  | 75986  | 716548  |
|  Bed Bath & Beyond, Inc. (a)(b)  | 35493  | 120676  |
|  Big 5 Sporting Goods Corp. (b)  | 11818  | 146661  |
|  Brilliant Earth Group, Inc. Class A (a)  | 5550  | 29304  |
|  CarLotz, Inc. Class A (a)(b)  | 309093  | 51773  |
|  Citi Trends, Inc. (a)(b)  | 5929  | 179174  |
|  Conn's, Inc. (a)(b)  | 16366  | 163005  |
|  DavidsTea, Inc. (a)  | 8243  | 6182  |
|  Destination XL Group, Inc. (a)  | 32101  | 213793  |
|  EVgo, Inc. Class A (a)(b)  | 38018  | 243315  |
|  Five Below, Inc. (a)  | 30513  | 4908321  |
|  GrowGeneration Corp. (a)(b)  | 43987  | 298672  |
|  Hibbett, Inc. (b)  | 7367  | 491084  |
|  JOANN, Inc. (b)  | 23229  | 116842  |
|  Kaixin Auto Holdings (a)(b)  | 90645  | 44416  |
|  Kirkland's, Inc. (a)(b)  | 7395  | 28397  |
|  Lazydays Holdings, Inc. (a)(b)  | 6139  | 85025  |
|  Leslie's, Inc. (a)(b)  | 104964  | 1532474  |
|  Monro, Inc. (b)  | 17865  | 812322  |
|  National Vision Holdings, Inc. (a)(b)  | 45468  | 1839635  |
|  O'Reilly Automotive, Inc. (a)  | 36022  | 31142460  |
|  OneWater Marine, Inc. Class A (a)  | 7834  | 256093  |
|  Petco Health & Wellness Co., Inc. (a)(b)  | 125762  | 1388412  |
|  Rent-A-Center, Inc.  | 35017  | 843560  |
|  Ross Stores, Inc.  | 199584  | 23485049  |
|  Shoe Carnival, Inc. (b)  | 16794  | 443530  |
|  Sleep Number Corp. (a)(b)  | 14174  | 414590  |
|  Smart Share Global Ltd. ADR (a)  | 5917  | 5030  |
|  Sportsman's Warehouse Holdings, Inc. (a)  | 25040  | 245893  |
|  The Children's Place, Inc. (a)  | 8107  | 287799  |
|  The ODP Corp. (a)  | 27379  | 1317751  |
|  Tile Shop Holdings, Inc.  | 26904  | 112997  |
|  Tractor Supply Co.  | 62207  | 14078066  |
|  TravelCenters of America LLC (a)  | 8015  | 409967  |
|  Ulta Beauty, Inc. (a)  | 28743  | 13360896  |
|  Urban Outfitters, Inc. (a)(b)  | 54234  | 1569532  |
|  Vroom, Inc. (a)(b)  | 133383  | 164061  |
|  Winmark Corp.  | 2110  | 506400  |
|  Zumiez, Inc. (a)(b)  | 11506  | 267515  |
|  |  | 105358080  |
| Textiles, Apparel & Luxury Goods - 0.4%  |  |  |
|  Allbirds, Inc. Class A (b)  | 51562  | 148499  |
|  Charles & Colvard Ltd. (a)  | 22010  | 19809  |
|  Columbia Sportswear Co.  | 35827  | 3209741  |
|  Crocs, Inc. (a)  | 37045  | 3741545  |
|  Crown Crafts, Inc.  | 9628  | 56709  |
|  Dogness (International) Corp. (a)  | 20518  | 18571  |
|  Ever-Glory International Group, Inc. (a)  | 13112  | 8523  |
|  Fossil Group, Inc. (a)  | 29540  | 140906  |
|  G-III Apparel Group Ltd. (a)  | 27453  | 593808  |
|  Lakeland Industries, Inc. (a)  | 4176  | 55666  |
|  lululemon athletica, Inc. (a)  | 69796  | 26544117  |
|  PLBY Group, Inc. (a)(b)  | 12468  | 45134  |
|  Rocky Brands, Inc.  | 4879  | 137978  |
|  Steven Madden Ltd.  | 45830  | 1582968  |
|  Superior Group of Companies, Inc. (b)  | 9905  | 99050  |
|  Toughbuilt Industries, Inc. (a)(b)  | 2250  | 5198  |
|  Vera Bradley, Inc. (a)  | 17686  | 67207  |
|  |  | 36475429  |
|  TOTAL CONSUMER DISCRETIONARY  |  | 1531069132  |
| CONSUMER STAPLES - 4.9%  |  |  |
| Beverages - 2.2%  |  |  |
|  Alkaline Water Co., Inc. (a)(b)  | 46022  | 8031  |
|  Celsius Holdings, Inc. (a)(b)  | 44020  | 4901187  |
|  Coca-Cola Bottling Co. Consolidated  | 4832  | 2376378  |
|  Coca-Cola European Partners PLC  | 263888  | 14009814  |
|  Eastside Distilling, Inc. (a)(b)  | 6163  | 1695  |
|  Keurig Dr. Pepper, Inc.  | 806783  | 31198299  |
|  MGP Ingredients, Inc. (b)  | 12465  | 1558873  |
|  Monster Beverage Corp. (a)  | 300510  | 30910459  |
|  National Beverage Corp. (b)  | 53052  | 2733770  |
|  PepsiCo, Inc.  | 783116  | 145275849  |
|  The Vita Coco Co., Inc. (a)(b)  | 31559  | 373659  |
|  Vintage Wine Estates, Inc. (a)(b)  | 37368  | 124062  |
|  Willamette Valley Vineyards, Inc. (a)  | 1065  | 6475  |
|  |  | 233478551  |
| Food & Staples Retailing - 1.6%  |  |  |
|  111, Inc. ADR (a)(b)  | 33100  | 98969  |
|  Andersons, Inc.  | 20649  | 794987  |
|  Bit Brother Ltd. (a)(b)  | 15078  | 4584  |
|  Casey's General Stores, Inc.  | 20433  | 4965628  |
|  Chefs' Warehouse Holdings (a)  | 21604  | 839315  |
|  China Jo-Jo Drugstores Holdings, Inc. (a)(b)  | 3930  | 7388  |
|  Costco Wholesale Corp.  | 252155  | 135974584  |
|  G Willi-Food International Ltd.  | 5646  | 90223  |
|  Grocery Outlet Holding Corp. (a)  | 54795  | 1658645  |
|  HF Foods Group, Inc. (a)  | 38952  | 172947  |
|  Ingles Markets, Inc. Class A  | 8837  | 893421  |
|  MedAvail Holdings, Inc. (a)(b)  | 18459  | 7736  |
|  Missfresh Ltd. ADR (a)(b)  | 625  | 963  |
|  PriceSmart, Inc.  | 18216  | 1294065  |
|  SpartanNash Co.  | 22023  | 723456  |
|  Sprouts Farmers Market LLC (a)  | 62788  | 2155512  |
|  Village Super Market, Inc. Class A (b)  | 6605  | 148877  |
|  Walgreens Boots Alliance, Inc.  | 493133  | 20465020  |
|  |  | 170296320  |
| Food Products - 1.0%  |  |  |
|  AgriFORCE Growing Systems Ltd. (a)(b)  | 17646  | 23469  |
|  Alico, Inc.  | 5485  | 169651  |
|  AppHarvest, Inc. (a)(b)  | 53353  | 48114  |
|  Arcadia Biosciences, Inc. (a)(b)  | 3696  | 1188  |
|  Barfresh Food Group, Inc. (a)  | 3883  | 4854  |
|  Beyond Meat, Inc. (a)(b)  | 25800  | 376422  |
|  Bridgford Foods Corp. (a)  | 3580  | 39129  |
|  Cal-Maine Foods, Inc.  | 24897  | 1450997  |
|  Calavo Growers, Inc.  | 11772  | 411549  |
|  Cresud S.A.C.I.F. y A. sponsored ADR (b)  | 30565  | 183084  |
|  Farmer Brothers Co. (a)  | 13797  | 79747  |
|  Farmmi, Inc. (a)(b)  | 4169  | 2293  |
|  Forafric Global PLC (a)(b)  | 11364  | 128300  |
|  Freshpet, Inc. (a)(b)  | 28067  | 1881050  |
|  Hostess Brands, Inc. Class A (a)  | 69302  | 1829573  |
|  J&J Snack Foods Corp.  | 11277  | 1849654  |
|  John B. Sanfilippo & Son, Inc.  | 5270  | 446316  |
|  Kalera PLC Class A (a)(b)  | 5152  | 773  |
|  Lancaster Colony Corp.  | 16021  | 3318590  |
|  Lifecore Biomedical (a)  | 22245  | 189305  |
|  Lifeway Foods, Inc. (a)(b)  | 9131  | 60995  |
|  Limoneira Co.  | 11551  | 148315  |
|  MamaMancini's Holdings, Inc. (a)(b)  | 12805  | 13061  |
|  Mission Produce, Inc. (a)  | 38524  | 612146  |
|  Mondelez International, Inc.  | 779642  | 52711596  |
|  Nuzee, Inc. (a)(b)  | 504772  | 165363  |
|  Oatly Group AB ADR (a)(b)  | 142119  | 231654  |
|  Origin Agritech Ltd. (a)(b)  | 9462  | 99919  |
|  Pilgrim's Pride Corp. (a)  | 134622  | 3521712  |
|  Pingtan Marine Enterprise Ltd. (a)(b)  | 62069  | 37167  |
|  RiceBran Technologies (a)(b)  | 2042  | 2246  |
|  Rocky Mountain Chocolate Factory, Inc. (a)  | 1651  | 10055  |
|  S&W Seed Co. (a)(b)  | 18677  | 20731  |
|  Seneca Foods Corp. Class A (a)  | 5752  | 369739  |
|  Sovos Brands, Inc. (a)  | 55871  | 803984  |
|  Steakholder Foods Ltd. ADR (a)(b)  | 3942  | 7293  |
|  Stryve Foods, Inc. (a)(b)  | 15166  | 13298  |
|  SunOpta, Inc. (a)(b)  | 67717  | 633154  |
|  Tattooed Chef, Inc. (a)(b)  | 50860  | 76799  |
|  TDH Holdings, Inc. (a)(b)  | 1828  | 4570  |
|  The Hain Celestial Group, Inc. (a)  | 48663  | 911945  |
|  The Kraft Heinz Co.  | 700335  | 27558182  |
|  The Simply Good Foods Co. (a)  | 54832  | 2187797  |
|  The Very Good Food Co., Inc. (a)(b)  | 42576  | 5109  |
|  Village Farms International, Inc. (a)(b)  | 42308  | 83770  |
|  Vital Farms, Inc. (a)  | 21819  | 311357  |
|  Westrock Coffee Holdings (a)(b)  | 8763  | 109450  |
|  Whole Earth Brands, Inc. Class A (a)  | 19675  | 85193  |
|  |  | 103230658  |
| Household Products - 0.1%  |  |  |
|  Central Garden & Pet Co. Class A (non-vtg.) (a)  | 36603  | 1430079  |
|  Reynolds Consumer Products, Inc. (b)  | 120924  | 3864731  |
|  WD-40 Co. (b)  | 7823  | 1310353  |
|  |  | 6605163  |
| Personal Products - 0.0%  |  |  |
|  DSwiss, Inc. (a)(b)(c)(d)  | 7648  | 1792  |
|  Flora Growth Corp. (a)(b)  | 20412  | 9390  |
|  Guardion Health Sciences, Inc. (a)(b)  | 26340  | 4583  |
|  Happiness Development Group Lt (a)  | 306  | 768  |
|  Inter Parfums, Inc.  | 18677  | 1779731  |
|  Jupiter Wellness, Inc. (a)(b)  | 21368  | 23291  |
|  Lifemd, Inc. (a)(b)  | 11075  | 26912  |
|  LifeVantage Corp.  | 9383  | 35092  |
|  Mannatech, Inc.  | 1514  | 33823  |
|  Natural Alternatives International, Inc. (a)(b)  | 4379  | 32186  |
|  Natural Health Trends Corp. (b)  | 3553  | 14461  |
|  Nature's Sunshine Products, Inc. (a)  | 13052  | 116163  |
|  Neptune Technologies & Bioressources, Inc. (a)  | 898  | 665  |
|  Olaplex Holdings, Inc. (a)(b)  | 365095  | 2179617  |
|  Shineco, Inc. (a)  | 3572  | 2661  |
|  The Beauty Health Co. (a)(b)  | 94997  | 1021218  |
|  The Honest Co., Inc. (a)(b)  | 93920  | 270490  |
|  Thorne HealthTech, Inc. (a)  | 13379  | 64219  |
|  United-Guardian, Inc.  | 2521  | 27958  |
|  Upexi, Inc. (a)(b)  | 8773  | 34566  |
|  Veru, Inc. (a)(b)  | 45307  | 257344  |
|  Waldencast PLC (a)(b)  | 11211  | 107401  |
|  Zivo Bioscience, Inc. (a)  | 3401  | 8911  |
|  |  | 6053242  |
| Tobacco - 0.0%  |  |  |
|  22nd Century Group, Inc. (a)(b)  | 102993  | 121532  |
|  TOTAL CONSUMER STAPLES  |  | 519785466  |
| ENERGY - 0.8%  |  |  |
| Energy Equipment & Services - 0.2%  |  |  |
|  Baker Hughes Co. Class A  | 577581  | 16761401  |
|  Championx Corp.  | 111772  | 3447048  |
|  CSI Compressco LP  | 68170  | 88962  |
|  DMC Global, Inc. (a)  | 9930  | 182613  |
|  ENGlobal Corp. (a)(b)  | 35026  | 34140  |
|  Geospace Technologies Corp. (a)(b)  | 17265  | 77175  |
|  Gulf Island Fabrication, Inc. (a)(b)  | 18749  | 101245  |
|  KLX Energy Services Holdings, Inc. (a)(b)  | 8196  | 129333  |
|  Mammoth Energy Services, Inc. (a)(b)  | 29614  | 178869  |
|  MIND Technology, Inc. (a)  | 28716  | 13385  |
|  NCS Multistage Holdings, Inc. (a)  | 2198  | 59346  |
|  Patterson-UTI Energy, Inc.  | 125863  | 2259241  |
|  Profire Energy, Inc. (a)  | 47414  | 52155  |
|  ProFrac Holding Corp.  | 27996  | 660146  |
|  Recon Technology Ltd. (a)(b)  | 15122  | 13826  |
|  Smart Sand, Inc. (a)  | 22511  | 43671  |
|  Weatherford International PLC (a)  | 38962  | 1690951  |
|  |  | 25793507  |
| Oil, Gas & Consumable Fuels - 0.6%  |  |  |
|  Aemetis, Inc. (a)(b)  | 18211  | 100343  |
|  Alliance Resource Partners LP  | 70985  | 1683054  |
|  Alto Ingredients, Inc. (a)  | 38730  | 135168  |
|  American Resources Corp. (a)(b)  | 86855  | 131151  |
|  Amplify Energy Corp. warrants 5/4/22 (a)(c)  | 717  | 0  |
|  APA Corp.  | 184096  | 8624898  |
|  Berry Corp.  | 49459  | 445626  |
|  Brooge Energy Ltd. (a)(b)  | 37918  | 193003  |
|  Calumet Specialty Products Partners LP (a)  | 49250  | 784553  |
|  Chesapeake Energy Corp. (b)  | 68295  | 7068533  |
|  Chord Energy Corp.  | 23637  | 3605352  |
|  Clean Energy Fuels Corp. (a)  | 121128  | 818825  |
|  Diamondback Energy, Inc.  | 99109  | 14670114  |
|  Dorchester Minerals LP  | 21696  | 656304  |
|  Ecoark Holdings, Inc. (a)  | 13299  | 8912  |
|  Epsilon Energy Ltd.  | 6275  | 46184  |
|  EzFill Holdings, Inc. (a)(b)  | 28590  | 11713  |
|  Gevo, Inc. (a)(b)  | 109249  | 238163  |
|  Golar LNG Ltd. (a)  | 59599  | 1494147  |
|  Green Plains Partners LP  | 18721  | 231953  |
|  Green Plains, Inc. (a)(b)  | 31051  | 1073123  |
|  Hallador Energy Co. (a)  | 23353  | 238201  |
|  HighPeak Energy, Inc. (b)  | 62566  | 1500333  |
|  Imperial Petroleum, Inc. (a)(b)  | 89993  | 32065  |
|  Lightbridge Corp. (a)(b)  | 12328  | 60037  |
|  Marine Petroleum Trust  | 339  | 2641  |
|  Martin Midstream Partners LP  | 33068  | 108132  |
|  National Energy Services Reunited Corp. (a)  | 66335  | 423881  |
|  New Fortress Energy, Inc.  | 119039  | 6059085  |
|  Nextdecade Corp. (a)(b)  | 149959  | 814277  |
|  OPAL Fuels, Inc. (a)(b)  | 17077  | 162232  |
|  PDC Energy, Inc.  | 53220  | 3955310  |
|  Plains All American Pipeline LP  | 394723  | 4902460  |
|  Plains GP Holdings LP Class A  | 107827  | 1426551  |
|  PrimeEnergy Corp. (a)(b)  | 938  | 76672  |
|  Ranger Oil Corp.  | 12018  | 523624  |
|  Stabilis Solutions, Inc. (a)  | 5194  | 36150  |
|  StealthGas, Inc. (a)  | 39172  | 117908  |
|  Top Ships, Inc. (a)(b)  | 2008  | 6064  |
|  TORM PLC (b)  | 45179  | 1264560  |
|  U.S. Energy Corp. (b)  | 15098  | 39859  |
|  Uranium Royalty Corp. (a)(b)  | 42856  | 125568  |
|  Vertex Energy, Inc. (a)(b)  | 41719  | 345851  |
|  Viper Energy Partners LP  | 40566  | 1339895  |
|  |  | 65582475  |
|  TOTAL ENERGY  |  | 91375982  |
| FINANCIALS - 5.1%  |  |  |
| Banks - 2.0%  |  |  |
|  1st Source Corp.  | 12820  | 732022  |
|  ACNB Corp.  | 4529  | 177990  |
|  Amalgamated Financial Corp.  | 18900  | 504063  |
|  Amerant Bancorp, Inc. Class A  | 21076  | 620899  |
|  American National Bankshares, Inc.  | 6531  | 251901  |
|  Ameris Bancorp  | 46800  | 2474784  |
|  Ames National Corp. (b)  | 6067  | 138934  |
|  Arrow Financial Corp.  | 10317  | 362849  |
|  Atlantic Union Bankshares Corp.  | 43652  | 1557067  |
|  Auburn National Bancorp., Inc.  | 551  | 12420  |
|  BancFirst Corp.  | 18889  | 1925545  |
|  Bancorp, Inc., Delaware (a)  | 35449  | 1062407  |
|  Bank First National Corp. (b)  | 3739  | 355317  |
|  Bank of Marin Bancorp  | 11894  | 426876  |
|  Bank OZK  | 64274  | 2966245  |
|  Bank7 Corp.  | 3616  | 100525  |
|  BankFinancial Corp.  | 14628  | 144232  |
|  Bankwell Financial Group, Inc. (b)  | 4285  | 126793  |
|  Banner Corp.  | 18237  | 1287897  |
|  BayCom Corp. (b)  | 3947  | 74835  |
|  BCB Bancorp, Inc.  | 9394  | 177077  |
|  BOK Financial Corp.  | 38544  | 4035942  |
|  Brookline Bancorp, Inc., Delaware  | 42470  | 603923  |
|  Business First Bancshares, Inc.  | 8715  | 204977  |
|  C & F Financial Corp.  | 2765  | 154868  |
|  California Bancorp, Inc. (a)(b)  | 2203  | 54965  |
|  Cambridge Bancorp  | 2788  | 247881  |
|  Camden National Corp.  | 8189  | 358514  |
|  Capital Bancorp, Inc.  | 5877  | 145867  |
|  Capital City Bank Group, Inc.  | 16718  | 588474  |
|  Capstar Financial Holdings, Inc.  | 13933  | 249401  |
|  Carter Bankshares, Inc. (a)  | 17756  | 329196  |
|  Cathay General Bancorp  | 43472  | 2020144  |
|  CB Financial Services, Inc.  | 591  | 13286  |
|  Central Valley Community Bancorp  | 8707  | 177623  |
|  Chemung Financial Corp.  | 4490  | 213275  |
|  ChoiceOne Financial Services, Inc.  | 2947  | 66897  |
|  Citizens & Northern Corp. (b)  | 4121  | 101129  |
|  Citizens Community Bancorp, Inc.  | 6202  | 90177  |
|  Citizens Holding Co.  | 2179  | 30419  |
|  City Holding Co.  | 8728  | 889558  |
|  Civista Bancshares, Inc.  | 12037  | 275166  |
|  CNB Financial Corp., Pennsylvania  | 11686  | 298577  |
|  Coastal Financial Corp. of Washington (a)  | 7239  | 361371  |
|  Codorus Valley Bancorp, Inc.  | 7465  | 176846  |
|  Colony Bankcorp, Inc.  | 7282  | 99836  |
|  Columbia Banking Systems, Inc. (b)  | 46065  | 1568974  |
|  Commerce Bancshares, Inc.  | 69107  | 5177496  |
|  Community Financial Corp.  | 4047  | 162082  |
|  Community Trust Bancorp, Inc.  | 8039  | 385148  |
|  ConnectOne Bancorp, Inc. (b)  | 23646  | 620471  |
|  CrossFirst Bankshares, Inc. (a)  | 29438  | 408305  |
|  CVB Financial Corp.  | 76652  | 2198379  |
|  DILA Capital Acquisition Corp. Class A (a)  | 4041  | 40531  |
|  Dime Community Bancshares, Inc.  | 22773  | 812313  |
|  Eagle Bancorp Montana, Inc.  | 2880  | 51264  |
|  Eagle Bancorp, Inc.  | 17724  | 835864  |
|  East West Bancorp, Inc.  | 79134  | 5555998  |
|  Eastern Bankshares, Inc.  | 100469  | 1970197  |
|  Enterprise Bancorp, Inc.  | 7478  | 261580  |
|  Enterprise Financial Services Corp.  | 22406  | 1172730  |
|  Equity Bancshares, Inc.  | 9183  | 335730  |
|  Esquire Financial Holdings, Inc.  | 4195  | 188104  |
|  Farmers & Merchants Bancorp, Inc. (b)  | 8160  | 234029  |
|  Farmers National Banc Corp.  | 18770  | 285492  |
|  Fidelity D & D Bancorp, Inc.  | 2330  | 113238  |
|  Fifth Third Bancorp  | 396097  | 14402087  |
|  Financial Institutions, Inc.  | 9689  | 245325  |
|  First Bancorp, North Carolina  | 21088  | 1025509  |
|  First Bancshares, Inc.  | 9721  | 332361  |
|  First Bank Hamilton New Jersey (b)  | 14532  | 222921  |
|  First Busey Corp.  | 27899  | 727327  |
|  First Business Finance Services, Inc.  | 4740  | 181637  |
|  First Capital, Inc. (b)  | 2233  | 54709  |
|  First Citizens Bancshares, Inc. (b)  | 7685  | 6274495  |
|  First Community Bankshares, Inc. (b)  | 10669  | 394220  |
|  First Community Corp.  | 3875  | 79748  |
|  First Financial Bancorp, Ohio (b)  | 55952  | 1478811  |
|  First Financial Bankshares, Inc.  | 80098  | 2959621  |
|  First Financial Corp., Indiana  | 8773  | 421718  |
|  First Financial Northwest, Inc.  | 9975  | 151421  |
|  First Foundation, Inc.  | 30319  | 424769  |
|  First Guaranty Bancshares, Inc. (b)  | 8053  | 201244  |
|  First Hawaiian, Inc.  | 72880  | 1934964  |
|  First Internet Bancorp  | 8345  | 216636  |
|  First Interstate Bancsystem, Inc.  | 64950  | 2833119  |
|  First Merchants Corp.  | 31340  | 1385541  |
|  First Mid-Illinois Bancshares, Inc.  | 11244  | 389605  |
|  First Northwest Bancorp  | 7546  | 110398  |
|  First of Long Island Corp.  | 15039  | 292509  |
|  First Savings Financial Group, Inc.  | 2781  | 62433  |
|  First U.S. Bancshares, Inc.  | 3641  | 30949  |
|  First Western Financial, Inc. (a)  | 3616  | 109926  |
|  Five Star Bancorp  | 9325  | 251775  |
|  Flushing Financial Corp.  | 19436  | 405435  |
|  FNCB Bancorp, Inc.  | 3698  | 29436  |
|  Franklin Financial Services Corp.  | 854  | 26303  |
|  Fulton Financial Corp.  | 96952  | 1802338  |
|  FVCBankcorp, Inc. (a)(b)  | 5834  | 115338  |
|  German American Bancorp, Inc.  | 16332  | 650994  |
|  Great Southern Bancorp, Inc.  | 7786  | 487793  |
|  Grupo Financiero Galicia SA sponsored ADR (b)  | 29288  | 237233  |
|  Guaranty Bancshares, Inc. Texas  | 8980  | 319688  |
|  Hancock Whitney Corp.  | 50242  | 2755271  |
|  Hanmi Financial Corp.  | 18233  | 493203  |
|  HarborOne Bancorp, Inc.  | 36797  | 538340  |
|  Hawthorn Bancshares, Inc. (b)  | 2866  | 60530  |
|  HBT Financial, Inc.  | 16600  | 326190  |
|  Heartland Financial U.S.A., Inc.  | 29421  | 1435451  |
|  Heritage Commerce Corp. (b)  | 41991  | 596692  |
|  Heritage Financial Corp., Washington  | 21942  | 721892  |
|  HomeStreet, Inc.  | 11829  | 322932  |
|  HomeTrust Bancshares, Inc.  | 11346  | 290458  |
|  Hope Bancorp, Inc.  | 64741  | 881772  |
|  Horizon Bancorp, Inc. Indiana  | 24746  | 402370  |
|  Huntington Bancshares, Inc.  | 829284  | 12837316  |
|  Independent Bank Corp.  | 26861  | 2431458  |
|  Independent Bank Corp.  | 10908  | 267682  |
|  Independent Bank Group, Inc.  | 23847  | 1572471  |
|  Inter & Co., Inc. Class A (a)(b)  | 76976  | 188591  |
|  International Bancshares Corp.  | 38617  | 2034344  |
|  Investar Holding Corp.  | 8715  | 192950  |
|  John Marshall Bankcorp, Inc. (b)  | 7918  | 229305  |
|  Lakeland Bancorp, Inc.  | 32751  | 611789  |
|  Lakeland Financial Corp.  | 14621  | 1154474  |
|  Landmark Bancorp, Inc. (b)  | 2919  | 75339  |
|  LCNB Corp.  | 12147  | 221561  |
|  Limestone Bancorp, Inc.  | 621  | 16022  |
|  Live Oak Bancshares, Inc. (b)  | 24006  | 800600  |
|  Logistics Innovation Technologies Corp. Class A (a)  | 22127  | 218393  |
|  Macatawa Bank Corp.  | 20908  | 232288  |
|  Mainstreet Bancshares, Inc.  | 1715  | 49564  |
|  Mercantile Bank Corp.  | 10866  | 378245  |
|  Meridian Bank/Malvern, PA  | 1866  | 62940  |
|  Metrocity Bankshares, Inc.  | 11608  | 261180  |
|  Mid Penn Bancorp, Inc.  | 7980  | 263340  |
|  Middlefield Banc Corp.  | 1133  | 32404  |
|  Midland States Bancorp, Inc.  | 11372  | 306021  |
|  MidWestOne Financial Group, Inc.  | 11723  | 409015  |
|  MVB Financial Corp.  | 5314  | 126898  |
|  National Bankshares, Inc.  | 4034  | 158536  |
|  NBT Bancorp, Inc. (b)  | 24469  | 1129489  |
|  Northeast Bank  | 7547  | 319540  |
|  Northrim Bancorp, Inc.  | 5057  | 281220  |
|  Northwest Bancshares, Inc. (b)  | 56561  | 864818  |
|  Norwood Financial Corp.  | 3432  | 109755  |
|  Oak Valley Bancorp Oakdale California (b)  | 5385  | 105061  |
|  OceanFirst Financial Corp.  | 33684  | 786858  |
|  Old National Bancorp, Indiana (b)  | 158691  | 3032585  |
|  Old Point Financial Corp.  | 2955  | 62705  |
|  Old Second Bancorp, Inc.  | 25984  | 453681  |
|  OptimumBank Holdings, Inc. (a)  | 3813  | 16930  |
|  Orange County Bancorp, Inc. (b)  | 1054  | 49917  |
|  Origin Bancorp, Inc.  | 13756  | 562896  |
|  Orrstown Financial Services, Inc.  | 7486  | 201448  |
|  Pacific Premier Bancorp, Inc. (b)  | 54299  | 2006348  |
|  PacWest Bancorp  | 66545  | 1738155  |
|  Parke Bancorp, Inc.  | 4103  | 89240  |
|  Partners Bancorp  | 4331  | 37203  |
|  Pathward Financial, Inc.  | 17376  | 756377  |
|  Patriot National Bancorp, Inc. (a)(b)  | 1781  | 18273  |
|  PCB Bancorp  | 9838  | 183184  |
|  PCSB Financial Corp.  | 10335  | 206493  |
|  Peapack-Gladstone Financial Corp.  | 10114  | 416899  |
|  Penns Woods Bancorp, Inc.  | 4912  | 127024  |
|  Peoples Bancorp of North Carolina (b)  | 3497  | 103931  |
|  Peoples Bancorp, Inc.  | 18541  | 556230  |
|  Peoples Financial Services Corp. (b)  | 4449  | 253326  |
|  Pinnacle Financial Partners, Inc.  | 47009  | 3943585  |
|  Plumas Bancorp  | 1220  | 43310  |
|  Popular, Inc.  | 41428  | 3025073  |
|  Preferred Bank, Los Angeles  | 7653  | 578490  |
|  Premier Financial Corp.  | 24001  | 700349  |
|  Primis Financial Corp. (b)  | 16511  | 203911  |
|  Professional Holdings Corp. (A Shares) (a)  | 9235  | 276773  |
|  QCR Holdings, Inc.  | 8225  | 432717  |
|  RBB Bancorp  | 8755  | 196725  |
|  Red River Bancshares, Inc.  | 3386  | 177765  |
|  Renasant Corp.  | 30122  | 1228074  |
|  Republic Bancorp, Inc., Kentucky Class A  | 10388  | 457799  |
|  Republic First Bancorp, Inc. (a)(b)  | 41243  | 105170  |
|  Richmond Mutual Bancorp., Inc.  | 1852  | 23928  |
|  Riverview Bancorp, Inc.  | 15015  | 113964  |
|  S&T Bancorp, Inc.  | 26065  | 975352  |
|  Salisbury Bancorp, Inc.  | 3260  | 95502  |
|  Sandy Spring Bancorp, Inc. (b)  | 26534  | 923914  |
|  SB Financial Group, Inc.  | 4710  | 77715  |
|  Seacoast Banking Corp., Florida (b)  | 34186  | 1175315  |
|  Shore Bancshares, Inc. (b)  | 11308  | 225142  |
|  Sierra Bancorp  | 9675  | 209367  |
|  Signature Bank  | 36799  | 5133461  |
|  Simmons First National Corp. Class A  | 86863  | 2016090  |
|  SmartFinancial, Inc.  | 10154  | 304417  |
|  Sound Financial Bancorp, Inc.  | 1189  | 47025  |
|  South Plains Financial, Inc.  | 9325  | 288702  |
|  Southern First Bancshares, Inc. (a)  | 4670  | 231165  |
|  Southern States Bancshares, Inc. (b)  | 3439  | 100041  |
|  Southside Bancshares, Inc. (b)  | 16588  | 602808  |
|  Southstate Corp.  | 42169  | 3704547  |
|  Stellar Bancorp, Inc. (b)  | 32804  | 1109103  |
|  Stock Yards Bancorp, Inc.  | 19408  | 1436580  |
|  Summit Financial Group, Inc.  | 11557  | 327757  |
|  Summit State Bank (b)  | 3743  | 61385  |
|  SVB Financial Group (a)  | 32643  | 7565995  |
|  Texas Capital Bancshares, Inc. (a)  | 28839  | 1730052  |
|  The Bank of Princeton (b)  | 4666  | 151878  |
|  The First Bancorp, Inc.  | 6787  | 213383  |
|  Third Coast Bancshares, Inc.  | 9897  | 194377  |
|  TowneBank  | 42448  | 1371070  |
|  Trico Bancshares  | 18864  | 1028088  |
|  Triumph Bancorp, Inc. (a)  | 13714  | 819549  |
|  Trustmark Corp.  | 33488  | 1224991  |
|  UMB Financial Corp.  | 26643  | 2278509  |
|  Umpqua Holdings Corp.  | 122454  | 2482143  |
|  Union Bankshares, Inc. (b)  | 2283  | 56390  |
|  United Bankshares, Inc., West Virginia (b)  | 74900  | 3212461  |
|  United Community Bank, Inc.  | 58004  | 2260416  |
|  United Security Bancshares, California  | 1456  | 10265  |
|  Unity Bancorp, Inc.  | 6284  | 179157  |
|  Univest Corp. of Pennsylvania  | 13955  | 393671  |
|  USCB Financial Holdings, Inc. (a)  | 3294  | 43744  |
|  Valley National Bancorp  | 326205  | 4129755  |
|  Veritex Holdings, Inc.  | 33332  | 1088623  |
|  VersaBank  | 1224  | 8176  |
|  Virginia National Bankshares C (b)  | 1549  | 54339  |
|  Washington Federal, Inc.  | 37556  | 1324600  |
|  Washington Trust Bancorp, Inc.  | 8141  | 405096  |
|  WesBanco, Inc.  | 35638  | 1441557  |
|  West Bancorp., Inc.  | 9814  | 235929  |
|  Westamerica Bancorp.  | 15600  | 963300  |
|  Wintrust Financial Corp.  | 31710  | 2899245  |
|  Zions Bancorp NA  | 83138  | 4308211  |
|  |  | 211972655  |
| Capital Markets - 1.6%  |  |  |
|  ABG Acquisition Corp. I Class A (a)  | 15211  | 152566  |
|  AGM Group Holdings, Inc. (a)(b)  | 12918  | 20410  |
|  ARYA Sciences Acquisition Corp. IV Class A (a)(b)  | 7820  | 78435  |
|  ARYA Sciences Acquisition Corp. V (a)  | 3281  | 32646  |
| B. Riley Financial, Inc. (b)  | 15733  | 690993  |
|  Belong Acquisition Corp. (a)  | 2319  | 23213  |
|  BGC Partners, Inc. Class A  | 186493  | 803785  |
|  Blucora, Inc. (a)  | 30712  | 769336  |
|  Capital Southwest Corp.  | 11251  | 204093  |
|  Carlyle Group LP  | 201669  | 6286023  |
|  Cartesian Growth Corp. Class A (a)(b)  | 15786  | 155808  |
|  Chavant Capital Acquisition Corp. (a)  | 3004  | 30461  |
|  Clarim Acquisition Corp. Class A (a)  | 10654  | 107179  |
|  CME Group, Inc.  | 204678  | 36125667  |
|  Coinbase Global, Inc. (a)(b)  | 101669  | 4649323  |
|  Colicity, Inc. (a)  | 14252  | 143233  |
|  Coliseum Acquisition Corp. Class A (a)  | 1078  | 10758  |
|  Compass Digital Acquisition Corp. (a)  | 13835  | 137174  |
|  CONX Corp. Class A (a)(b)  | 52880  | 530386  |
|  Cowen Group, Inc. Class A  | 16234  | 627606  |
|  Crescent Capital BDC, Inc. (b)  | 12883  | 180104  |
|  Deep Lake Capital Acquisition Corp. Class A (a)  | 16837  | 169380  |
|  Diamond Hill Investment Group, Inc.  | 1539  | 273880  |
|  Eqonex Ltd. (a)(b)  | 13223  | 463  |
|  Fintech Acquisition Corp. V (a)  | 13427  | 134941  |
|  Focus Financial Partners, Inc. Class A (a)  | 42754  | 1631493  |
|  Forum Merger IV Corp. (a)(b)  | 20165  | 200843  |
|  Freedom Holding Corp. (a)(b)  | 34184  | 2156669  |
|  Frontier Acquisition Corp. (a)  | 6646  | 66693  |
|  Frontier Investment Corp. Class A (a)  | 2054  | 20478  |
|  FTAC Parnassus Acquisition Corp. Class A (a)  | 18931  | 188363  |
|  Futu Holdings Ltd. ADR (a)(b)  | 39748  | 2444105  |
|  GCM Grosvenor, Inc. Class A (b)  | 32247  | 282806  |
|  Glass Houses Acquisition Corp. Class A (a)  | 8758  | 88105  |
|  Global Consumer Acquisition Corp. (a)(b)  | 10041  | 92779  |
|  Golden Arrow Merger Corp. Class A (a)  | 14830  | 148893  |
|  Goldenbridge Acquisition Ltd. (a)(b)  | 7095  | 72795  |
|  Good Works II Acquisition Corp. (a)  | 1091  | 10725  |
|  Gores Holdings VIII, Inc. Class A (a)  | 13407  | 133400  |
|  Gores Technology Partners II, Inc. Class A (a)  | 59362  | 592433  |
|  Gores Technology Partners, Inc. Class A (a)  | 27380  | 272705  |
|  Hamilton Lane, Inc. Class A  | 20275  | 1497917  |
|  Hennessy Advisors, Inc. (b)  | 4729  | 43034  |
|  Heritage Global, Inc. (a)(b)  | 28350  | 68040  |
|  Horizon Technology Finance Corp.  | 7992  | 105095  |
|  Hudson Executive Investment Corp. III Class A (a)  | 54449  | 548301  |
|  Hywin Holdings Ltd. ADR (a)(b)  | 6913  | 41063  |
|  IG Acquisition Corp. Class A (a)  | 41208  | 412904  |
|  Interactive Brokers Group, Inc.  | 57514  | 4618374  |
|  Investcorp Credit Management BDC, Inc.  | 16938  | 66566  |
|  Itiquira Acquisition Corp. Class A (a)  | 9673  | 97117  |
|  Jaguar Global Growth Corp. I Class A (a)  | 17091  | 173474  |
|  JOFF Fintech Acquisition Corp. Class A (a)  | 50245  | 505465  |
|  Kairos Acquisition Corp. Class A (a)  | 22423  | 225351  |
|  Kernel Group Holdings, Inc. (a)(b)  | 21554  | 216402  |
|  Khosla Ventures Acquisition Co. (a)  | 27782  | 276709  |
|  KINS Technology Group, Inc. Class A (a)  | 28603  | 289176  |
|  Kismet Acquisition Two Corp. (a)  | 7900  | 79000  |
|  KL Acquisition Corp. Class A (a)  | 18259  | 183868  |
|  Lion Group Holding Ltd. ADR (a)(b)  | 11889  | 16050  |
|  Logan Ridge Finance Corp. (a)(b)  | 3628  | 76333  |
|  LPL Financial  | 45022  | 10657158  |
|  Magic Empire Global Ltd. (b)  | 2805  | 6311  |
|  MarketAxess Holdings, Inc.  | 21449  | 5746616  |
|  MarketWise, Inc. Class A (a)(b)  | 13610  | 25859  |
|  Model Performance Acquisition Corp. (a)(b)  | 2807  | 29333  |
|  Morningstar, Inc.  | 24242  | 5942441  |
|  Mount Rainier Acquisition Corp. (a)  | 4225  | 43053  |
|  NASDAQ, Inc.  | 275691  | 18873806  |
|  New Mountain Finance Corp.  | 53270  | 680258  |
|  Newtek Business Services Corp. (b)  | 13878  | 262017  |
|  Northern Trust Corp.  | 116815  | 10876645  |
|  Open Lending Corp. (a)  | 54243  | 383498  |
|  Panacea Acquisition Corp. II (a)  | 10372  | 102994  |
|  Pathfinder Acquisition Corp. (a)  | 17794  | 177228  |
|  Patria Investments Ltd.  | 31353  | 427968  |
|  Perella Weinberg Partners Class A  | 23081  | 220885  |
|  PhenixFIN Corp. (b)  | 762  | 26099  |
|  Pine Technology Acquisition Corp. Class A (a)  | 40041  | 399209  |
|  Pioneer Merger Corp. Class A (a)  | 65628  | 660874  |
|  Portage Fintech Acquisition Corp. Class A (a)  | 11581  | 115694  |
|  Progress Acquisition Corp. Class A (a)(b)  | 13405  | 135391  |
|  Puhui Wealth Investment Management Co. Ltd. (a)  | 11943  | 5255  |
|  Puyi, Inc. ADR (a)(b)  | 12308  | 87141  |
|  Robinhood Markets, Inc. (a)(b)  | 434881  | 4170509  |
|  Runway Growth Finance Corp. (b)  | 18253  | 219401  |
|  ScION Tech Growth II Class A (a)  | 20634  | 207578  |
|  SEI Investments Co.  | 73307  | 4565560  |
|  Senior Connect Acquisition Corp. I Class A (a)  | 50774  | 510279  |
|  Shelter Acquisition Corp. I Class A (a)  | 3618  | 36325  |
|  Siebert Financial Corp. (a)(b)  | 14080  | 21965  |
|  Silvercrest Asset Management Group Class A (b)  | 8360  | 158004  |
|  StepStone Group, Inc. Class A  | 38064  | 1141159  |
|  StoneX Group, Inc. (a)  | 11264  | 1142958  |
|  Summit Healthcare Acquisition Corp. Class A (a)  | 9526  | 95069  |
|  SVF Investment Corp. 2 (a)  | 26630  | 267099  |
| T. Rowe Price Group, Inc.  | 128963  | 16108768  |
|  TCV Acquisition Corp. Class A (a)  | 38580  | 383871  |
|  Tio Tech A Class A (a)  | 16841  | 168578  |
|  Top Financial Group Ltd. (b)  | 19596  | 91317  |
|  TPG, Inc. (b)  | 39979  | 1331301  |
|  Tradeweb Markets, Inc. Class A  | 61730  | 3793926  |
|  Trinity Capital, Inc. (b)  | 14443  | 156995  |
|  Twelve Seas Investment Co. II (a)  | 11364  | 113413  |
|  U.S. Global Investors, Inc. Class A  | 8407  | 23708  |
|  Up Fintech Holdings Ltd. ADR (a)(b)  | 68253  | 354233  |
|  Value Line, Inc. (b)  | 5984  | 335104  |
|  Velocity Acquisition Corp. Class A (a)  | 8116  | 81566  |
|  Victory Capital Holdings, Inc.  | 41611  | 1206719  |
|  Vinci Partners Investments Ltd. (b)  | 27294  | 272667  |
|  Virtu Financial, Inc. Class A  | 59093  | 1310683  |
|  Virtus Investment Partners, Inc.  | 4472  | 867300  |
|  XP, Inc. Class A (a)  | 257445  | 4507862  |
|  |  | 169811037  |
| Consumer Finance - 0.2%  |  |  |
|  360 DigiTech, Inc. ADR  | 75999  | 1192424  |
|  7GC & Co. Holdings, Inc. Class A (a)  | 32674  | 327720  |
|  Atlanticus Holdings Corp. (a)(b)  | 9306  | 268013  |
|  Consumer Portfolio Services, Inc. (a)(b)  | 14707  | 126774  |
|  Credit Acceptance Corp. (a)(b)  | 7311  | 3465122  |
|  Encore Capital Group, Inc. (a)(b)  | 13454  | 678082  |
|  EZCORP, Inc. (non-vtg.) Class A (a)  | 28924  | 289818  |
|  FirstCash Holdings, Inc.  | 27895  | 2618225  |
|  Jiayin Group, Inc. ADR (a)(b)  | 5761  | 11580  |
|  Katapult Holdings, Inc. (a)(b)  | 46564  | 55877  |
|  LendingTree, Inc. (a)  | 12323  | 295136  |
|  LexinFintech Holdings Ltd. ADR (a)  | 73996  | 133933  |
|  Medallion Financial Corp. (b)  | 10141  | 75550  |
|  Mogo, Inc. (a)(b)  | 22529  | 13292  |
|  Navient Corp.  | 83476  | 1383197  |
|  NerdWallet, Inc.  | 28927  | 367373  |
|  Nicholas Financial, Inc. (a)  | 5880  | 38573  |
|  Oportun Financial Corp. (a)  | 16861  | 93410  |
|  Pintec Technology Holdings Ltd. ADR (a)(b)  | 4579  | 1677  |
|  PRA Group, Inc. (a)  | 22082  | 759179  |
|  Senmiao Technology Ltd. (a)(b)  | 1673  | 1489  |
|  SLM Corp.  | 152212  | 2657622  |
|  SoFi Technologies, Inc. (a)(b)  | 516239  | 2493434  |
|  Upstart Holdings, Inc. (a)(b)  | 40964  | 800846  |
|  World Acceptance Corp. (a)(b)  | 3875  | 274776  |
|  |  | 18423122  |
| Diversified Financial Services - 0.4%  |  |  |
|  10X Capital Venture Acquisition Corp. II (a)  | 12375  | 122636  |
|  26 Capital Acquisition Corp. Class A (a)  | 18108  | 181804  |
|  7 Acquisition Corp. Class A (a)  | 4692  | 47999  |
|  8i Acquisition 2 Corp. (a)(b)  | 2778  | 8001  |
|  A SPAC I Acquisition Corp. (a)  | 1374  | 13960  |
|  A SPAC II Acquisition Corp. (a)  | 13668  | 138320  |
|  A-Mark Precious Metals, Inc.  | 13443  | 463784  |
|  Acacia Research Corp. (a)  | 26315  | 108681  |
|  Accretion Acquisition Corp. (a)  | 31080  | 311111  |
|  ACE Convergence Acquisition Corp. Class A (a)(b)  | 15037  | 57592  |
|  Ace Global Business Acquisition Ltd. (a)  | 1698  | 17982  |
|  Achari Ventures Holdings Corp. I (a)  | 6078  | 61813  |
|  Aequi Acquisition Corp. Class A (a)(b)  | 19142  | 188932  |
|  Aesther Healthcare Acquisition Corp. Class A (a)  | 2871  | 29600  |
|  Aetherium Acquisition Corp. Class A (a)  | 2757  | 27901  |
|  AF Acquisition Corp. Class A (a)  | 3090  | 31085  |
|  Agba Group Holding Ltd. (a)(b)  | 972  | 2867  |
|  Agile Growth Corp. Class A (a)  | 11857  | 118807  |
|  Ahren Acquisition Corp. Class A (a)  | 20270  | 206551  |
|  Alerus Financial Corp.  | 9517  | 225172  |
|  Alpha Partners Technology Merger Corp. (a)  | 7353  | 73236  |
|  Alpine Acquisition Corp. (a)  | 1573  | 16186  |
|  AltEnergy Acquisition Corp. Class A (a)  | 6664  | 67573  |
|  Altitude Acquisition Corp. Class A (a)(b)  | 41617  | 412008  |
|  AMCI Acquisition Corp. II (a)  | 1196  | 11816  |
|  American Acquisition Opportunity, Inc. Class A (a)(b)  | 2024  | 20220  |
|  Anthemis Digital Acquisitions I Corp. (a)  | 6810  | 69632  |
|  Anzu Special Acquisition Corp. I Class A (a)  | 19079  | 190599  |
|  APx Acquisition Corp. I (a)  | 4358  | 44626  |
|  Arbor Rapha Capital Bioholding Corp. I (a)  | 8774  | 90197  |
|  Arena Fortify Acquisition Corp. Class A (a)  | 15078  | 154700  |
|  Argus Capital Corp. Class A (a)  | 18585  | 190310  |
|  Aries I Acquisition Corp. Class A (a)  | 5956  | 60811  |
|  Armada Acquisition Corp. I (a)  | 5183  | 51726  |
|  Arogo Capital Acquisition Corp. Class A (a)  | 1679  | 16773  |
|  Arrowroot Acquisition Corp. Class A (a)  | 14007  | 139510  |
|  Artemis Strategic Investment Corp. (a)  | 10298  | 103134  |
|  Astrea Acquisition Corp. Class A (a)  | 10590  | 106218  |
|  Athlon Acquisition Corp. (a)  | 20350  | 204111  |
|  Atlantic Coastal Acquisition Corp. Class A (a)  | 24695  | 246209  |
|  Atlantic Coastal Acquisition Corp. II (a)  | 27493  | 277954  |
|  Aurora Acquisition Corp. Class A (a)  | 11702  | 116669  |
|  Aurora Technology Acquisition Corp. Class A (a)(b)  | 9115  | 92426  |
|  Authentic Equity Acquisition Corp. (a)  | 8207  | 82562  |
|  Avalon Acquisition, Inc. Class A (a)  | 33099  | 334962  |
|  AxonPrime Infrastructure Acquisition Corp. (a)  | 3754  | 36864  |
| B. Riley Principal 250 Merger Corp. (a)  | 3432  | 33908  |
|  Banner Acquisition Corp. (a)  | 5512  | 55120  |
|  Better World Acquisition Corp. (a)  | 3600  | 37476  |
|  Big Sky Growth Partners, Inc. Class A (a)  | 3611  | 36363  |
|  Bilander Acquisition Corp. Class A (a)(b)  | 4788  | 46731  |
|  BioPlus Acquisition Corp. (a)  | 6657  | 67835  |
|  Biotech Acquisition Co. Class A (a)  | 7901  | 79326  |
|  Bleuacacia Ltd. Class A (a)(b)  | 50133  | 500829  |
|  Blockchain Coinvestors Acquisition Corp. I Class A (a)  | 8779  | 89546  |
|  Blockchain Moon Acquisition Corp. (a)  | 6188  | 62808  |
|  Blue Whale Acquisition Corp. I (a)  | 12116  | 118131  |
|  Blue World Acquisition Corp. (a)  | 1613  | 16372  |
|  Breeze Holdings Acquisition Corp. (a)(b)  | 4436  | 46090  |
|  Bridgetown Holdings Ltd. Class A (a)  | 70587  | 693870  |
|  Bright Lights Acquisition Corp. (a)  | 17617  | 177051  |
|  Brilliant Acquisition Corp. (a)  | 4918  | 52278  |
|  Broadscale Acquisition Corp. Class A (a)  | 21877  | 219864  |
|  Bullpen Parlay Acquisition Co. (a)  | 3726  | 37931  |
|  Burtech Acquisition Corp. (a)  | 3639  | 37081  |
|  byNordic Acquisition Corp. (a)  | 9284  | 93026  |
|  BYTE Acquisition Corp. Class A (a)  | 22411  | 224782  |
|  Cactus Acquisition Corp. 1 Ltd. (a)  | 6618  | 67504  |
|  Canna-Global Acquisition Corp. (a)  | 10398  | 106580  |
|  Carney Technology Acquisition Corp. II Class A (a)  | 26127  | 262576  |
|  Cartesian Growth Corp. II (a)  | 5956  | 60692  |
|  Cascadia Acquisition Corp. Class A (a)  | 2973  | 29581  |
|  Catalyst Partners Acquisition Corp. Class A (a)  | 12698  | 127043  |
|  CENAQ Energy Corp. (a)  | 3630  | 36990  |
|  CF Acquisition Corp. IV Class A (a)  | 47181  | 472754  |
|  CF Acquisition Corp. VII Class A (a)  | 4271  | 42838  |
|  CF Acquisition Corp. VIII Class A (a)(b)  | 11894  | 122984  |
|  Chain Bridge I Class A (a)  | 13927  | 142055  |
|  CIIG Capital Partners II, Inc. Class A (a)  | 22298  | 224318  |
|  Clean Earth Acquisitions Corp. Class A (a)  | 13802  | 137675  |
|  ClimateRock Class A (a)  | 1009  | 10211  |
|  Conyers Park III Acquisition Corp. Class A (a)  | 11482  | 113098  |
|  Corazon Capital V838 Monoceros Corp. (a)  | 3759  | 37740  |
|  Corner Growth Acquisition Corp. (a)  | 56198  | 565352  |
|  Corner Growth Acquisition Corp. 2 Class A (a)  | 11847  | 120602  |
|  Counter Press Acquisition Corp. (a)  | 3944  | 40189  |
|  COVA Acquisition Corp. Class A (a)  | 20529  | 206522  |
|  Crescera Capital Acquisition Corp. Class A (a)  | 2264  | 23093  |
|  Crixus BH3 Acquisition Co. (a)  | 4612  | 46351  |
|  Crypto 1 Acquisition Corp. Class A (a)  | 2552  | 25865  |
|  DA32 Life Science Tech Acquision Corp. (a)  | 2365  | 23390  |
|  Data Knights Acquisition Corp. Class A (a)(b)  | 4680  | 49093  |
|  Decarbonization Plus Acquisition Corp. IV Class A (a)  | 19641  | 199160  |
|  Deep Medicine Acquisition Corp. Class A (a)  | 21476  | 219270  |
|  Denali Capital Acquisition Corp. Class A (a)  | 1252  | 12758  |
|  DHB Capital Corp. (a)  | 11268  | 113469  |
|  DHC Acquisition Corp. (a)  | 12386  | 124232  |
|  DiamondHead Holdings Corp. (a)  | 20014  | 200440  |
|  Digital Health Acquisition Corp. (a)  | 1431  | 15068  |
|  Digital Transformation Opportunities Corp. (a)  | 13139  | 130602  |
|  Digital World Acquisition Corp. (a)(b)  | 17141  | 390986  |
|  Disruptive Acquisition Corp. I (a)  | 16328  | 163607  |
|  DP Cap Acquisition Corp. I Class A (a)  | 13527  | 138111  |
|  Dragoneer Growth Opportunities Corp. III (a)  | 52306  | 515214  |
|  DTRT Health Acquisition Corp. Class A (a)  | 22501  | 228610  |
|  Dune Acquisition Corp. (a)  | 26599  | 259074  |
|  East Resources Acquisition Co. (a)  | 9378  | 94624  |
|  Edify Acquisition Corp. (a)  | 21442  | 215063  |
|  Edoc Acquisition Corp. Class A (a)  | 1542  | 16021  |
|  EdtechX Holdings Acquisition Corp. II (a)  | 600  | 6210  |
|  Energem Corp. Class A (a)(b)  | 2351  | 24450  |
|  Enterprise 4.0 Technology Acquisition Corp. (a)  | 6380  | 65267  |
|  Epiphany Technology Acquisition Corp. Class A (a)  | 29000  | 291450  |
|  ESGEN Acquisition Corp. Class A (a)  | 19076  | 195911  |
|  Eucrates Biomedical Acquisition Corp. (a)  | 4558  | 44987  |
|  European Biotech Acquisition Corp. Class A (a)  | 1100  | 11011  |
|  Evo Acquisition Corp. Class A (a)  | 5911  | 59110  |
|  ExcelFin Acquisition Corp. Class A (a)  | 12469  | 125563  |
|  Fat Projects Acquisition Corp. (a)  | 20151  | 202921  |
|  Feutune Light Acquisition Corp. Class A (a)  | 6342  | 64181  |
|  Fifth Wall Acquisition Corp. III Class A (a)  | 52330  | 523300  |
|  Finnovate Acquisition Corp. Class A (a)  | 10151  | 103540  |
|  FinServ Acquisition Corp. II Class A (a)  | 23391  | 233442  |
|  FinTech Acquisition Corp. VI Class A (a)  | 22192  | 223252  |
|  Fintech Ecosystem Development Corp. Class A (a)  | 6729  | 68299  |
|  First Reserve Sustainable Growth Corp. (a)  | 14459  | 144445  |
|  FlexShopper, Inc. (a)(b)  | 15072  | 16278  |
|  Focus Impact Acquisition Corp. Class A (a)  | 6444  | 64956  |
|  Forbion European Acquisition Corp. Class A (a)  | 201  | 2060  |
|  Fortistar Sustainable Solution Corp. Class A (a)  | 20963  | 210259  |
|  FoxWayne Enterprises Acquisition Corp. Class A (a)  | 2038  | 20645  |
|  FTAC Athena Acquisition Corp. Class A (a)  | 6871  | 68985  |
|  FTAC Hera Acquisition Corp. (a)  | 76967  | 771979  |
|  FTAC Zeus Acquisition Corp. Class A (a)  | 42674  | 428874  |
|  Future Health ESG Corp. (a)  | 3358  | 33882  |
|  Games & Esports Experience Acquisition Corp. Class A (a)  | 1402  | 14356  |
|  Gaming & Hospitality Acquisition Corp. (a)  | 6677  | 67104  |
|  Genesis Growth Tech Acquisition Corp. (a)  | 712  | 7319  |
|  Gesher I Acquisition Corp. Class A (a)  | 3590  | 36295  |
|  GigInternational1, Inc. (a)  | 6855  | 70538  |
|  Glenfarne Merger Corp. (a)  | 40502  | 407450  |
|  Global Blockchain Acquisition Corp. (a)  | 5501  | 55120  |
|  Global Partner Acquisition Corp. II Class A (a)  | 17671  | 177859  |
|  Global Systems Dynamics, Inc. (a)  | 3884  | 39694  |
|  Global Technology Acquisition Corp. I Class A (a)  | 10407  | 106255  |
|  Globalink Investment, Inc. (a)  | 3677  | 36917  |
|  Goal Acquisitions Corp. (a)  | 29937  | 297873  |
|  Gores Holdings IX, Inc. (a)  | 17849  | 174920  |
|  Gores Holdings VII, Inc. Class A (a)  | 42109  | 419827  |
|  Green Visor Financial Technology Acquisition Corp. I Class A (a)  | 8197  | 84101  |
|  Group Nine Acquisition Corp. Class A (a)  | 18015  | 180871  |
|  Growth For Good Acquisition Corp. (a)  | 9242  | 92328  |
|  GSR II Meteora Acquisition Corp. Class A (a)  | 10323  | 102611  |
|  GX Acquisition Corp. II (a)  | 18396  | 183040  |
|  Hamilton Lane Alliance Holdings I, Inc. (a)  | 13261  | 132610  |
|  HCM Acquisition Corp. (a)  | 2102  | 21461  |
|  Health Sciences Acquisitions Corp. 2 (a)  | 12421  | 122968  |
|  Healthcare AI Acquisition Corp. (a)  | 12820  | 130379  |
|  Healthcare Services Acquisition Corp. (a)  | 3190  | 31996  |
|  Healthwell Acquisition Corp. I (a)  | 6406  | 63035  |
|  Hennessy Capital Investment Corp. V Class A (a)  | 38419  | 385343  |
|  Hennessy Capital Investment Corp. VI Class A (a)  | 15376  | 151915  |
|  HHG Capital Corp. (a)  | 1448  | 14625  |
|  Home Plate Acquisition Corp. (a)  | 6074  | 60558  |
|  Hudson Executive Investment Corp. II (a)  | 10912  | 109884  |
|  HumanCo Acquisition Corp. (a)  | 51798  | 521606  |
|  Inception Growth Acquisition Ltd. (a)  | 16315  | 163966  |
|  Independence Holdings Corp. Class A (a)  | 34694  | 347981  |
|  Industrial Tech Acquisitions II, Inc. (a)  | 3192  | 32112  |
|  Inflection Point Acquisition Corp. Class A (a)  | 16204  | 161230  |
|  Innovative International Acquisition Corp. Class A (a)  | 9297  | 95480  |
|  INSU Acquisition Corp. III (a)  | 32969  | 331338  |
|  Integral Acquisition Corp. 1 (a)  | 1063  | 10683  |
|  Intelligent Medicine Acquisition Corp. Class A (a)  | 4559  | 46547  |
|  International Media Acquisition Corp. (a)  | 6960  | 71131  |
|  InterPrivate IV InfraTech Partners, Inc. (a)  | 11915  | 118912  |
|  Investcorp Europe Acquisition Corp. I (a)  | 11247  | 115169  |
|  Investcorp India Acquisition Corp. (a)  | 1467  | 15051  |
|  Iris Acquisition Corp. Class A (a)  | 36092  | 361642  |
|  Iron Spark I, Inc. Class A  | 50700  | 505479  |
|  IX Acquisition Corp. Class A (a)(b)  | 10419  | 104815  |
|  Jack Creek Investment Corp. (a)  | 20697  | 207798  |
|  Jaws Hurricane Acquisition Corp. Class A (a)  | 21452  | 211731  |
|  Jaws Juggernaut Acquisition Corp. Class A (a)  | 6008  | 59960  |
|  Jupiter Acquisition Corp. (a)  | 5254  | 51542  |
|  Kadem Sustainable Impact Corp. Class A (a)  | 5251  | 52247  |
|  Keyarch Acquisition Corp. (a)(b)  | 1883  | 18943  |
|  Khosla Ventures Acquisition Co. III (a)  | 143369  | 1427955  |
|  KludeIn I Acquisition Corp. (a)  | 16700  | 169338  |
|  L Catterton Asia Acquisition Corp. Class A (a)  | 13075  | 130881  |
|  LAMF Global Ventures Corp. I (a)  | 13867  | 141305  |
|  Landcadia Holdings IV, Inc. Class A (a)  | 43419  | 434624  |
|  Larkspur Health Acquisition Corp. Class A (a)  | 4076  | 41412  |
|  LatAmGrowth SPAC (a)  | 4041  | 41259  |
|  LAVA Medtech Acquisition Corp. Class A (a)  | 6705  | 68324  |
|  Lazard Growth Acquisition Corp. I (a)  | 51149  | 513024  |
|  LDH Growth Corp. I Class A (a)  | 10420  | 104408  |
|  Lead Edge Growth Opportunities Ltd. Class A (a)  | 15211  | 152414  |
|  Legato Merger Corp. II (a)(b)  | 18435  | 185640  |
|  Lerer Hippeau Acquisition Corp. Class A (a)  | 47693  | 479315  |
|  Levere Holdings Corp. Class A (a)  | 12733  | 127585  |
|  LF Capital Acquisition Corp. II (a)  | 48609  | 494354  |
|  Liberty Media Acquisition Corp. (a)(b)  | 47071  | 473534  |
|  Liberty Resources Acquisition Corp. Class A (a)  | 3303  | 33558  |
|  LightJump Acquisition Corp. (a)  | 1028  | 10434  |
|  Lionheart III Corp. (a)  | 3529  | 35925  |
|  LIV Capital Acquisition Corp. II (a)  | 1805  | 18537  |
|  LM Funding America, Inc. (a)  | 6078  | 4072  |
|  Macondray Capital Acquisition Corp. I Class A (a)  | 6983  | 70668  |
|  Malacca Straits Acquisition Co. Ltd. Class A (a)  | 6813  | 69629  |
|  Maquia Capital Acquisition Corp. Class A (a)(b)  | 23638  | 245835  |
|  Marblegate Acquisition Corp. (a)  | 13895  | 140340  |
|  Marlin Technology Corp. (a)  | 26389  | 266001  |
|  Maxpro Capital Acquisition Corp. (a)  | 13427  | 137895  |
|  McLaren Technology Acquisition Corp. Class A (a)(b)  | 5544  | 56216  |
|  Medicus Sciences Acquisition Corp. Class A (a)  | 7814  | 78062  |
|  MedTech Acquisition Corp. Class A (a)  | 17239  | 173252  |
|  MELI Kaszek Pioneer Corp. (a)(b)  | 15932  | 157727  |
|  Mercato Partners Acquisition Corp. Class A (a)  | 3381  | 34250  |
|  Mercury Ecommerce Acquisition Corp. Class A (a)  | 3822  | 38793  |
|  Metal Sky Star Acquisition Corp. (a)  | 10593  | 106672  |
|  MicroCloud Hologram, Inc. (a)(b)  | 27535  | 70490  |
|  Minority Equality Opportunities Acquisition, Inc. Class A (a)  | 1582  | 16231  |
|  Monterey Bio Acquisition Corp. (a)(b)  | 13454  | 138576  |
|  Monument Circle Acquisition Corp. Class A (a)  | 16211  | 162596  |
|  Moringa Acquisition Corp. Class A (a)  | 5285  | 53061  |
|  Mountain & Co. I Acquisition Corp. (a)  | 6280  | 64998  |
|  Mountain Crest Acquisition Corp. III (a)(b)  | 1605  | 16130  |
|  Mountain Crest Acquisition Corp. IV (a)  | 2322  | 23220  |
|  Mountain Crest Acquisition Corp. V (a)  | 17855  | 179264  |
|  MSD Acquisition Corp. Class A (a)  | 40622  | 407845  |
|  New Providence Acquisition Corp. II Class A (a)  | 5325  | 53729  |
|  New Vista Acquisition Corp. (a)  | 7455  | 74699  |
|  Newbury Street Acquisition Corp. (a)  | 6961  | 68914  |
|  Newcourt Acquisition Corp. Class A (a)(b)  | 10488  | 107502  |
|  NewHold Investment Corp. II Class A (a)  | 13519  | 136947  |
|  NightDragon Acquisition Corp. (a)  | 10595  | 106056  |
|  Noble Rock Acquisition Corp. Class A (a)  | 11942  | 120017  |
|  Nocturne Acquisition Corp. (a)  | 17571  | 182387  |
|  North Atlantic Acquisition Corp. Class A (a)  | 20192  | 203132  |
|  Nova Vision Acquisition Corp. (a)  | 150  | 1548  |
|  OCA Acquisition Corp. Class A (a)  | 8868  | 90276  |
|  OceanTech Acquisitions I Corp. Class A (a)(b)  | 1749  | 17945  |
|  Omega Alpha SPAC (a)  | 1370  | 13741  |
|  OmniLit Acquisition Corp. Class A (a)  | 2506  | 25636  |
|  One Equity Partners Open Water I Corp. (a)  | 14822  | 150147  |
|  Onyx Acquisition Co. I Class A (a)  | 10960  | 112340  |
|  OPY Acquisition Corp. I Class A (a)  | 1750  | 17535  |
|  Orion Acquisition Corp. Class A (a)(b)  | 15860  | 159710  |
|  Orion Biotech Opportunities Corp. Class A (a)  | 5741  | 57353  |
|  Oxbridge Acquisition Corp. Class A (a)(b)  | 7561  | 78181  |
|  Oxus Acquisition Corp. (a)  | 8028  | 82126  |
|  Oyster Enterprises Acquisition Corp. Class A (a)  | 10376  | 104071  |
|  Pacifico Acquisition Corp. (a)  | 1928  | 10373  |
|  Parsec Capital Acquisitions Co. Class A (a)  | 10132  | 102992  |
|  PepperLime Health Acquisition Corp. Class A (a)  | 7163  | 72418  |
|  Perception Capital Corp. II Class A (a)  | 6893  | 70378  |
|  Phoenix Biotech Acquisition Corp. (a)  | 10588  | 108209  |
|  PHP Ventures Acquisition Corp. Class A (a)  | 1807  | 18486  |
|  Plum Acquisition Corp. I Class A (a)  | 6545  | 65515  |
|  Pono Capital Corp. Class A (a)  | 2112  | 21627  |
|  Power & Digital Infrastructure Acquisition II Corp. (a)  | 13806  | 137508  |
|  Powered Brands Class A (a)  | 21975  | 220629  |
|  PowerUp Acquisition Corp. Class A (a)  | 5490  | 56273  |
|  Priveterra Acquisition Corp. (a)  | 14763  | 147187  |
|  Property Solutions Acquisition Corp. II Class A (a)  | 16796  | 167960  |
|  PropTech Investment Corp. II (a)(b)  | 12250  | 79380  |
|  Prospector Capital Corp. Class A (a)  | 31408  | 315964  |
|  Relativity Acquisition Corp. Class A (a)  | 3558  | 36434  |
|  Research Alliance Corp. II (a)  | 40873  | 410774  |
|  Revelstone Capital Acquisition Corp. (a)  | 3211  | 32046  |
|  Revolution Healthcare Acquisition Corp. (a)  | 30471  | 305929  |
|  RF Acquisition Corp. (a)  | 385  | 3858  |
|  RMG Acquisition Corp. III Class A (a)  | 23202  | 232484  |
|  ROC Energy Acquisition Corp. (a)  | 6729  | 68299  |
|  Rose Hill Acquisition Corp. Class A (a)  | 5199  | 53446  |
|  Rosecliff Acquisition Corp. I (a)  | 14419  | 144478  |
|  Roth CH Acquisition IV Co. (a)  | 4724  | 48090  |
|  Roth CH Acquisition V Co. (a)  | 9625  | 96250  |
|  RXR Acquisition Corp. (a)  | 20047  | 201472  |
|  Schultze Special Purpose Acquisition Corp. II Class A (a)  | 1986  | 19920  |
|  Science Strategic Acquisition Corp. Alpha (a)  | 11309  | 113599  |
|  ScION Tech Growth I Class A (a)  | 66567  | 669664  |
|  SCP & CO Healthcare Acquisition Co. (a)  | 8705  | 87746  |
|  Screaming Eagle Acquisition Corp. (a)  | 39390  | 387598  |
|  Seaport Calibre Materials Acquisition Corp. (a)  | 25959  | 262445  |
|  SEATech Ventures Corp. (a)(c)  | 3755  | 128  |
|  Semper Paratus Acquisition Corp. Class A (a)  | 5967  | 61281  |
|  SHUAA Partners Acquisition Corp. I Class A (a)  | 3561  | 36500  |
|  Sierra Lake Acquisition Corp. Class A (a)(b)  | 17915  | 180942  |
|  Silver Spike Acquisition Corp. II Class A (a)  | 5656  | 56673  |
|  SILVERspac, Inc. Class A (a)  | 5375  | 53481  |
|  Sizzle Acquisition Corp. (a)  | 10451  | 106600  |
|  SK Growth Opportunities Corp. (a)(b)  | 11427  | 116041  |
|  Skydeck Acquisition Corp. Class A (a)  | 3706  | 37060  |
|  Slam Corp. (a)  | 29043  | 291156  |
|  Social Capital Suvretta Holdings Corp. II (a)  | 6600  | 65868  |
|  Social Capital Suvretta Holdings Corp. IV (a)  | 6040  | 60219  |
|  Sound Point Acquisition Corp. I Ltd. (a)  | 601  | 6172  |
|  Spindletop Health Acquisition Corp. Class A (a)  | 4428  | 45276  |
|  SPK Acquisition Corp. (a)(b)  | 4813  | 48900  |
|  Sports Ventures Acquisition Corp. Class A (a)  | 15350  | 154114  |
|  SportsMap Tech Acquisition Corp. (a)  | 7111  | 71679  |
|  SportsTek Acquisition Corp. Class A (a)  | 6720  | 67334  |
|  Springwater Special Situations Corp. (a)  | 13177  | 132561  |
|  StoneBridge Acquisition Corp. (a)  | 7553  | 76965  |
|  Stratim Cloud Acquisition Corp. (a)  | 3529  | 35114  |
|  Sustainable Development Acquisition I Corp. Class A (a)  | 22589  | 226568  |
|  SVF Investment Corp. (a)  | 53443  | 537102  |
|  Swiftmerge Acquisition Corp. Class A (a)  | 2517  | 25371  |
|  SWK Holdings Corp. (a)(b)  | 5279  | 102677  |
|  Talon 1 Acquisition Corp. Class A (a)  | 2685  | 27682  |
|  Target Global Acquisition I Corp. (a)  | 2760  | 28097  |
|  Tastemaker Acquisition Corp. Class A (a)  | 23872  | 241585  |
|  TB SA Acquisition Corp. (a)  | 12266  | 122905  |
|  Tech and Energy Transition Corp. Class A (a)  | 38470  | 382777  |
|  TG Venture Acquisition Corp. (a)  | 5333  | 53970  |
|  Thrive Acquisition Corp. Class A (a)  | 3811  | 39444  |
|  Thunder Bridge Capital Partner IV, Inc. (a)  | 4969  | 48796  |
|  Thunder Bridge Capital Partners III, Inc. Class A (a)  | 19136  | 192317  |
|  Tishman Speyer Innovation Corp. II (a)  | 13246  | 133387  |
|  TKB Critical Technologies 1 Class A (a)(b)  | 29046  | 297867  |
|  TLGY Acquisition Corp. (a)  | 1607  | 16472  |
|  TPB Acquisition Corp. I Class A (a)  | 2118  | 21180  |
|  TradeUP Acquisition Corp. (a)  | 1582  | 16041  |
|  TZP Strategies Acquisition Corp. (a)(b)  | 11527  | 115385  |
|  UTA Acquisition Corp. Class A (a)  | 12234  | 124236  |
|  Vahanna Tech Edge Acquisition I Corp. (a)  | 2626  | 26811  |
|  Valuence Merger Corp. I Class A (a)  | 960  | 9878  |
|  VectoIQ Acquisition Corp. II (a)  | 21822  | 219311  |
|  Vector Acquisition Corp. II Class A (a)  | 145008  | 1452980  |
|  Venus Acquisition Corp. (a)(b)  | 2403  | 23549  |
|  Vision Sensing Acquisition Corp. Class A (a)  | 3608  | 36946  |
|  VMG Consumer Acquisition Corp. Class A (a)  | 3946  | 39934  |
|  VPC Impact Acquisition Holding II Class A (a)(b)  | 9812  | 98512  |
|  Welsbach Technology Metals Acquisition Corp. (a)  | 1791  | 18000  |
|  Western Acquisition Ventures Corp. (a)  | 1125  | 11329  |
|  WinVest Acquisition Corp. (a)  | 1876  | 19116  |
|  Worldwide Webb Acquisition Corp. Class A (a)  | 4207  | 42491  |
|  XPAC Acquisition Corp. (a)  | 1680  | 16699  |
|  Yotta Acquisition Corp. (a)  | 2168  | 21582  |
|  Z-Work Acquisition Corp. Class A (a)  | 23176  | 232455  |
|  Zimmer Energy Transition Acquisition Corp. (a)  | 12820  | 127174  |
|  |  | 47207087  |
| Insurance - 0.7%  |  |  |
|  Amerisafe, Inc.  | 9587  | 569180  |
|  Arch Capital Group Ltd. (a)  | 210458  | 12608539  |
|  Atlantic American Corp. (b)  | 8809  | 24841  |
|  Brighthouse Financial, Inc. (a)(b)  | 43342  | 2415883  |
|  BRP Group, Inc. (a)  | 39507  | 1186790  |
|  Cincinnati Financial Corp.  | 92351  | 10247267  |
|  Conifer Holdings, Inc. (a)(b)  | 3312  | 5134  |
|  Donegal Group, Inc. Class A  | 18229  | 271065  |
|  eHealth, Inc. (a)  | 14424  | 51349  |
|  Enstar Group Ltd. (a)  | 9493  | 2069379  |
|  Erie Indemnity Co. Class A  | 25749  | 7271260  |
|  Fanhua, Inc. ADR (b)  | 18931  | 87461  |
|  FG Financial Group, Inc. (a)(b)  | 3213  | 7743  |
|  GoHealth, Inc. (a)(b)  | 2924  | 38012  |
|  Goosehead Insurance (a)(b)  | 13948  | 566428  |
|  Greenlight Capital Re, Ltd. (a)  | 7844  | 61419  |
|  Hallmark Financial Services, Inc. (a)  | 8243  | 5193  |
|  Huize Holding Ltd. ADR (a)(b)  | 8820  | 9790  |
|  International General Insurance Holdings Ltd. (b)  | 24436  | 186935  |
|  Investors Title Co.  | 1165  | 178874  |
|  James River Group Holdings Ltd.  | 24967  | 599707  |
|  Kingstone Companies, Inc.  | 5340  | 5393  |
|  Maiden Holdings Ltd. (a)(b)  | 52310  | 109328  |
|  Midwest Holding, Inc. (a)(b)  | 1575  | 23657  |
|  National Western Life Group, Inc. (b)  | 1743  | 367424  |
|  NI Holdings, Inc. (a)  | 13483  | 182021  |
|  Oxbridge Re Holdings Ltd. (a)  | 5511  | 9754  |
|  Palomar Holdings, Inc. (a)  | 14396  | 903205  |
|  Principal Financial Group, Inc.  | 138688  | 12437540  |
|  Reliance Global Group, Inc. (a)(b)  | 3189  | 1850  |
|  Root, Inc. (a)(b)  | 3480  | 25300  |
|  Safety Insurance Group, Inc. (b)  | 8823  | 809422  |
|  Selective Insurance Group, Inc.  | 32232  | 3098140  |
|  Sirius International Insurance rights 12/31/99 (a)(c)  | 58865  | 1  |
|  Tian Ruixiang Holdings Ltd. (a)(b)  | 300  | 693  |
|  Tiptree, Inc.  | 21813  | 302546  |
|  Trean Insurance Group, Inc. (a)  | 28354  | 78257  |
|  Trupanion, Inc. (a)(b)  | 22228  | 1161858  |
|  Unico American Corp. (a)  | 851  | 996  |
|  United Fire Group, Inc. (b)  | 16750  | 511713  |
|  United Insurance Holdings Corp.  | 1147  | 367  |
|  Vericity, Inc. (a)  | 6650  | 45353  |
|  Willis Towers Watson PLC  | 61635  | 15172072  |
|  |  | 73709139  |
| Mortgage Real Estate Investment Trusts - 0.0%  |  |  |
|  AGNC Investment Corp. (b)  | 324666  | 3243413  |
|  Manhattan Bridge Capital, Inc. (b)  | 8746  | 50902  |
|  New York Mortgage Trust, Inc. (b)  | 284523  | 799510  |
|  |  | 4093825  |
| Thrifts & Mortgage Finance - 0.2%  |  |  |
|  1895 Bancorp of Wisconsin, Inc. (a)(b)  | 3059  | 31202  |
|  America First Tax Exempt Investors LP  | 13183  | 251400  |
|  Blue Foundry Bancorp (a)  | 14520  | 189776  |
|  Bogota Financial Corp. (a)  | 8810  | 100610  |
|  Bridgewater Bancshares, Inc. (a)  | 13282  | 255944  |
|  Broadway Financial Corp. (a)  | 16771  | 15976  |
|  Capitol Federal Financial, Inc.  | 85642  | 716824  |
|  Carver Bancorp, Inc. (a)  | 7032  | 28550  |
|  Columbia Financial, Inc. (a)  | 68761  | 1518243  |
|  Cullman Bancorp, Inc.  | 1695  | 19120  |
|  Enact Holdings, Inc.  | 94039  | 2332167  |
|  FS Bancorp, Inc.  | 6150  | 210330  |
|  Greene County Bancorp, Inc.  | 5226  | 398587  |
|  Hingham Institution for Savings (b)  | 1454  | 426720  |
|  HMN Financial, Inc.  | 3382  | 75757  |
|  Home Bancorp, Inc.  | 7434  | 319513  |
|  Home Federal Bancorp, Inc. (b)  | 813  | 15032  |
|  Home Point Capital, Inc. (b)  | 64166  | 101382  |
|  Kearny Financial Corp. (b)  | 43102  | 416796  |
|  Luther Burbank Corp.  | 22484  | 266660  |
|  Magyar Bancorp, Inc.  | 3540  | 45843  |
|  Merchants Bancorp  | 24579  | 628977  |
|  Mr. Cooper Group, Inc. (a)  | 42203  | 1905887  |
|  NMI Holdings, Inc. (a)  | 48402  | 1042095  |
|  Northeast Community Bancorp, Inc. (b)  | 1901  | 27469  |
|  Northfield Bancorp, Inc. (b)  | 31683  | 505344  |
|  Oconee Federal Financial Corp. (b)  | 878  | 18807  |
|  OP Bancorp (b)  | 5419  | 63402  |
|  PB Bankshares, Inc. (a)  | 871  | 11262  |
|  Pioneer Bancorp, Inc. (a)  | 10879  | 127828  |
|  Ponce Financial Group, Inc. (a)(b)  | 13052  | 129084  |
|  Provident Bancorp, Inc.  | 14544  | 100935  |
|  Redwoods Acquisition Corp. (a)  | 11252  | 112070  |
|  Security National Financial Corp. Class A  | 7773  | 50447  |
|  Southern Missouri Bancorp, Inc.  | 6368  | 330244  |
|  Sterling Bancorp, Inc. (a)(b)  | 23636  | 152216  |
|  TC Bancshares, Inc. (b)  | 3351  | 50265  |
|  Territorial Bancorp, Inc. (b)  | 4189  | 95090  |
|  TFS Financial Corp. (b)  | 171062  | 2334996  |
|  Timberland Bancorp, Inc./Washington  | 5704  | 197929  |
|  Trustco Bank Corp., New York  | 10680  | 414811  |
|  Valor Latitude Acquisition Corp. Class A (a)  | 13041  | 130410  |
|  Waterstone Financial, Inc.  | 16746  | 280496  |
|  Western New England Bancorp, Inc.  | 19217  | 191017  |
|  William Penn Bancorp, Inc. (b)  | 6289  | 73581  |
|  WSFS Financial Corp.  | 38651  | 1874960  |
|  |  | 18586054  |
|  TOTAL FINANCIALS  |  | 543802919  |
| HEALTH CARE - 9.6%  |  |  |
| Biotechnology - 5.5%  |  |  |
|  180 Life Sciences Corp. (a)(b)  | 16870  | 7025  |
|  2seventy bio, Inc. (a)(b)  | 27817  | 435892  |
|  4D Molecular Therapeutics, Inc. (a)  | 28878  | 697981  |
|  4D Pharma PLC ADR (a)(b)(c)  | 2099  | 3463  |
|  89Bio, Inc. (a)  | 26832  | 214656  |
|  Aadi Bioscience, Inc. (a)(b)  | 11601  | 155221  |
|  Aadi Bioscience, Inc. rights (a)(c)  | 22410  | 0  |
|  Abcam PLC ADR (a)(b)  | 12703  | 203756  |
|  Abeona Therapeutics, Inc. (a)(b)  | 3435  | 12916  |
|  Absci Corp. (a)(b)  | 51699  | 129248  |
|  ABVC BioPharma, Inc. (a)  | 49915  | 35440  |
|  AC Immune SA (a)(b)  | 37118  | 94651  |
|  ACADIA Pharmaceuticals, Inc. (a)(b)  | 95418  | 1486612  |
|  Achieve Life Sciences, Inc. (a)(b)  | 10358  | 28795  |
|  Achilles Therapeutics PLC ADR (a)  | 21590  | 43612  |
|  Acorda Therapeutics, Inc. (a)(b)  | 6110  | 3903  |
|  Acumen Pharmaceuticals, Inc. (a)(b)  | 21758  | 123585  |
|  Acurx Pharmaceuticals, Inc. (a)(b)  | 8683  | 27438  |
|  Adagene, Inc. ADR (a)(b)  | 10309  | 11134  |
|  Adamas Pharmaceuticals, Inc.:  |  |  |
|  rights (a)(c)  | 26195  | 1572  |
|  rights (a)(c)  | 26195  | 1572  |
|  Adaptimmune Therapeutics PLC sponsored ADR (a)(b)  | 105910  | 229825  |
|  Adicet Bio, Inc. (a)  | 21229  | 385943  |
|  Adicet Bio, Inc. rights (a)(c)  | 3438  | 0  |
|  Aditxt, Inc. (a)(b)  | 1779  | 3184  |
|  ADMA Biologics, Inc. (a)  | 115355  | 385286  |
|  Adverum Biotechnologies, Inc. (a)  | 11628  | 7790  |
|  Aeglea BioTherapeutics, Inc. (a)(b)  | 34317  | 14242  |
|  Aerovate Therapeutics, Inc. (a)(b)  | 13597  | 256167  |
|  Aeterna Zentaris, Inc. (a)(b)  | 3659  | 14051  |
|  Affimed NV (a)  | 135947  | 290927  |
|  Agenus, Inc. (a)  | 174976  | 472435  |
|  Agios Pharmaceuticals, Inc. (a)(b)  | 32726  | 986362  |
|  Aikido Pharma, Inc. (a)(b)  | 4540  | 15527  |
|  Aileron Therapeutics, Inc. (a)  | 4039  | 11188  |
|  Akebia Therapeutics, Inc. (a)  | 81930  | 22162  |
|  Akero Therapeutics, Inc. (a)  | 27027  | 1256756  |
|  Akouos, Inc. (a)(b)  | 22594  | 300274  |
|  Alaunos Therapeutics, Inc. (a)(b)  | 133508  | 85178  |
|  Albireo Pharma, Inc. (a)(b)  | 10788  | 238199  |
|  Aldeyra Therapeutics, Inc. (a)  | 30129  | 168722  |
|  Alector, Inc. (a)  | 43832  | 372134  |
|  Aligos Therapeutics, Inc. (a)  | 30622  | 30622  |
|  Alkermes PLC (a)  | 93120  | 2307514  |
|  Allakos, Inc. (a)  | 41210  | 339983  |
|  Allogene Therapeutics, Inc. (a)(b)  | 79583  | 784688  |
|  Allovir, Inc. (a)(b)  | 63966  | 480385  |
|  Alnylam Pharmaceuticals, Inc. (a)  | 68405  | 15089459  |
|  Alpine Immune Sciences, Inc. (a)(b)  | 19449  | 122140  |
|  Alterity Therapeutics Ltd. ADR (a)(b)  | 12128  | 4487  |
|  Altimmune, Inc. (a)(b)  | 30555  | 304022  |
|  Alvotech SA (a)(b)  | 7792  | 48544  |
|  ALX Oncology Holdings, Inc. (a)(b)  | 22550  | 250305  |
|  Alzamend Neuro, Inc. (a)(b)  | 40587  | 46675  |
|  Amarin Corp. PLC ADR (a)(b)  | 214385  | 246543  |
|  Amgen, Inc.  | 303944  | 87049562  |
|  Amicus Therapeutics, Inc. (a)  | 168225  | 2035523  |
|  AnaptysBio, Inc. (a)(b)  | 15023  | 415085  |
|  Anavex Life Sciences Corp. (a)(b)  | 53320  | 470282  |
|  Anika Therapeutics, Inc. (a)  | 7769  | 245034  |
|  Anixa Biosciences, Inc. (a)  | 24102  | 121474  |
|  Annexon, Inc. (a)(b)  | 25755  | 140107  |
|  AnPac Bio-Medical Science Co. Ltd. ADR (a)(b)  | 3401  | 12108  |
|  Apellis Pharmaceuticals, Inc. (a)  | 61463  | 3068848  |
|  Apexigen, Inc. (a)  | 21401  | 37024  |
|  Applied Therapeutics, Inc. (a)  | 23060  | 25827  |
|  Aptevo Therapeutics, Inc. (a)(b)  | 7524  | 23475  |
|  Aptinyx, Inc. (a)(b)  | 71538  | 19673  |
|  Aptorum Group Ltd. (a)  | 24136  | 13393  |
|  Aptose Biosciences, Inc. (a)(b)  | 32455  | 21583  |
|  AquaBounty Technologies, Inc. (a)  | 39718  | 27322  |
|  Aravive, Inc. (a)(b)  | 17702  | 23721  |
|  Arbutus Biopharma Corp. (a)  | 163622  | 384512  |
|  ARCA Biopharma, Inc. (a)(b)  | 25116  | 52995  |
|  Arcellx, Inc.  | 25227  | 503026  |
|  Arcturus Therapeutics Holdings, Inc. (a)(b)  | 15029  | 277135  |
|  Arcutis Biotherapeutics, Inc. (a)  | 33142  | 571037  |
|  Ardelyx, Inc. (a)(b)  | 64411  | 110787  |
|  Argenx SE ADR (a)  | 17376  | 6915127  |
|  Aridis Pharmaceuticals, Inc. (a)(b)  | 19230  | 17499  |
|  Arrowhead Pharmaceuticals, Inc. (a)  | 64730  | 2084306  |
|  Ars Pharmaceuticals, Inc. (a)  | 16976  | 105591  |
|  Ascendis Pharma A/S sponsored ADR (a)(b)  | 31251  | 3845748  |
|  Aslan Pharmaceuticals Ltd. ADR (a)(b)  | 39841  | 21901  |
|  Assembly Biosciences, Inc. (a)  | 29090  | 38108  |
|  Astria Therapeutics, Inc. (a)  | 30771  | 309249  |
|  Atara Biotherapeutics, Inc. (a)  | 70653  | 320058  |
|  Athenex, Inc. (a)  | 44542  | 9354  |
|  Athersys, Inc. (a)(b)  | 5183  | 3085  |
|  Atossa Therapeutics, Inc. (a)(b)  | 65687  | 49265  |
|  Atreca, Inc. (a)(b)  | 11273  | 12062  |
|  aTyr Pharma, Inc. (a)  | 16950  | 36612  |
|  Aura Biosciences, Inc. (a)  | 16064  | 229394  |
|  Aurinia Pharmaceuticals, Inc. (a)  | 76895  | 394471  |
|  Autolus Therapeutics PLC ADR (a)(b)  | 133438  | 352276  |
|  Avalo Therapeutics, Inc. (a)(b)  | 4548  | 24559  |
|  AVEO Pharmaceuticals, Inc. (a)  | 19123  | 285889  |
|  Avid Bioservices, Inc. (a)(b)  | 33787  | 529104  |
|  Avidity Biosciences, Inc. (a)(b)  | 35416  | 412242  |
|  Avita Medical, Inc. (a)(b)  | 12445  | 82759  |
|  AVROBIO, Inc. (a)  | 1470  | 1336  |
|  Axcella Health, Inc. (a)(b)  | 23744  | 19954  |
|  Ayala Pharmaceuticals, Inc. (a)(b)  | 10596  | 5828  |
|  Aziyo Biologics, Inc. (a)(b)  | 2648  | 18271  |
|  Beam Therapeutics, Inc. (a)(b)  | 40229  | 1858178  |
|  BeiGene Ltd. ADR (a)(b)  | 27601  | 5288628  |
|  Bellerophon Therapeutics, Inc. (a)(b)  | 4969  | 4969  |
|  Bellicum Pharmaceuticals, Inc. (a)(b)  | 22867  | 23782  |
|  BELLUS Health, Inc. (a)  | 84292  | 831962  |
|  Benitec Biopharma, Inc. (a)(b)  | 11813  | 2422  |
|  BeyondSpring, Inc. (a)(b)  | 20183  | 11706  |
|  Bicycle Therapeutics PLC ADR (a)(b)  | 17144  | 496490  |
|  Bio-Path Holdings, Inc. (a)(b)  | 15100  | 22197  |
|  BioAtla, Inc. (a)  | 17439  | 192003  |
|  BioCardia, Inc. (a)(b)  | 17950  | 32490  |
|  Biocept, Inc. (a)(b)  | 5682  | 4375  |
|  BioCryst Pharmaceuticals, Inc. (a)(b)  | 104504  | 1396173  |
|  Biogen, Inc. (a)  | 81911  | 24996780  |
|  BioLine RX Ltd. sponsored ADR (a)(b)  | 32026  | 22575  |
|  BioMarin Pharmaceutical, Inc. (a)  | 103668  | 10468395  |
|  Biomea Fusion, Inc. (a)  | 17536  | 126084  |
|  BioNTech SE ADR  | 50523  | 8438351  |
|  Biora Therapeutics, Inc. (a)(b)  | 27652  | 6775  |
|  BioRestorative Therapies, Inc. (b)  | 3862  | 11779  |
|  BioVie, Inc. (a)(b)  | 24909  | 167887  |
|  BioXcel Therapeutics, Inc. (a)(b)  | 22376  | 370770  |
|  Black Diamond Therapeutics, Inc. (a)(b)  | 8326  | 17568  |
|  Blue Water Vaccines, Inc. (b)  | 3818  | 4734  |
|  bluebird bio, Inc. (a)(b)  | 49567  | 386127  |
|  Blueprint Medicines Corp. (a)  | 35974  | 1719197  |
|  Bolt Biotherapeutics, Inc. (a)(b)  | 25402  | 37595  |
|  Bone Biologics Corp. (a)(b)  | 5900  | 1599  |
|  BrainStorm Cell Therpeutic, Inc. (a)(b)  | 23733  | 39159  |
|  BriaCell Therapeutics Corp. (a)(b)  | 7229  | 38820  |
|  BridgeBio Pharma, Inc. (a)(b)  | 93528  | 876357  |
|  Brooklyn ImmunoTherapeutics, Inc. (a)(b)  | 1165  | 3810  |
|  Burning Rock Biotech Ltd. ADR (a)(b)  | 18289  | 45905  |
|  C4 Therapeutics, Inc. (a)(b)  | 24762  | 212210  |
|  Cabaletta Bio, Inc. (a)(b)  | 14388  | 64458  |
|  Calithera Biosciences, Inc. (a)(b)  | 1177  | 2354  |
|  Calyxt, Inc. (a)(b)  | 37971  | 5791  |
|  Candel Therapeutics, Inc. (a)  | 13241  | 23172  |
|  Capricor Therapeutics, Inc. (a)(b)  | 16945  | 75744  |
|  Cardiff Oncology, Inc. (a)  | 13765  | 21886  |
|  CareDx, Inc. (a)  | 27154  | 351644  |
|  Caribou Biosciences, Inc. (a)  | 29872  | 278108  |
|  CASI Pharmaceuticals, Inc. (a)(b)  | 22221  | 43331  |
|  Catalyst Biosciences, Inc. (a)  | 25124  | 13818  |
|  Catalyst Pharmaceutical Partners, Inc. (a)  | 57557  | 965231  |
|  Celcuity, Inc. (a)(b)  | 9722  | 88859  |
|  Celldex Therapeutics, Inc. (a)  | 25225  | 935595  |
|  Cellectar Biosciences, Inc. (a)(b)  | 5942  | 11171  |
|  Cellectis SA sponsored ADR (a)  | 10776  | 23707  |
|  Celularity, Inc. Class A (a)(b)  | 79434  | 135832  |
|  Celyad Oncology SA ADR (a)(b)  | 2012  | 1973  |
|  Centessa Pharmaceuticals PLC ADR (a)(b)  | 13428  | 53712  |
|  Centogene NV (a)(b)  | 11156  | 8811  |
|  Century Therapeutics, Inc. (a)  | 33174  | 348327  |
|  Cerevel Therapeutics Holdings (a)(b)  | 83352  | 2413874  |
|  Checkpoint Therapeutics, Inc. (a)(b)  | 44383  | 26182  |
|  Chemomab Therapeutics Ltd. ADR (a)(b)  | 11737  | 24648  |
|  Chimerix, Inc. (a)  | 52138  | 113139  |
|  Chinook Therapeutics, Inc. (a)(b)  | 40508  | 917506  |
|  Chinook Therapeutics, Inc. rights (a)(c)  | 11497  | 0  |
|  Cidara Therapeutics, Inc. (a)(b)  | 66465  | 42544  |
|  Clementia Pharmaceuticals, Inc. rights (a)(c)  | 21066  | 28439  |
|  Clene, Inc. (a)(b)  | 39010  | 42131  |
|  Codiak Biosciences, Inc. (a)  | 21826  | 15062  |
|  Coeptis Therapeutics Holdings (a)  | 2844  | 5148  |
|  Cogent Biosciences, Inc. (a)(b)  | 39208  | 493237  |
|  Cogent Biosciences, Inc. rights (a)(c)  | 12548  | 0  |
|  CohBar, Inc. (a)  | 3590  | 5744  |
|  Coherus BioSciences, Inc. (a)(b)  | 43446  | 298040  |
|  Collplant Biotechnologies Ltd. (a)  | 5925  | 30158  |
|  Comera Life Sciences Holdings, Inc. (a)(b)  | 4547  | 6957  |
|  Compass Pathways PLC ADR (a)(b)  | 13678  | 140883  |
|  Compass Therapeutics, Inc.  | 28789  | 118323  |
|  Concert Pharmaceuticals, Inc. (a)  | 24247  | 116871  |
|  Connect Biopharma Holdings Ltd. ADR (a)(b)  | 19032  | 13804  |
|  ContraFect Corp. (a)(b)  | 24369  | 4304  |
|  Corbus Pharmaceuticals Holdings, Inc. (a)(b)  | 65054  | 12653  |
|  Corvus Pharmaceuticals, Inc. (a)(b)  | 27371  | 25515  |
|  Crinetics Pharmaceuticals, Inc. (a)  | 40924  | 731312  |
|  CRISPR Therapeutics AG (a)(b)  | 46207  | 2531682  |
|  CTI BioPharma Corp. (a)(b)  | 70768  | 426023  |
|  Cue Biopharma, Inc. (a)  | 20320  | 78435  |
|  Cullinan Oncology, Inc. (a)  | 22932  | 285045  |
|  CureVac NV (a)(b)  | 90873  | 658829  |
|  Curis, Inc. (a)(b)  | 54553  | 44019  |
|  Cyclacel Pharmaceuticals, Inc. (a)(b)  | 10654  | 8815  |
|  Cyclerion Therapeutics, Inc. (a)  | 50166  | 47658  |
|  Cyclo Therapeutics, Inc. (a)  | 6976  | 10394  |
|  Cyteir Therapeutics, Inc. (a)(b)  | 22035  | 31730  |
|  Cytokinetics, Inc. (a)(b)  | 54647  | 2322498  |
|  CytomX Therapeutics, Inc. (a)(b)  | 30189  | 52529  |
|  Day One Biopharmaceuticals, Inc. (a)  | 49045  | 1041225  |
|  DBV Technologies SA sponsored ADR (a)(b)  | 23666  | 31949  |
|  Decibel Therapeutics, Inc. (a)(b)  | 8575  | 26325  |
|  Deciphera Pharmaceuticals, Inc. (a)  | 39810  | 633377  |
|  Denali Therapeutics, Inc. (a)  | 68612  | 2189409  |
|  DermTech, Inc. (a)(b)  | 10120  | 25806  |
|  Design Therapeutics, Inc. (a)(b)  | 29265  | 409710  |
|  DiaMedica Therapeutics, Inc. (a)  | 42740  | 50861  |
|  Diffusion Pharmaceuticals, Inc. (a)(b)  | 2365  | 14852  |
|  Dyadic International, Inc. (a)(b)  | 48866  | 73299  |
|  Dynavax Technologies Corp. (a)(b)  | 71327  | 885168  |
|  Dyne Therapeutics, Inc. (a)  | 27351  | 320007  |
|  Eagle Pharmaceuticals, Inc. (a)  | 7885  | 286383  |
|  Edesa Biotech, Inc. (a)(b)  | 19777  | 18238  |
|  Editas Medicine, Inc. (a)(b)  | 38353  | 406542  |
|  Effector Therapeutics, Inc. Class A (a)(b)  | 24005  | 9938  |
|  Eiger Biopharmaceuticals, Inc. (a)  | 23309  | 105823  |
|  Eledon Pharmaceuticals, Inc. (a)(b)  | 10482  | 25995  |
|  Elevation Oncology, Inc. (a)(b)  | 12156  | 10989  |
|  Eliem Therapeutics, Inc. (a)(b)  | 14651  | 36921  |
|  Enanta Pharmaceuticals, Inc. (a)  | 11608  | 508314  |
|  Enlivex Therapeutics Ltd. (a)(b)  | 10420  | 47932  |
|  Enochian Biosciences, Inc. (a)(b)  | 25710  | 38694  |
|  Ensysce Biosciences, Inc. (a)(b)  | 1042  | 3022  |
|  Entera Bio Ltd. (a)(b)  | 17597  | 11945  |
|  Entrada Therapeutics, Inc. (a)  | 17653  | 264265  |
|  EQRx, Inc. (a)  | 284839  | 1070995  |
|  Equillium, Inc. (a)(b)  | 18701  | 31044  |
|  Erasca, Inc. (a)  | 68217  | 515038  |
|  Erytech Pharma SA ADR (a)(b)  | 2542  | 1525  |
|  Essa Pharma, Inc. (a)(b)  | 19039  | 70254  |
|  Evaxion Biotech A/S ADR (a)(b)  | 2428  | 5220  |
|  Evelo Biosciences, Inc. (a)(b)  | 35177  | 73520  |
|  Evogene Ltd. (a)(b)  | 59007  | 37027  |
|  Exact Sciences Corp. (a)(b)  | 102914  | 4625984  |
|  Exagen, Inc. (a)(b)  | 8533  | 23039  |
|  Exelixis, Inc. (a)  | 178272  | 3044886  |
|  Exicure, Inc. (a)(b)  | 2041  | 2041  |
|  Exscientia Ltd. ADR (a)(b)  | 16032  | 91382  |
|  F-star Therapeutics, Inc. (a)  | 12945  | 73010  |
|  F-star Therapeutics, Inc.:  |  |  |
|  rights (a)(c)  | 1855  | 0  |
|  rights (a)(c)  | 1855  | 0  |
|  Fate Therapeutics, Inc. (a)(b)  | 62224  | 1295504  |
|  Fennec Pharmaceuticals, Inc. (a)(b)  | 19507  | 190388  |
|  FibroGen, Inc. (a)  | 57654  | 828488  |
|  Finch Therapeutics Group, Inc. (a)(b)  | 25491  | 24984  |
|  First Wave BioPharma, Inc. (a)(b)  | 337  | 280  |
|  Flexion Therapeutics, Inc. rights (a)(c)  | 69500  | 1  |
|  Foghorn Therapeutics, Inc. (a)(b)  | 23691  | 159914  |
|  Fortress Biotech, Inc. (a)  | 60011  | 39685  |
|  Forward Pharma A/S sponsored ADR (a)  | 4735  | 14063  |
|  Frequency Therapeutics, Inc. (a)  | 14063  | 31220  |
|  Fresh Tracks Therapeutics, Inc. (a)(b)  | 2323  | 4530  |
|  Fusion Pharmaceuticals, Inc. (a)  | 25136  | 57059  |
|  G1 Therapeutics, Inc. (a)  | 21859  | 130280  |
|  Gain Therapeutics, Inc. (a)(b)  | 10062  | 30890  |
|  Galapagos NV sponsored ADR (a)  | 10095  | 401478  |
|  Galectin Therapeutics, Inc. (a)(b)  | 67748  | 86040  |
|  Galecto, Inc. (a)  | 6022  | 9455  |
|  Galera Therapeutics, Inc. (a)(b)  | 19470  | 32126  |
|  Galmed Pharmaceuticals Ltd. (a)  | 27177  | 7985  |
|  Gamida Cell Ltd. (a)(b)  | 36417  | 58267  |
|  Gemini Therapeutics, Inc. (a)(b)  | 10484  | 18032  |
|  Generation Bio Co. (a)  | 30848  | 164420  |
|  Genetron Holdings Ltd. ADR (a)(b)  | 12262  | 12507  |
|  Genfit ADR (a)(b)  | 3215  | 11767  |
|  Genmab A/S ADR (a)(b)  | 26826  | 1248214  |
|  Genprex, Inc. (a)(b)  | 35156  | 47461  |
|  GeoVax Labs, Inc. (a)(b)  | 6138  | 4872  |
|  Geron Corp. (a)  | 216933  | 503285  |
|  Gilead Sciences, Inc.  | 712962  | 62619452  |
|  GlycoMimetics, Inc. (a)  | 30238  | 65314  |
|  Gossamer Bio, Inc. (a)  | 56091  | 480139  |
|  Gracell Biotechnologies, Inc. ADR (a)  | 33164  | 107783  |
|  Graphite Bio, Inc. (a)  | 6112  | 21575  |
|  GreenLight Biosciences Holdings PBC Class A (a)(b)  | 72309  | 107017  |
|  Greenwich Lifesciences, Inc. (a)(b)  | 7220  | 100719  |
|  Grifols SA ADR (a)  | 70799  | 577012  |
|  Gritstone Bio, Inc. (a)(b)  | 38068  | 111920  |
|  Gt Biopharma, Inc. (a)(b)  | 30673  | 50610  |
|  Halozyme Therapeutics, Inc. (a)  | 77113  | 4415490  |
|  Harpoon Therapeutics, Inc. (a)(b)  | 20157  | 13810  |
|  HCW Biologics, Inc. (a)(b)  | 23272  | 49104  |
|  Heron Therapeutics, Inc. (a)(b)  | 53573  | 145183  |
|  HilleVax, Inc. (b)  | 18155  | 363100  |
|  Histogen, Inc. (a)  | 2611  | 2663  |
|  Homology Medicines, Inc. (a)  | 29351  | 45201  |
|  Hookipa Pharma, Inc. (a)  | 14947  | 15844  |
|  Horizon Therapeutics PLC (a)  | 131796  | 13217821  |
|  Humacyte, Inc. Class A (a)(b)  | 58271  | 181806  |
|  Humanigen, Inc. (a)(b)  | 42206  | 5993  |
|  I-Mab ADR (a)  | 34347  | 127084  |
|  Icosavax, Inc. (a)(b)  | 21560  | 72010  |
|  Ideaya Biosciences, Inc. (a)(b)  | 20579  | 367953  |
|  IGM Biosciences, Inc. (a)(b)  | 20964  | 461418  |
|  Imago BioSciences, Inc. (a)  | 17255  | 615831  |
|  Immatics NV (a)(b)  | 33359  | 351604  |
|  Immucell Corp. (a)  | 2008  | 13654  |
|  Immuneering Corp. (a)(b)  | 12929  | 83909  |
|  Immunic, Inc. (a)(b)  | 24307  | 32571  |
|  ImmunityBio, Inc. (a)(b)  | 241028  | 1328064  |
|  Immunocore Holdings PLC ADR (a)  | 14458  | 908107  |
|  ImmunoGen, Inc. (a)  | 118035  | 612602  |
|  Immunome, Inc. (a)(b)  | 5950  | 25407  |
|  Immunovant, Inc. (a)  | 69125  | 906229  |
|  Immutep Ltd. ADR (a)(b)  | 18722  | 44933  |
|  Impel Pharmaceuticals, Inc. (a)(b)  | 15005  | 40063  |
|  Imunon, Inc. (a)(b)  | 4368  | 6115  |
|  IMV, Inc. (a)(b)  | 48826  | 12831  |
|  In8bio, Inc. (a)(b)  | 6860  | 11936  |
|  Incyte Corp. (a)  | 124372  | 9908717  |
|  Indaptus Therapeutics, Inc. (a)(b)  | 14123  | 25704  |
|  Infinity Pharmaceuticals, Inc. (a)  | 53051  | 29109  |
|  InflaRx NV (a)(b)  | 26327  | 68450  |
|  Inhibikase Therapeutics, Inc. (a)(b)  | 19623  | 11876  |
|  Inhibrx, Inc. (a)(b)  | 21784  | 653084  |
|  Inmune Bio, Inc. (a)(b)  | 9762  | 69798  |
|  Inovio Pharmaceuticals, Inc. (a)(b)  | 144978  | 295755  |
|  Inozyme Pharma, Inc. (a)(b)  | 11828  | 17151  |
|  Insmed, Inc. (a)  | 81603  | 1508839  |
|  Instil Bio, Inc. (a)  | 28855  | 38377  |
|  Intellia Therapeutics, Inc. (a)  | 42922  | 2208766  |
|  Intercept Pharmaceuticals, Inc. (a)  | 26978  | 402242  |
|  Inventiva SA ADR (a)(b)  | 2231  | 8969  |
|  Invivyd, Inc. (a)(b)  | 35200  | 79552  |
|  IO Biotech, Inc. (b)  | 12730  | 37044  |
|  Ionis Pharmaceuticals, Inc. (a)  | 79115  | 3227101  |
|  Iovance Biotherapeutics, Inc. (a)  | 100219  | 641402  |
|  Ironwood Pharmaceuticals, Inc. Class A (a)  | 85592  | 1036519  |
|  iTeos Therapeutics, Inc. (a)  | 21888  | 441043  |
|  Iveric Bio, Inc. (a)  | 68193  | 1610719  |
|  Janux Therapeutics, Inc. (a)(b)  | 24032  | 327796  |
|  Jasper Therapeutics, Inc. (a)(b)  | 11380  | 6968  |
|  Jounce Therapeutics, Inc. (a)  | 24576  | 21627  |
|  Kalvista Pharmaceuticals, Inc. (a)  | 13938  | 75126  |
|  Kamada Ltd. (a)(b)  | 25878  | 121627  |
|  Karuna Therapeutics, Inc. (a)  | 19413  | 4568073  |
|  Karyopharm Therapeutics, Inc. (a)(b)  | 56050  | 296505  |
|  Kazia Therapeutics Ltd. sponsored ADR (a)(b)  | 4948  | 2987  |
|  Keros Therapeutics, Inc. (a)  | 16512  | 822958  |
|  Kezar Life Sciences, Inc. (a)(b)  | 32480  | 253669  |
|  Kiniksa Pharmaceuticals Ltd. (a)  | 21394  | 360061  |
|  Kinnate Biopharma, Inc. (a)(b)  | 23511  | 186207  |
|  Kintara Therapeutics, Inc. (a)(b)  | 1217  | 8154  |
|  Kiromic BioPharma, Inc. (a)(b)  | 36662  | 9444  |
|  Kodiak Sciences, Inc. (a)  | 24583  | 181423  |
|  Kronos Bio, Inc. (a)  | 6000  | 11400  |
|  Krystal Biotech, Inc. (a)(b)  | 16323  | 1268950  |
|  Kura Oncology, Inc. (a)  | 42255  | 666361  |
|  Kymera Therapeutics, Inc. (a)(b)  | 28402  | 823090  |
|  Lantern Pharma, Inc. (a)(b)  | 6838  | 34190  |
|  Larimar Therapeutics, Inc. (a)  | 9372  | 29709  |
|  LAVA Therapeutics NV (a)(b)  | 11124  | 61293  |
|  Leap Therapeutics, Inc. (a)(b)  | 56927  | 34418  |
|  Legend Biotech Corp. ADR (a)  | 31542  | 1624728  |
|  Lexicon Pharmaceuticals, Inc. (a)  | 99564  | 213067  |
|  LianBio ADR (b)  | 9426  | 14799  |
|  Liminal BioSciences, Inc. (a)  | 22737  | 10232  |
|  Lixte Biotechnology Holdings, Inc. (a)(b)  | 25794  | 20248  |
|  Longeveron, Inc. (a)(b)  | 5000  | 19400  |
|  Lumos Pharma, Inc. (a)  | 10037  | 51389  |
|  Lyell Immunopharma, Inc. (a)(b)  | 139442  | 587051  |
|  Macrogenics, Inc. (a)  | 33170  | 213283  |
|  Madrigal Pharmaceuticals, Inc. (a)(b)  | 9320  | 653425  |
|  Magenta Therapeutics, Inc. (a)(b)  | 44600  | 51290  |
|  Mainz Biomed BV (b)  | 6180  | 54384  |
|  MannKind Corp. (a)(b)  | 145163  | 679363  |
|  Marker Therapeutics, Inc. (a)(b)  | 23429  | 7029  |
|  Medicenna Therapeutics Corp. (a)  | 34144  | 18096  |
|  MediciNova, Inc. (a)(b)  | 25966  | 68550  |
|  MEI Pharma, Inc. (a)(b)  | 63738  | 21684  |
|  MeiraGTx Holdings PLC (a)  | 27678  | 170496  |
|  Mereo Biopharma Group PLC ADR (a)  | 96630  | 76154  |
|  Merrimack Pharmaceuticals, Inc. (a)  | 5307  | 63206  |
|  Mersana Therapeutics, Inc. (a)  | 62187  | 414165  |
|  Merus BV (a)(b)  | 24770  | 380220  |
|  Mesoblast Ltd. sponsored ADR (a)(b)  | 7548  | 27928  |
|  Metacrine, Inc. (a)(b)  | 8616  | 3490  |
|  Midatech Pharma PLC ADR (a)(b)  | 1479  | 2263  |
|  MiMedx Group, Inc. (a)  | 60376  | 196222  |
|  Minerva Neurosciences, Inc. (a)(b)  | 6000  | 21240  |
|  MiNK Therapeutics, Inc. (a)(b)  | 16475  | 43659  |
|  Mirati Therapeutics, Inc. (a)  | 31112  | 2843015  |
|  Mirum Pharmaceuticals, Inc. (a)  | 18963  | 353660  |
|  Moderna, Inc. (a)  | 223048  | 39236374  |
|  Molecular Partners AG ADR (a)  | 1070  | 6902  |
|  Molecular Templates, Inc. (a)(b)  | 52167  | 27643  |
|  Moleculin Biotech, Inc. (a)(b)  | 15561  | 22408  |
|  Monopar Therapeutics, Inc. (a)(b)  | 13453  | 34574  |
|  Monte Rosa Therapeutics, Inc. (a)(b)  | 24310  | 206149  |
|  Moonlake Immunotherapeutics (a)(b)  | 11451  | 110273  |
|  Morphic Holding, Inc. (a)(b)  | 25856  | 711557  |
|  Morphosys AG sponsored ADR (a)  | 6994  | 28815  |
|  Mustang Bio, Inc. (a)  | 45890  | 23174  |
|  Myriad Genetics, Inc. (a)  | 44051  | 892473  |
|  Nanobiotix SA ADR (a)(b)  | 1588  | 6273  |
|  Natera, Inc. (a)  | 54647  | 2247085  |
|  Neoleukin Therapeutics, Inc. (a)  | 22529  | 11490  |
|  Neubase Therapeutics, Inc. (a)(b)  | 19719  | 4581  |
|  Neurobo Pharmaceuticals, Inc. (a)(b)  | 915  | 1327  |
|  Neurobo Pharmaceuticals, Inc. rights (a)(c)  | 612  | 0  |
|  Neurocrine Biosciences, Inc. (a)  | 53541  | 6802919  |
|  NewAmsterdam Pharma Co. NV (a)  | 8914  | 72203  |
|  Neximmune, Inc. (a)(b)  | 11947  | 5293  |
|  NextCure, Inc. (a)(b)  | 15140  | 21347  |
|  Nkarta, Inc. (a)(b)  | 31469  | 266857  |
|  Novavax, Inc. (a)(b)  | 37615  | 620271  |
|  NuCana PLC ADR (a)  | 12486  | 10573  |
|  Nurix Therapeutics, Inc. (a)  | 35104  | 434939  |
|  Nuvalent, Inc. Class A (a)  | 24898  | 818646  |
|  Nuvectis Pharma, Inc. (b)  | 2904  | 21112  |
|  Nymox Pharmaceutical Corp. (a)(b)  | 50678  | 15452  |
|  ObsEva SA (a)(b)  | 82227  | 14135  |
|  Ocugen, Inc. (a)(b)  | 111130  | 173363  |
|  Olema Pharmaceuticals, Inc. (a)  | 19973  | 57323  |
|  Omega Therapeutics, Inc. (a)(b)  | 27098  | 189686  |
|  Omniab, Inc. (c)  | 3424  | 7362  |
|  Omniab, Inc. (c)  | 3424  | 6916  |
|  OncoCyte Corp. (a)(b)  | 67850  | 31896  |
|  Oncolytics Biotech, Inc. (a)(b)  | 34659  | 61000  |
|  Oncorus, Inc. (a)(b)  | 5013  | 2407  |
|  OncoSec Medical, Inc. (a)(b)  | 706  | 1998  |
|  Oncternal Therapeutics, Inc. (a)(b)  | 28548  | 25982  |
|  Oncternal Therapeutics, Inc. rights (a)(c)  | 4319  | 0  |
|  OpGen, Inc. (a)(b)  | 26107  | 5169  |
|  Opthea Ltd. ADR (a)(b)  | 5049  | 25245  |
|  Orchard Therapeutics PLC ADR (a)  | 26079  | 11535  |
|  Organogenesis Holdings, Inc. Class A (a)  | 71506  | 195926  |
|  Organovo Holdings, Inc. (a)(b)  | 6946  | 10488  |
|  Orgenesis, Inc. (a)(b)  | 14931  | 29862  |
|  ORIC Pharmaceuticals, Inc. (a)(b)  | 4177  | 14995  |
|  Outlook Therapeutics, Inc. (a)(b)  | 106981  | 111260  |
|  Ovid Therapeutics, Inc. (a)(b)  | 34929  | 61824  |
|  Oyster Point Pharma, Inc. (a)  | 14178  | 158510  |
|  Panbela Therapeutics, Inc. (a)  | 5902  | 777  |
|  Pardes Biosciences, Inc. (a)  | 30249  | 27230  |
|  Passage Bio, Inc. (a)  | 20164  | 24600  |
|  PDS Biotechnology Corp. (a)(b)  | 17716  | 159975  |
|  PepGen, Inc.  | 13803  | 206493  |
|  PharmaCyte Biotech, Inc. (a)(b)  | 26211  | 79157  |
|  Pharming Group NV ADR (a)  | 2093  | 27711  |
|  PhaseBio Pharmaceuticals, Inc. (a)  | 69132  | 3159  |
|  Phio Pharmaceuticals Corp. (a)(b)  | 34287  | 14401  |
|  Pieris Pharmaceuticals, Inc. (a)  | 22483  | 21932  |
|  Pluri, Inc. (a)(b)  | 25169  | 19884  |
|  Plus Therapeutics, Inc. (a)  | 133500  | 53720  |
|  PMV Pharmaceuticals, Inc. (a)(b)  | 22093  | 220488  |
|  Point Biopharma Global, Inc. (a)(b)  | 64547  | 439565  |
|  Polarityte, Inc. (a)(b)  | 4691  | 3248  |
|  Portage Biotech, Inc. (a)(b)  | 6935  | 40778  |
|  Poseida Therapeutics, Inc. (a)  | 45001  | 205205  |
|  Praxis Precision Medicines, Inc. (a)  | 30282  | 66923  |
|  Precigen, Inc. (a)(b)  | 111174  | 202337  |
|  Precision BioSciences, Inc. (a)  | 32101  | 43978  |
|  Prelude Therapeutics, Inc. (a)(b)  | 34715  | 231549  |
|  Prenetics Global Ltd. (a)(b)  | 2516  | 4604  |
|  Prime Medicine, Inc. (b)  | 31560  | 542516  |
|  ProKidney Corp. (a)(b)  | 10249  | 93368  |
|  Prometheus Biosciences, Inc. (a)  | 21739  | 893690  |
|  ProQR Therapeutics BV (a)(b)  | 36293  | 44640  |
|  Protagenic Therapeutics, Inc. (a)  | 20025  | 10633  |
|  Protagonist Therapeutics, Inc. (a)  | 41621  | 329222  |
|  Prothena Corp. PLC (a)  | 25528  | 1595755  |
|  PTC Therapeutics, Inc. (a)  | 39780  | 1650472  |
|  Puma Biotechnology, Inc. (a)  | 21531  | 97320  |
|  PureTech Health PLC ADR (a)(b)  | 566  | 19244  |
|  Pyxis Oncology, Inc. (a)(b)  | 17549  | 25446  |
|  Qualigen Therapeutics, Inc. (a)  | 4888  | 7332  |
|  Quince Therapeutics, Inc. (a)(b)  | 15115  | 11140  |
|  Radius Health, Inc. (c)  | 26855  | 2148  |
|  Rallybio Corp. (a)  | 18015  | 103766  |
|  RAPT Therapeutics, Inc. (a)  | 15878  | 280723  |
|  Recursion Pharmaceuticals, Inc. (a)(b)  | 90378  | 849553  |
|  Regeneron Pharmaceuticals, Inc. (a)  | 61021  | 45869486  |
|  REGENXBIO, Inc. (a)  | 23128  | 552759  |
|  Regulus Therapeutics, Inc. (a)(b)  | 9205  | 15741  |
|  Relay Therapeutics, Inc. (a)(b)  | 70041  | 1301362  |
|  Reneo Pharmaceuticals, Inc. (a)(b)  | 13048  | 28967  |
|  RenovoRx, Inc. (a)(b)  | 3794  | 7398  |
|  Repare Therapeutics, Inc. (a)(b)  | 26544  | 425500  |
|  Repligen Corp. (a)(b)  | 31171  | 5574622  |
|  Replimune Group, Inc. (a)  | 34598  | 708221  |
|  Revelation Biosciences, Inc. (a)(b)  | 1542  | 324  |
|  Revolution Medicines, Inc. (a)(b)  | 53109  | 1252841  |
|  Rezolute, Inc. (a)(b)  | 7752  | 12713  |
|  Rhythm Pharmaceuticals, Inc. (a)(b)  | 28353  | 759010  |
|  Rigel Pharmaceuticals, Inc. (a)  | 90653  | 60883  |
|  Rocket Pharmaceuticals, Inc. (a)(b)  | 49396  | 932596  |
|  Roivant Sciences Ltd. (a)(b)  | 403636  | 2163489  |
|  Rubius Therapeutics, Inc. (a)(b)  | 49919  | 11082  |
|  S.A.B. Biotherapeutics, Inc. (a)(b)  | 14671  | 15845  |
|  Sage Therapeutics, Inc. (a)  | 32980  | 1353499  |
|  Salarius Pharmaceuticals, Inc. (a)  | 1402  | 2706  |
|  Salarius Pharmaceuticals, Inc. warrants 1/20/25 (a)(b)  | 122366  | 13  |
|  Sana Biotechnology, Inc. (a)(b)  | 125768  | 627582  |
|  Sangamo Therapeutics, Inc. (a)  | 74184  | 271513  |
|  Sarepta Therapeutics, Inc. (a)(b)  | 48781  | 5990795  |
|  Savara, Inc. (a)  | 71163  | 112438  |
|  Scholar Rock Holding Corp. (a)(b)  | 38010  | 295338  |
|  Seagen, Inc. (a)  | 105237  | 12774719  |
|  Selecta Biosciences, Inc. (a)(b)  | 116771  | 152970  |
|  Sellas Life Sciences Group, Inc. (a)(b)  | 12014  | 28713  |
|  Sensei Biotherapeutics, Inc. (a)(b)  | 16931  | 24042  |
|  Senti Biosciences, Inc. (a)(b)  | 28123  | 64683  |
|  Sera Prognostics, Inc. (a)(b)  | 16037  | 21490  |
|  Seres Therapeutics, Inc. (a)  | 77368  | 502892  |
|  Sesen Bio, Inc. (a)(b)  | 92579  | 51270  |
|  Shattuck Labs, Inc. (a)  | 21179  | 48076  |
|  Sigilon Therapeutics, Inc. (a)  | 10210  | 4255  |
|  Silence Therapeutics PLC ADR (a)(b)  | 13177  | 206615  |
|  Sinovac Biotech Ltd. (a)(c)  | 27717  | 179329  |
|  Sio Gene Therapies, Inc. (a)(b)  | 27754  | 8545  |
|  Societal Cdmo, Inc. (a)(b)  | 19350  | 34830  |
|  Soleno Therapeutics, Inc. (a)(b)  | 4007  | 4328  |
|  Solid Biosciences, Inc. (a)(b)  | 4251  | 28482  |
|  Soligenix, Inc. (a)(b)  | 54007  | 30303  |
|  Sorrento Therapeutics, Inc. (a)(b)  | 278594  | 362172  |
|  Spectrum Pharmaceuticals, Inc. (a)(b)  | 45316  | 20873  |
|  Spero Therapeutics, Inc. (a)(b)  | 4197  | 8142  |
|  SpringWorks Therapeutics, Inc. (a)(b)  | 27008  | 653053  |
|  Spruce Biosciences, Inc. (a)(b)  | 9482  | 10430  |
|  Statera Biopharma, Inc. (a)(b)  | 11084  | 1386  |
|  Stoke Therapeutics, Inc. (a)  | 30371  | 228997  |
|  Summit Therapeutics, Inc. (a)  | 54355  | 43484  |
|  Sunshine Biopharma, Inc. (b)  | 20179  | 15964  |
|  Surface Oncology, Inc. (a)  | 23135  | 21284  |
|  Surrozen, Inc. (a)(b)  | 16964  | 10518  |
|  Sutro Biopharma, Inc. (a)  | 41361  | 309794  |
|  Synaptogenix, Inc. (a)(b)  | 5004  | 29724  |
|  Syndax Pharmaceuticals, Inc. (a)  | 38393  | 919896  |
|  Synlogic, Inc. (a)  | 71644  | 42857  |
|  Syros Pharmaceuticals, Inc. (a)(b)  | 3168  | 12545  |
|  T2 Biosystems, Inc. (a)(b)  | 3228  | 5391  |
|  Talaris Therapeutics, Inc. (a)  | 2104  | 3072  |
|  Tango Therapeutics, Inc. (a)  | 57955  | 435242  |
|  Taysha Gene Therapies, Inc. (a)  | 3167  | 6999  |
|  TCR2 Therapeutics, Inc. (a)  | 7938  | 10558  |
|  Tempest Therapeutics, Inc. (a)(b)  | 11414  | 17920  |
|  Tenax Therapeutics, Inc. (a)(b)  | 30408  | 4500  |
|  Tenaya Therapeutics, Inc. (a)  | 21980  | 58247  |
|  TG Therapeutics, Inc. (a)  | 95642  | 843562  |
|  Theratechnologies, Inc. (a)  | 51510  | 109716  |
|  Tiziana Life Sciences Ltd. (a)(b)  | 55884  | 35486  |
|  Tobira Therapeutics, Inc. rights (a)(b)(c)  | 6103  | 0  |
|  TONIX Pharmaceuticals Holding (a)(b)  | 6759  | 2602  |
|  TRACON Pharmaceuticals, Inc. (a)  | 18969  | 28643  |
|  TransCode Therapeutics, Inc. (a)(b)  | 17023  | 6809  |
|  Travere Therapeutics, Inc. (a)  | 38619  | 777400  |
|  Trevena, Inc. (a)(b)  | 7457  | 25764  |
|  TScan Therapeutics, Inc. (a)  | 12786  | 27490  |
|  Twist Bioscience Corp. (a)  | 32492  | 888656  |
|  Tyra Biosciences, Inc. (a)(b)  | 23991  | 168177  |
|  Ultragenyx Pharmaceutical, Inc. (a)  | 38924  | 1412941  |
|  Unicycive Therapeutics, Inc. (a)(b)  | 26109  | 18595  |
|  uniQure B.V. (a)  | 25416  | 672507  |
|  United Therapeutics Corp. (a)  | 25367  | 7099970  |
|  UNITY Biotechnology, Inc. (a)(b)  | 4580  | 12595  |
|  UroGen Pharma Ltd. (a)(b)  | 14376  | 123202  |
|  Vaccinex, Inc. (a)(b)  | 39392  | 19889  |
|  Vaccitech PLC ADR (a)(b)  | 7880  | 17651  |
|  Valneva SE ADR (a)(b)  | 359  | 4520  |
|  Vanda Pharmaceuticals, Inc. (a)  | 35063  | 382537  |
|  Vascular Biogenics Ltd. (a)(b)  | 40323  | 6448  |
|  Vaxart, Inc. (a)(b)  | 167528  | 197683  |
|  Vaxcyte, Inc. (a)  | 44411  | 2045571  |
|  Vaxxinity, Inc. Class A (b)  | 40244  | 105439  |
|  VBI Vaccines, Inc. (a)(b)  | 280778  | 146005  |
|  VectivBio Holding AG (a)  | 23054  | 193193  |
|  Vera Therapeutics, Inc. (a)(b)  | 14729  | 245974  |
|  Veracyte, Inc. (a)(b)  | 42321  | 1173985  |
|  Verastem, Inc. (a)(b)  | 111497  | 51289  |
|  Vericel Corp. (a)  | 25530  | 582850  |
|  Vertex Pharmaceuticals, Inc. (a)  | 145804  | 46132386  |
|  Verve Therapeutics, Inc. (a)(b)  | 34834  | 809194  |
|  Vigil Neuroscience, Inc.  | 7791  | 97388  |
|  Viking Therapeutics, Inc. (a)(b)  | 46434  | 188058  |
|  Vincerx Pharma, Inc. (a)(b)  | 9297  | 6508  |
|  Vir Biotechnology, Inc. (a)  | 76218  | 2150872  |
|  Viracta Therapeutics, Inc. (a)  | 25757  | 59756  |
|  Viridian Therapeutics, Inc. (a)(b)  | 30260  | 764670  |
|  Viridian Therapeutics, Inc. rights (a)(c)  | 30380  | 0  |
|  Virios Therapeutics, Inc. (a)(b)  | 3038  | 881  |
|  VistaGen Therapeutics, Inc. (a)  | 109903  | 15178  |
|  Vor Biopharma, Inc. (a)(b)  | 17145  | 78867  |
|  Voyager Therapeutics, Inc. (a)(b)  | 22411  | 133121  |
|  vTv Therapeutics, Inc. Class A (a)(b)  | 44768  | 36763  |
|  Vyant Bio, Inc. (a)  | 3943  | 4889  |
|  Werewolf Therapeutics, Inc. (a)(b)  | 15965  | 29216  |
|  Windtree Therapeutics, Inc. (a)(b)  | 19030  | 3663  |
|  X4 Pharmaceuticals, Inc. (a)  | 45600  | 68400  |
|  Xbiotech, Inc. (a)  | 15395  | 49880  |
|  Xencor, Inc. (a)  | 34666  | 1030274  |
|  Xenetic Biosciences, Inc. (a)(b)  | 20698  | 8910  |
|  Xenon Pharmaceuticals, Inc. (a)  | 36857  | 1359286  |
|  Xilio Therapeutics, Inc. (a)(b)  | 15714  | 40228  |
|  XOMA Corp. (a)(b)  | 6585  | 139404  |
|  XTL Biopharmaceuticals Ltd. ADR (a)  | 8903  | 10506  |
|  Y-mAbs Therapeutics, Inc. (a)(b)  | 12280  | 54892  |
|  Yield10 Bioscience, Inc. (a)(b)  | 7586  | 17751  |
|  Yumanity Therapeutics, Inc. (a)  | 21160  | 37876  |
|  Yumanity Therapeutics, Inc. rights (a)(c)  | 39785  | 0  |
|  Zai Lab Ltd. ADR (a)  | 38656  | 1490575  |
|  Zentalis Pharmaceuticals, Inc. (a)(b)  | 32066  | 709300  |
|  |  | 588683722  |
| Health Care Equipment & Supplies - 2.0%  |  |  |
|  Abiomed, Inc. (a)  | 25975  | 9813095  |
|  Accelerate Diagnostics, Inc. (a)(b)  | 83483  | 72447  |
|  Accuray, Inc. (a)(b)  | 50472  | 103468  |
|  Acutus Medical, Inc. (a)(b)  | 5828  | 4721  |
|  Aethlon Medical, Inc. (a)(b)  | 31992  | 13533  |
|  Align Technology, Inc. (a)  | 44262  | 8704565  |
|  Allied Healthcare Products, Inc. (a)  | 1352  | 1555  |
|  Alpha Tau Medical Ltd. Class A (a)  | 20242  | 80766  |
|  Alphatec Holdings, Inc. (a)  | 53739  | 551362  |
|  Angiodynamics, Inc. (a)  | 20081  | 260049  |
|  Apollo Endosurgery, Inc. (a)(b)  | 16872  | 170913  |
|  Apyx Medical Corp. (a)  | 18122  | 31895  |
|  Aspira Women's Health, Inc. (a)(b)  | 64182  | 23234  |
|  Atricure, Inc. (a)  | 25041  | 1140868  |
|  Atrion Corp.  | 1094  | 661651  |
|  Avinger, Inc. (a)(b)  | 3056  | 3789  |
|  AxoGen, Inc. (a)  | 22322  | 244426  |
|  Axonics Modulation Technologies, Inc. (a)  | 25864  | 1771167  |
|  Beyond Air, Inc. (a)(b)  | 24913  | 142751  |
|  BioLase Technology, Inc. (a)(b)  | 4175  | 4033  |
|  Biomerica, Inc. (a)(b)  | 5860  | 20393  |
|  BioSig Technologies, Inc. (a)(b)  | 16167  | 6627  |
|  Bioventus, Inc. (a)(b)  | 34854  | 67965  |
|  BrainsWay Ltd. ADR (a)(b)  | 3457  | 6534  |
|  Cardiovascular Systems, Inc. (a)  | 23790  | 333298  |
|  Cerus Corp. (a)  | 93501  | 374004  |
|  Check Capital Ltd. (a)(b)  | 2931  | 10141  |
|  Chembio Diagnostics, Inc. (a)(b)  | 75338  | 22601  |
|  ClearPoint Neuro, Inc. (a)(b)  | 13370  | 126079  |
|  Co.-Diagnostics, Inc. (a)(b)  | 17214  | 51814  |
|  ConforMis, Inc. (a)(b)  | 3067  | 8588  |
|  Cue Health, Inc. (a)(b)  | 79656  | 254899  |
|  Cutera, Inc. (a)(b)  | 10797  | 513721  |
|  CVRx, Inc. (a)(b)  | 10458  | 139928  |
|  CytoSorbents Corp. (a)(b)  | 21655  | 30317  |
|  DarioHealth Corp. (a)(b)  | 11331  | 56202  |
|  Delcath Systems, Inc. (a)(b)  | 2322  | 6594  |
|  Dentsply Sirona, Inc.  | 121331  | 3671476  |
|  DexCom, Inc. (a)  | 224366  | 26089278  |
|  Eargo, Inc. (a)(b)  | 149766  | 95131  |
|  EDAP TMS SA sponsored ADR (a)(b)  | 22764  | 257688  |
|  Ekso Bionics Holdings, Inc. (a)(b)  | 5843  | 6077  |
|  electroCore, Inc. (a)(b)  | 164752  | 54566  |
|  Embecta Corp. (b)  | 34326  | 1130012  |
|  ENDRA Life Sciences, Inc. (a)(b)  | 35458  | 6297  |
|  Envveno Medical Corp. (a)(b)  | 20487  | 120873  |
|  Establishment Labs Holdings, Inc. (a)(b)  | 13987  | 891811  |
|  Femasys, Inc. (a)(b)  | 6504  | 7024  |
|  Fonar Corp. (a)  | 3366  | 63348  |
|  Helius Medical Technologies, Inc. (U.S.) (a)(b)  | 2717  | 848  |
|  Heska Corp. (a)  | 5658  | 364092  |
|  Hologic, Inc. (a)  | 140785  | 10722186  |
|  Hyperfine, Inc. (a)(b)  | 25802  | 20642  |
|  IceCure Medical Ltd. (a)(b)  | 3905  | 4100  |
|  ICU Medical, Inc. (a)(b)  | 13670  | 2176674  |
|  IDEXX Laboratories, Inc. (a)  | 47739  | 20330608  |
|  Inari Medical, Inc. (a)  | 30948  | 2277154  |
|  InMode Ltd. (a)(b)  | 49249  | 1890669  |
|  Inogen, Inc. (a)  | 13301  | 296878  |
|  Inspira Technologies Oxy BHN Ltd. (a)  | 2924  | 3421  |
|  InspireMD, Inc. (a)(b)  | 14051  | 17423  |
|  Insulet Corp. (a)  | 39670  | 11876008  |
|  Integra LifeSciences Holdings Corp. (a)  | 47719  | 2621682  |
|  Intuitive Surgical, Inc. (a)  | 203728  | 55086014  |
|  InVivo Therapeutics Holdings Corp. (a)(b)  | 1757  | 3584  |
|  INVO Bioscience, Inc. (a)(b)  | 4947  | 4723  |
|  IRadimed Corp.  | 7986  | 236066  |
|  iRhythm Technologies, Inc. (a)  | 16900  | 1842945  |
|  Iridex Corp. (a)  | 7305  | 17678  |
|  Kewaunee Scientific Corp. (a)  | 1782  | 29492  |
|  KORU Medical Systems, Inc. (a)(b)  | 31356  | 92500  |
|  Lantheus Holdings, Inc. (a)  | 38748  | 2405476  |
|  Lantheus Holdings, Inc. rights (a)(c)  | 50063  | 1  |
|  LeMaitre Vascular, Inc. (b)  | 12899  | 604318  |
|  LENSAR, Inc. (a)  | 5527  | 18294  |
|  LivaNova PLC (a)  | 29154  | 1614257  |
|  LMF Acquisition Opportunities, Inc. (a)(b)  | 1152  | 4908  |
|  LogicMark, Inc. (a)(b)  | 6057  | 3875  |
|  Lucid Diagnostics, Inc. (a)(b)  | 11733  | 21823  |
|  Lucira Health, Inc. (a)(b)  | 19597  | 7447  |
|  LumiraDx Ltd. (a)(b)  | 24829  | 34016  |
|  Masimo Corp. (a)  | 29536  | 4280948  |
|  Medigus Ltd. ADR (a)  | 510  | 3218  |
|  Meihua International Medical Technologies Co. Ltd. (b)  | 6446  | 86570  |
|  Meridian Bioscience, Inc. (a)  | 24681  | 789792  |
|  Merit Medical Systems, Inc. (a)  | 31052  | 2235744  |
|  Mesa Laboratories, Inc. (b)  | 2822  | 477398  |
|  Microbot Medical, Inc. (a)(b)  | 2681  | 12199  |
|  Minerva Surgical, Inc. (a)  | 7396  | 1332  |
|  Motus GI Holdings, Inc. (a)(b)  | 2146  | 2876  |
|  Nano-X Imaging Ltd. (a)(b)  | 29795  | 317317  |
|  NanoVibronix, Inc. (a)(b)  | 25676  | 10399  |
|  Nemaura Medical, Inc. (a)(b)  | 11700  | 25038  |
|  Neogen Corp. (a)  | 129217  | 2139834  |
|  Neovasc, Inc. (a)(b)  | 854  | 7473  |
|  NeuroMetrix, Inc. (a)(b)  | 2657  | 4464  |
|  Neuronetics, Inc. (a)  | 6338  | 39803  |
|  NeuroOne Medical Technologies Corp. (a)(b)  | 1701  | 2398  |
|  NeuroPace, Inc. (a)(b)  | 12686  | 20424  |
|  NEXGEL, Inc. (a)  | 547  | 651  |
|  Novocure Ltd. (a)(b)  | 59933  | 4605252  |
|  NuVasive, Inc. (a)  | 29326  | 1139022  |
|  Nyxoah SA (a)(b)  | 3633  | 18892  |
|  Omnicell, Inc. (a)  | 24667  | 1273064  |
|  OraSure Technologies, Inc. (a)  | 41450  | 208908  |
|  Orthofix International NV (a)  | 9251  | 166425  |
|  OrthoPediatrics Corp. (a)  | 15188  | 668120  |
|  Outset Medical, Inc. (a)  | 25168  | 530541  |
|  PAVmed, Inc. (a)(b)  | 45379  | 31765  |
|  PetVivo Holdings, Inc. (a)(b)  | 12298  | 29884  |
|  Predictive Oncology, Inc. (a)(b)  | 131210  | 50529  |
|  Pro-Dex, Inc. (a)  | 3523  | 61829  |
|  PROCEPT BioRobotics Corp. (a)  | 25611  | 1098712  |
|  Profound Medical Corp. (a)(b)  | 10870  | 51741  |
|  Pulse Biosciences, Inc. (a)(b)  | 15897  | 31794  |
|  QuidelOrtho Corp. (a)  | 45625  | 3997206  |
|  Quotient Ltd. (a)(b)  | 1501  | 1141  |
|  ReWalk Robotics Ltd. (a)(b)  | 29639  | 27309  |
|  Rockwell Medical Technologies, Inc. (a)(b)  | 3194  | 3481  |
|  RxSight, Inc. (a)  | 21683  | 276892  |
|  Sanara Medtech, Inc. (a)(b)  | 4237  | 158760  |
|  Seaspine Holdings Corp. (a)  | 37511  | 280957  |
|  Semler Scientific, Inc. (a)  | 4084  | 121050  |
|  Sensus Healthcare, Inc. (a)(b)  | 10687  | 71389  |
|  Shockwave Medical, Inc. (a)  | 20121  | 5102686  |
|  SI-BONE, Inc. (a)  | 17331  | 212825  |
|  Sientra, Inc. (a)(b)  | 31005  | 8681  |
|  Sight Sciences, Inc. (a)(b)  | 24595  | 274726  |
|  Silk Road Medical, Inc. (a)  | 19105  | 1017341  |
|  Sintx Technologies, Inc. (a)(b)  | 21155  | 2833  |
|  SmileDirectClub, Inc. (a)(b)  | 44592  | 27116  |
|  Staar Surgical Co. (a)  | 26676  | 1523466  |
|  STRATA Skin Sciences, Inc. (a)(b)  | 17447  | 15008  |
|  Surgalign Holdings, Inc. (a)(b)  | 11452  | 25767  |
|  SurModics, Inc. (a)  | 7764  | 280513  |
|  Tactile Systems Technology, Inc. (a)  | 12519  | 107163  |
|  Talis Biomedical Corp. (a)(b)  | 13579  | 7451  |
|  Tandem Diabetes Care, Inc. (a)  | 35812  | 1505895  |
|  Tela Bio, Inc. (a)  | 6966  | 58445  |
|  Thermogenesis Holdings, Inc. (a)  | 6501  | 926  |
|  Titan Medical, Inc. (a)(b)  | 76620  | 37544  |
|  TransMedics Group, Inc. (a)  | 17684  | 1094109  |
|  Treace Medical Concepts, Inc. (a)  | 28866  | 668248  |
|  Trinity Biotech PLC sponsored ADR (a)  | 5165  | 6818  |
|  UFP Technologies, Inc. (a)  | 5073  | 609014  |
|  Utah Medical Products, Inc.  | 2529  | 225233  |
|  Varex Imaging Corp. (a)  | 23722  | 503855  |
|  Venus Concept, Inc. (a)(b)  | 28117  | 6475  |
|  ViewRay, Inc. (a)  | 126726  | 610819  |
|  Vivani Medical, Inc. (a)  | 3026  | 4236  |
|  Viveve Medical, Inc. (a)(b)  | 3780  | 1588  |
|  Zimvie, Inc. (a)  | 17620  | 157523  |
|  Zynex, Inc. (b)  | 24118  | 330899  |
|  |  | 212643120  |
| Health Care Providers & Services - 0.5%  |  |  |
|  1Life Healthcare, Inc. (a)  | 111478  | 1894011  |
|  23andMe Holding Co. Class A (a)(b)  | 182416  | 556369  |
|  Acadia Healthcare Co., Inc. (a)  | 50937  | 4536449  |
|  Accolade, Inc. (a)  | 37420  | 330419  |
|  AdaptHealth Corp. (a)  | 75766  | 1690339  |
|  Addus HomeCare Corp. (a)  | 8720  | 961642  |
|  Aesthetic Medical International Holdings Group Ltd. ADR (a)(b)  | 2491  | 3462  |
|  AirSculpt Technologies, Inc. (b)  | 29506  | 105631  |
|  Akumin, Inc. (a)(b)  | 36627  | 38458  |
|  Alerislife, Inc. (a)  | 17017  | 13462  |
|  Alignment Healthcare, Inc. (a)  | 103822  | 1380833  |
|  Amedisys, Inc. (a)  | 18157  | 1653921  |
|  Apollo Medical Holdings, Inc. (a)(b)  | 31352  | 892278  |
|  Assure Holdings Corp. (a)  | 603  | 242  |
|  Aveanna Healthcare Holdings, Inc. (a)(b)  | 100162  | 67960  |
|  BIMI International Medical, Inc. (a)(b)  | 3568  | 801  |
|  Biodesix, Inc. (a)(b)  | 16804  | 33608  |
|  CareMax, Inc. Class A (a)(b)  | 48842  | 193414  |
|  Castle Biosciences, Inc. (a)  | 13646  | 321909  |
|  Clover Health Investments Corp. (a)(b)  | 296263  | 388105  |
|  Corvel Corp. (a)  | 10115  | 1547292  |
|  Cosmos Holdings, Inc. (a)(b)  | 1384  | 823  |
|  Cross Country Healthcare, Inc. (a)  | 22341  | 799361  |
|  DocGo, Inc. Class A (a)  | 55906  | 410909  |
|  Fulgent Genetics, Inc. (a)  | 15751  | 571289  |
|  G Medical Innovations Holdings Ltd. (a)(b)  | 1112  | 3670  |
|  Great Elm Group, Inc. (a)  | 7056  | 13759  |
|  Greenbrook TMS, Inc. (a)  | 16163  | 35235  |
|  Guardant Health, Inc. (a)  | 59938  | 3137155  |
|  HealthEquity, Inc. (a)  | 48065  | 3051166  |
|  Henry Schein, Inc. (a)  | 77434  | 6265959  |
|  IMAC Holdings, Inc. (a)  | 54807  | 17686  |
|  Innovage Holding Corp. (a)(b)  | 77714  | 503587  |
|  LHC Group, Inc. (a)  | 17264  | 2821110  |
|  LifeStance Health Group, Inc. (a)(b)  | 205726  | 1047145  |
|  Lisata Therapeutics, Inc. (a)(b)  | 2010  | 7176  |
|  Modivcare, Inc. (a)  | 7758  | 597366  |
|  MSP Recovery, Inc. (a)(b)  | 13433  | 14911  |
|  MSP Recovery, Inc. warrants 5/23/27 (a)(b)  | 1585094  | 33287  |
|  National Research Corp. Class A  | 15135  | 586330  |
|  Novo Integrated Sciences, Inc. (a)(b)  | 12127  | 3032  |
|  Ontrak, Inc. (a)(b)  | 10232  | 4400  |
|  Opko Health, Inc. (a)(b)  | 430736  | 646104  |
|  Option Care Health, Inc. (a)  | 102132  | 3075195  |
|  P3 Health Partners, Inc. Class A (a)(b)  | 55233  | 264014  |
|  Patterson Companies, Inc.  | 54157  | 1540225  |
|  Pennant Group, Inc. (a)  | 17279  | 178665  |
|  PetIQ, Inc. Class A (a)  | 15095  | 179178  |
|  Precipio, Inc. (a)(b)  | 61940  | 47496  |
|  Premier, Inc.  | 68207  | 2274703  |
|  Privia Health Group, Inc. (a)  | 60872  | 1456667  |
|  Progyny, Inc. (a)  | 56927  | 2085236  |
|  Psychemedics Corp.  | 4592  | 25991  |
|  Quipt Home Medical Corp. (a)(b)  | 18355  | 82047  |
|  R1 Rcm, Inc. (a)  | 234912  | 2125954  |
|  RadNet, Inc. (a)  | 43419  | 858394  |
|  Reunion Neuroscience, Inc. (a)  | 925  | 1184  |
|  Sema4 Holdings Corp. Class A (a)(b)  | 167679  | 69453  |
|  Star Equity Holdings, Inc. (a)(b)  | 11004  | 10673  |
|  Surgery Partners, Inc. (a)  | 49363  | 1397467  |
|  Talkspace, Inc. Class A (a)(b)  | 79242  | 69733  |
|  The Ensign Group, Inc.  | 31601  | 3002095  |
|  The Joint Corp. (a)(b)  | 8305  | 123828  |
|  The Oncology Institute, Inc. (a)  | 32634  | 46014  |
|  Viemed Healthcare, Inc. (a)  | 19429  | 142609  |
|  Virax Biolabs Group Ltd. (b)(d)  | 5416  | 8449  |
|  Vivos Therapeutics, Inc. (a)(b)  | 36452  | 18190  |
|  |  | 56265525  |
| Health Care Technology - 0.1%  |  |  |
|  Akili, Inc. (a)(b)  | 24847  | 36277  |
|  Allscripts Healthcare Solutions, Inc. (a)  | 71702  | 1358036  |
|  Augmedix, Inc. (a)(b)  | 8640  | 10886  |
|  Better Therapeutics, Inc. (a)(b)  | 6986  | 10234  |
|  Biotricity, Inc. (a)(b)  | 31571  | 32834  |
|  CareCloud, Inc. (a)(b)  | 13011  | 43327  |
|  Certara, Inc. (a)  | 90887  | 1543261  |
|  Computer Programs & Systems, Inc. (a)  | 10575  | 313020  |
|  Definitive Healthcare Corp. (a)(b)  | 59328  | 674559  |
|  Field Trip Health & Wellness Ltd. (a)  | 3980  | 374  |
|  Forian, Inc. (a)(b)  | 18658  | 46085  |
|  GoodRx Holdings, Inc. (a)(b)  | 67879  | 295952  |
|  Health Catalyst, Inc. (a)  | 27691  | 290202  |
|  HealthStream, Inc. (a)  | 16614  | 421996  |
|  HTG Molecular Diagnostics (a)(b)  | 9321  | 3076  |
|  iCAD, Inc. (a)  | 17375  | 31275  |
|  iSpecimen, Inc. (a)(b)  | 5334  | 8374  |
|  NantHealth, Inc. (a)(b)  | 55825  | 14235  |
|  Nextgen Healthcare, Inc. (a)  | 39057  | 812386  |
|  Nutex Health, Inc. (a)(b)  | 91634  | 142033  |
|  OptimizeRx Corp. (a)  | 10957  | 231083  |
|  Pear Therapeutics, Inc. Class A (a)(b)  | 76730  | 141951  |
|  Renalytix AI PLC ADR (a)(b)  | 4865  | 9876  |
|  Schrodinger, Inc. (a)  | 31764  | 571752  |
|  SCWorx, Corp. (a)  | 21155  | 9941  |
|  Sharecare, Inc. Class A (a)(b)  | 177650  | 339312  |
|  Simulations Plus, Inc. (b)  | 11532  | 468084  |
|  SOPHiA GENETICS SA (a)(b)  | 20681  | 47773  |
|  Streamline Health Solutions, Inc. (a)(b)  | 14467  | 27921  |
|  Tabula Rasa HealthCare, Inc. (a)(b)  | 16205  | 72923  |
|  Telemynd, Inc. (a)(c)  | 92  | 0  |
|  |  | 8009038  |
| Life Sciences Tools & Services - 0.6%  |  |  |
|  10X Genomics, Inc. (a)  | 50271  | 1943477  |
|  AbCellera Biologics, Inc. (a)(b)  | 166652  | 2144811  |
|  Adaptive Biotechnologies Corp. (a)  | 96336  | 845830  |
|  Akoya Biosciences, Inc. (a)(b)  | 25075  | 325474  |
|  Alpha Teknova, Inc. (a)  | 16055  | 75780  |
|  Applied DNA Sciences, Inc. (a)(b)  | 15383  | 20921  |
|  Avista Public Acquisition Corp. II (a)  | 30218  | 106972  |
|  Azenta, Inc.  | 41417  | 2493718  |
|  Berkeley Lights, Inc. (a)  | 56654  | 166563  |
|  Bio-Techne Corp.  | 87520  | 7438325  |
|  BioLife Solutions, Inc. (a)  | 22958  | 486021  |
|  BioNano Genomics, Inc. (a)(b)  | 155696  | 312949  |
|  Bruker Corp.  | 84447  | 5692572  |
|  Champions Oncology, Inc. (a)  | 10958  | 75610  |
|  ChromaDex, Inc. (a)(b)  | 42495  | 73091  |
|  Codex DNA, Inc. (a)(b)  | 4784  | 6937  |
|  Codexis, Inc. (a)  | 35046  | 191702  |
|  Compugen Ltd. (a)(b)  | 27170  | 32604  |
|  CryoPort, Inc. (a)(b)  | 26414  | 521677  |
|  Cytek Biosciences, Inc. (a)  | 77112  | 993974  |
|  Evotec SE ADR  | 13238  | 115700  |
|  Genetic Technologies Ltd. ADR (a)(b)  | 2511  | 2812  |
|  Harvard Bioscience, Inc. (a)  | 25302  | 64773  |
|  ICON PLC (a)  | 45714  | 9848624  |
|  Illumina, Inc. (a)  | 89926  | 19611062  |
|  ImmunoPrecise Antibodies Ltd. (a)(b)  | 17484  | 84448  |
|  Inotiv, Inc. (a)(b)  | 12964  | 78303  |
|  IsoPlexis Corp. (a)(b)  | 21237  | 28882  |
|  Maravai LifeSciences Holdings, Inc. (a)  | 75470  | 1122994  |
|  MaxCyte, Inc. (a)  | 54747  | 327935  |
|  Medpace Holdings, Inc. (a)  | 18516  | 3886323  |
|  Miromatrix Medical, Inc. (a)(b)  | 10203  | 42751  |
|  Nanostring Technologies, Inc. (a)  | 19570  | 136794  |
|  Nautilus Biotechnology, Inc. (a)(b)  | 73031  | 132186  |
|  NeoGenomics, Inc. (a)  | 71021  | 796145  |
|  Olink Holding AB ADR (a)(b)  | 19562  | 466162  |
|  Pacific Biosciences of California, Inc. (a)(b)  | 137017  | 1472933  |
|  Personalis, Inc. (a)(b)  | 23807  | 60470  |
|  Quanterix Corp. (a)  | 17243  | 229332  |
|  Quantum-Si, Inc. (a)(b)  | 64799  | 154222  |
|  Quoin Pharmaceuticals Ltd.:  |  |  |
|  ADR (a)(b)(e)  | 1151  | 1922  |
|  rights (a)(c)  | 3438400  | 34  |
|  Rapid Micro Biosystems, Inc. (a)(b)  | 21522  | 44120  |
|  Science 37 Holdings, Inc. (a)  | 82595  | 49243  |
|  Seer, Inc. (a)(b)  | 35353  | 228380  |
|  Singular Genomics Systems, Inc. (a)  | 20061  | 40924  |
|  SomaLogic, Inc. Class A (a)  | 147281  | 412387  |
|  Sotera Health Co. (a)  | 159442  | 1329746  |
|  Standard BioTools, Inc. (a)(b)  | 41862  | 58188  |
|  Syneos Health, Inc. (a)  | 57615  | 2032657  |
|  |  | 66809460  |
| Pharmaceuticals - 0.9%  |  |  |
|  9 Meters Biopharma, Inc. (a)(b)  | 6852  | 11717  |
|  A Menarini Industrie Farmaceut rights (a)(c)  | 32407  | 0  |
|  Acasti Pharma, Inc. (a)(b)  | 18348  | 7521  |
|  AcelRx Pharmaceuticals, Inc. (a)(b)  | 7485  | 17889  |
|  Acer Therapeutics, Inc. (a)(b)  | 14284  | 18141  |
|  Aclaris Therapeutics, Inc. (a)  | 38620  | 587796  |
|  Adamis Pharmaceuticals Corp. (a)(b)  | 87706  | 17515  |
|  Adial Pharmaceuticals, Inc. (a)(b)  | 16546  | 4320  |
|  Agile Therapeutics, Inc. (a)(b)  | 2400  | 504  |
|  Akari Therapeutics PLC sponsored ADR (a)(b)  | 30264  | 16724  |
|  Alimera Sciences, Inc. (a)(b)  | 5507  | 18999  |
|  Altamira Therapeutics Ltd. (a)(b)  | 943  | 5460  |
|  Amphastar Pharmaceuticals, Inc. (a)  | 29456  | 868657  |
|  Amryt Pharma PLC ADR (a)(b)  | 32094  | 228509  |
|  Amylyx Pharmaceuticals, Inc.  | 38285  | 1468995  |
|  AN2 Therapeutics, Inc.  | 3789  | 37776  |
|  Anebulo Pharmaceuticals, Inc. (a)(b)  | 4108  | 9038  |
|  Angion Biomedica Corp. (a)  | 16608  | 14117  |
|  ANI Pharmaceuticals, Inc. (a)  | 9565  | 401252  |
|  Aquestive Therapeutics, Inc. (a)(b)  | 39828  | 36960  |
|  Artelo Biosciences, Inc. (a)(b)  | 3253  | 8002  |
|  Arvinas Holding Co. LLC (a)  | 34821  | 1429054  |
|  Assertio Holdings, Inc. (a)(b)  | 29212  | 90557  |
|  AstraZeneca PLC sponsored ADR  | 349258  | 23739066  |
|  atai Life Sciences NV (a)(b)  | 64644  | 228193  |
|  Atea Pharmaceuticals, Inc. (a)  | 43830  | 205563  |
|  Athira Pharma, Inc. (a)  | 16877  | 52487  |
|  Aurora Cannabis, Inc. (a)(b)  | 148904  | 189108  |
|  Avadel Pharmaceuticals PLC sponsored ADR (a)(b)  | 40528  | 371642  |
|  Avenue Therapeutics, Inc. (a)(b)  | 1272  | 1704  |
|  Axsome Therapeutics, Inc. (a)(b)  | 23269  | 1682116  |
|  Baudax Bio, Inc. (a)(b)  | 17792  | 2624  |
|  Belite Bio, Inc. ADR (b)  | 5895  | 193179  |
|  Biofrontera, Inc. (a)(b)  | 10901  | 11446  |
|  Biondvax Pharmaceuticals Ltd. ADR (a)(b)  | 1376  | 13430  |
|  Bright Green Corp. (a)(b)  | 89677  | 51977  |
|  Calliditas Therapeutics AB ADR (a)  | 5831  | 107874  |
|  Cara Therapeutics, Inc. (a)(b)  | 34753  | 410085  |
|  Cardiol Therapeutics, Inc. (a)  | 52435  | 26878  |
|  Cassava Sciences, Inc. (a)(b)  | 22322  | 777475  |
|  China SXT Pharmaceuticals, Inc. (a)(b)  | 1333  | 906  |
|  CinCor Pharma, Inc. (b)  | 22257  | 262633  |
|  Citius Pharmaceuticals, Inc. (a)(b)  | 75361  | 88172  |
|  Clearside Biomedical, Inc. (a)  | 38079  | 46076  |
|  Clever Leaves Holdings, Inc. (a)(b)  | 14276  | 6417  |
|  CNS Pharmaceuticals, Inc. (a)(b)  | 1356  | 4109  |
|  Cocrystal Pharma, Inc. (a)(b)  | 4223  | 11571  |
|  Cognition Therapeutics, Inc. (a)(b)  | 8935  | 31362  |
|  Collegium Pharmaceutical, Inc. (a)  | 23387  | 511474  |
|  Context Therapeutics, Inc. (a)  | 2231  | 3079  |
|  Corcept Therapeutics, Inc. (a)  | 62375  | 1576840  |
|  CorMedix, Inc. (a)(b)  | 22697  | 94420  |
|  Cronos Group, Inc. (a)(b)  | 260717  | 810830  |
|  Cumberland Pharmaceuticals, Inc. (a)(b)  | 11327  | 25712  |
|  CymaBay Therapeutics, Inc. (a)  | 58261  | 196922  |
|  Dare Bioscience, Inc. (a)(b)  | 29994  | 26698  |
|  Dermata Therapeutics, Inc. (a)  | 15860  | 10030  |
|  DICE Therapeutics, Inc. (a)  | 21028  | 731985  |
|  Dova Pharmaceuticals, Inc. rights (a)(c)  | 23572  | 0  |
|  Durect Corp. (a)(b)  | 139062  | 58392  |
|  Edgewise Therapeutics, Inc. (a)  | 29375  | 262906  |
|  Elanco Animal Health, Inc. rights (a)(c)  | 45364  | 0  |
|  Eloxx Pharmaceuticals, Inc. (a)  | 118190  | 16074  |
|  Enliven Therapeutics, Inc. (a)(b)  | 3704  | 15779  |
|  Enveric Biosciences, Inc. (a)(b)  | 96  | 276  |
|  Esperion Therapeutics, Inc. (a)  | 48336  | 323851  |
|  Eton Pharmaceuticals, Inc. (a)(b)  | 19371  | 58500  |
|  Evoke Pharma, Inc. (a)  | 4486  | 6729  |
|  Evolus, Inc. (a)(b)  | 29762  | 215477  |
|  Eyenovia, Inc. (a)(b)  | 21508  | 42371  |
|  Eyepoint Pharmaceuticals, Inc. (a)(b)  | 15491  | 49571  |
|  Fulcrum Therapeutics, Inc. (a)(b)  | 37833  | 259156  |
|  GH Research PLC (a)(b)  | 28173  | 308213  |
|  Harmony Biosciences Holdings, Inc. (a)(b)  | 33782  | 2019150  |
|  Harrow Health, Inc. (a)(b)  | 22525  | 251154  |
|  Hepion Pharmaceuticals, Inc. (a)(b)  | 40121  | 14652  |
|  HEXO Corp. (a)(b)  | 80723  | 13465  |
|  High Tide, Inc. (a)(b)  | 46134  | 85809  |
|  Hoth Therapeutics, Inc. (a)(b)  | 1988  | 8111  |
|  HUTCHMED China Ltd. sponsored ADR (a)(b)  | 22305  | 270560  |
|  Ikena Oncology, Inc. (a)(b)  | 27112  | 60460  |
|  Incannex Healthcare Ltd. ADR (a)  | 489  | 2054  |
|  InMed Pharmaceuticals, Inc. (a)  | 556  | 1473  |
|  Innoviva, Inc. (a)  | 42389  | 556568  |
|  InterCure Ltd. (a)  | 14148  | 70174  |
|  Intra-Cellular Therapies, Inc. (a)  | 53306  | 2890251  |
|  Ipsen SA (c)  | 103469  | 1  |
|  Iterum Therapeutics PLC (a)(b)  | 6139  | 7919  |
|  Jaguar Health, Inc. (a)(b)  | 39619  | 5150  |
|  Jazz Pharmaceuticals PLC (a)  | 34609  | 5430498  |
|  Kala Pharmaceuticals, Inc. (a)(b)  | 790  | 4179  |
|  KemPharm, Inc. (a)(b)  | 18495  | 88036  |
|  Landos Biopharma, Inc. (a)(b)  | 23054  | 4957  |
|  Lexaria Bioscience Corp. (a)(b)  | 2740  | 8110  |
|  Ligand Pharmaceuticals, Inc.:  |  |  |
|  Class B (a)  | 11014  | 802921  |
|  General CVR (a)(c)  | 1518  | 11  |
|  Glucagon CVR (a)(c)  | 1518  | 8  |
|  rights (a)  | 1518  | 10  |
|  TR Beta CVR (a)(c)  | 1518  | 228  |
|  Lipocine, Inc. (a)(b)  | 61226  | 27558  |
|  Liquidia Technologies, Inc. (a)  | 36922  | 185348  |
|  Longboard Pharmaceuticals, Inc. (a)  | 6573  | 35297  |
|  Lyra Therapeutics, Inc. (a)(b)  | 10575  | 37118  |
|  Marinus Pharmaceuticals, Inc. (a)(b)  | 20303  | 97251  |
|  MediWound Ltd. (a)(b)  | 18827  | 29747  |
|  Milestone Pharmaceuticals, Inc. (a)  | 17576  | 86298  |
|  Mind Medicine (MindMed), Inc. (a)(b)  | 34366  | 87633  |
|  MyMD Pharmaceuticals, Inc. (a)(b)  | 21161  | 45285  |
|  Nabriva Therapeutics PLC (a)(b)  | 1709  | 3845  |
|  Nektar Therapeutics (a)  | 141181  | 395307  |
|  NGM Biopharmaceuticals, Inc. (a)  | 63741  | 352488  |
|  NLS Pharmaceutics Ltd. (a)(b)  | 14362  | 11920  |
|  Novan, Inc. (a)(b)  | 10162  | 9654  |
|  NRX Pharmaceuticals, Inc. (a)(b)  | 30907  | 44506  |
|  Nutriband, Inc. (a)(b)  | 6718  | 26335  |
|  Ocular Therapeutix, Inc. (a)  | 35651  | 105883  |
|  Ocuphire Pharma, Inc. (a)(b)  | 34766  | 107079  |
|  Omeros Corp. (a)(b)  | 40138  | 85895  |
|  Onconova Therapeutics, Inc. (a)  | 33198  | 27720  |
|  Opiant Pharmaceuticals, Inc. (a)  | 3728  | 75007  |
|  OptiNose, Inc. (a)(b)  | 50383  | 89178  |
|  Oramed Pharmaceuticals, Inc. (a)(b)  | 18130  | 153199  |
|  Otonomy, Inc. (a)(b)  | 53180  | 9540  |
|  Pacira Biosciences, Inc. (a)  | 26424  | 1274958  |
|  PainReform Ltd. (a)(b)  | 19107  | 8210  |
|  Palisade Bio, Inc. (a)(b)  | 1306  | 5080  |
|  Palisade Bio, Inc. rights (a)(b)(c)  | 29628  | 0  |
|  Paratek Pharmaceuticals, Inc. (a)(b)  | 29676  | 65881  |
|  Petros Pharmaceuticals, Inc. (a)(b)  | 6734  | 2814  |
|  Pharvaris BV (a)(b)  | 18643  | 38405  |
|  Phathom Pharmaceuticals, Inc. (a)(b)  | 20885  | 208432  |
|  Phibro Animal Health Corp. Class A  | 16621  | 204605  |
|  Pliant Therapeutics, Inc. (a)  | 30123  | 553661  |
|  PLx Pharma PLC (a)(b)  | 25849  | 8582  |
|  PolyPid Ltd. (a)(b)  | 12545  | 9909  |
|  Procaps Group SA (a)(b)  | 18661  | 120737  |
|  Processa Pharmaceuticals, Inc. (a)(b)  | 11057  | 20842  |
|  ProPhase Labs, Inc. (b)  | 11262  | 116787  |
|  Provention Bio, Inc. (a)(b)  | 51462  | 465216  |
|  Pulmatrix, Inc. (a)(b)  | 2220  | 8303  |
|  Purple Biotech Ltd. ADR (a)  | 12666  | 24825  |
|  Qilian International Holding Group Ltd. (a)(b)  | 23641  | 27660  |
|  Rain Therapeutics, Inc. (a)(b)  | 10662  | 82311  |
|  Rani Therapeutics Holdings, Inc. (a)(b)  | 14915  | 123496  |
|  Reata Pharmaceuticals, Inc. (a)(b)  | 18956  | 750278  |
|  RedHill Biopharma Ltd. sponsored ADR (a)(b)  | 41637  | 14989  |
|  Regencell Bioscience Holdings Ltd. (a)(b)  | 6816  | 199436  |
|  Relmada Therapeutics, Inc. (a)(b)  | 14221  | 66128  |
|  Revance Therapeutics, Inc. (a)  | 47886  | 1039605  |
|  Reviva Pharmaceuticals Holdings, Inc. (a)(b)  | 12478  | 45794  |
|  Royalty Pharma PLC  | 249891  | 10987707  |
|  RVL Pharmaceuticals PLC (a)(b)  | 45207  | 65098  |
|  Sanofi SA sponsored ADR  | 169917  | 7705736  |
|  Satsuma Pharmaceuticals, Inc. (a)  | 19951  | 18161  |
|  Scilex Holding Co. (a)(b)  | 11817  | 53177  |
|  scPharmaceuticals, Inc. (a)(b)  | 18268  | 133904  |
|  SCYNEXIS, Inc. (a)(b)  | 18298  | 43183  |
|  Seelos Therapeutics, Inc. (a)(b)  | 84689  | 69326  |
|  Seelos Therapeutics, Inc. rights (a)(b)(c)  | 2932  | 0  |
|  SenesTech, Inc. (a)(b)  | 1582  | 4714  |
|  SIGA Technologies, Inc. (b)  | 42115  | 386616  |
|  Sol-Gel Technologies Ltd. (a)(b)  | 13406  | 64081  |
|  Sonoma Pharmaceuticals, Inc. (a)  | 4975  | 8507  |
|  Supernus Pharmaceuticals, Inc. (a)  | 32482  | 1192739  |
|  Tarsus Pharmaceuticals, Inc. (a)(b)  | 17259  | 290124  |
|  Terns Pharmaceuticals, Inc. (a)(b)  | 14756  | 114654  |
|  TFF Pharmaceuticals, Inc. (a)(b)  | 10670  | 12911  |
|  The Valens Co., Inc. (a)(b)  | 18380  | 16439  |
|  TherapeuticsMD, Inc. (a)(b)  | 2275  | 10420  |
|  Theravance Biopharma, Inc. (a)(b)  | 43005  | 462734  |
|  Theseus Pharmaceuticals, Inc. (a)(b)  | 20295  | 133744  |
|  Third Harmonics Bio, Inc. (b)  | 3768  | 73476  |
|  Tilray Brands, Inc. Class 2 (a)(b)  | 370726  | 1434710  |
|  Titan Pharmaceuticals, Inc. (a)(b)  | 19257  | 16078  |
|  Trevi Therapeutics, Inc. (a)(b)  | 21600  | 40608  |
|  Tricida, Inc. (a)(b)  | 34018  | 8164  |
|  Universe Pharmaceuticals, Inc. (a)(b)  | 8802  | 15932  |
|  Vallon Pharamceuticals, Inc. (a)(b)  | 9542  | 2356  |
|  Ventyx Biosciences, Inc. (a)  | 30212  | 875846  |
|  Verona Pharma PLC ADR (a)(b)  | 31654  | 408337  |
|  Verrica Pharmaceuticals, Inc. (a)  | 16292  | 52949  |
|  Viatris, Inc.  | 702601  | 7749689  |
|  Virpax Pharmaceuticals, Inc. (a)  | 6419  | 5314  |
|  Vyne Therapeutics, Inc. (a)(b)  | 30249  | 7036  |
|  WAVE Life Sciences (a)  | 49083  | 208112  |
|  Xeris Biopharma Holdings, Inc. (a)(b)  | 76277  | 114416  |
|  Xeris Biopharma Holdings, Inc. rights (a)(c)  | 39901  | 0  |
|  Zogenix, Inc. rights (a)(c)  | 35750  | 24310  |
|  Zynerba Pharmaceuticals, Inc. (a)(b)  | 21768  | 11696  |
|  |  | 92455829  |
|  TOTAL HEALTH CARE  |  | 1024866694  |
| INDUSTRIALS - 4.8%  |  |  |
| Aerospace & Defense - 0.2%  |  |  |
|  A2Z Smart Technologies Corp. (a)  | 2393  | 3398  |
|  AeroVironment, Inc. (a)  | 14029  | 1290528  |
|  AerSale Corp. (a)  | 32388  | 513350  |
|  Astra Space, Inc. Class A (a)(b)  | 107445  | 53089  |
|  Astronics Corp. (a)  | 11489  | 96508  |
|  Astrotech Corp. (a)(b)  | 36874  | 12463  |
|  Axon Enterprise, Inc. (a)  | 40377  | 7430579  |
|  Byrna Technologies, Inc. (a)(b)  | 14709  | 127380  |
|  Draganfly, Inc. (a)  | 18003  | 16403  |
|  EHang Holdings Ltd. ADR (a)(b)  | 17186  | 80602  |
|  Elbit Systems Ltd. (b)  | 25289  | 4416218  |
|  Innovative Solutions & Support, Inc. (a)  | 6779  | 62367  |
|  Kratos Defense & Security Solutions, Inc. (a)  | 68797  | 654947  |
|  Leonardo DRS, Inc. (a)(b)  | 29760  | 300874  |
|  Lilium NV (a)(b)  | 154385  | 217683  |
|  Mercury Systems, Inc. (a)  | 33713  | 1713295  |
|  Momentus, Inc. Class A (a)(b)  | 35057  | 37862  |
|  Rocket Lab U.S.A., Inc. Class A (a)(b)  | 282570  | 1183968  |
|  Satellogic, Inc. Class A (a)(b)  | 49366  | 219679  |
|  Sigma Additive Solutions, Inc. (a)(b)  | 14199  | 8164  |
|  TAT Technologies Ltd. (a)(b)  | 4899  | 31109  |
|  Virgin Orbit Holdings, Inc. (a)(b)  | 176023  | 484063  |
|  VirTra, Inc. (a)(b)  | 1810  | 8579  |
|  Woodward, Inc.  | 33738  | 3232100  |
|  |  | 22195208  |
| Air Freight & Logistics - 0.2%  |  |  |
|  Addentax Group Corp. (a)(b)  | 2062  | 3505  |
|  Air T, Inc. (a)  | 1316  | 30755  |
|  Air Transport Services Group, Inc. (a)  | 43309  | 1214384  |
|  Atlas Air Worldwide Holdings, Inc. (a)  | 15134  | 1525053  |
|  C.H. Robinson Worldwide, Inc. (b)  | 71213  | 7136967  |
|  Expeditors International of Washington, Inc.  | 96156  | 11159865  |
|  Forward Air Corp.  | 15781  | 1773311  |
|  Freight Technologies, Inc. (a)(b)  | 7601  | 2272  |
|  Hub Group, Inc. Class A (a)  | 18738  | 1576803  |
|  |  | 24422915  |
| Airlines - 0.2%  |  |  |
|  Allegiant Travel Co. (a)  | 13320  | 1100365  |
|  American Airlines Group, Inc. (a)(b)  | 360724  | 5205247  |
|  Blade Air Mobility, Inc. (a)  | 44231  | 217617  |
|  Frontier Group Holdings, Inc. (a)  | 120000  | 1564800  |
|  Hawaiian Holdings, Inc. (a)  | 31196  | 433624  |
|  JetBlue Airways Corp. (a)(b)  | 186955  | 1488162  |
|  Mesa Air Group, Inc. (a)  | 19225  | 24031  |
|  Ryanair Holdings PLC sponsored ADR (a)  | 56333  | 4263845  |
|  SkyWest, Inc. (a)  | 28361  | 523260  |
|  Sun Country Airlines Holdings, Inc. (a)(b)  | 30637  | 618867  |
|  United Airlines Holdings, Inc. (a)  | 187791  | 8294728  |
|  |  | 23734546  |
| Building Products - 0.1%  |  |  |
|  AAON, Inc.  | 32726  | 2593863  |
|  AeroClean Technologies, Inc. (b)  | 7134  | 23756  |
|  American Woodmark Corp. (a)  | 8946  | 484873  |
|  Antelope Enterprise Holdings L (a)(b)  | 13809  | 7096  |
|  Apogee Enterprises, Inc.  | 12606  | 608240  |
|  Applied UV, Inc. (a)  | 4305  | 4081  |
|  Caesarstone Sdot-Yam Ltd.  | 30851  | 193436  |
|  CSW Industrials, Inc.  | 8472  | 1024688  |
|  DIRTT Environmental Solutions Ltd. (a)(b)  | 44471  | 13177  |
|  Gibraltar Industries, Inc. (a)  | 18047  | 913359  |
|  Intelligent Living Application Group, Inc. (b)  | 8624  | 14833  |
|  UFP Industries, Inc.  | 35108  | 2873941  |
|  View, Inc. Class A (a)(b)  | 117562  | 164587  |
|  |  | 8919930  |
| Commercial Services & Supplies - 0.6%  |  |  |
|  ACV Auctions, Inc. Class A (a)(b)  | 77974  | 689290  |
|  Aqua Metals, Inc. (a)(b)  | 36541  | 27113  |
|  Aurora Innovation, Inc. (a)(b)  | 450965  | 568216  |
|  Casella Waste Systems, Inc. Class A (a)  | 27982  | 2408970  |
|  CECO Environmental Corp. (a)  | 21695  | 262943  |
|  Cimpress PLC (a)  | 15021  | 444471  |
|  Cintas Corp.  | 58089  | 26824338  |
|  Copart, Inc. (a)  | 273137  | 18179999  |
|  Driven Brands Holdings, Inc. (a)  | 94370  | 2869792  |
|  Fuel Tech, Inc. (a)  | 7428  | 9285  |
|  Greenwave Technology Solutions, Inc. (a)(b)  | 7560  | 9148  |
|  Guardforce AI Co. Ltd. (a)(b)  | 4796  | 927  |
|  Healthcare Services Group, Inc.  | 46535  | 649163  |
|  Heritage-Crystal Clean, Inc. (a)  | 13663  | 431751  |
|  Interface, Inc.  | 29819  | 322940  |
|  Kimball International, Inc. Class B  | 34877  | 249719  |
|  Knightscope, Inc. Class A (b)  | 8793  | 19169  |
|  Matthews International Corp. Class A  | 14831  | 469549  |
|  Millerknoll, Inc. (b)  | 40332  | 822369  |
|  Odyssey Marine Exploration, Inc. (a)(b)  | 6411  | 20195  |
|  Performant Financial Corp. (a)  | 25601  | 61186  |
|  Perma-Fix Environmental Services, Inc. (a)  | 9998  | 36993  |
|  PyroGenesis Canada, Inc. (a)(b)  | 105149  | 76916  |
|  Quest Resource Holding Corp. (a)(b)  | 5212  | 35442  |
|  Quhuo Ltd. ADR (a)(b)  | 348  | 491  |
|  Recycling Asset Holdings, Inc. (a)(c)  | 694  | 24  |
|  Sentage Holdings, Inc. (a)(b)  | 347  | 836  |
|  Smart Powerr Corp. (a)(b)  | 2863  | 8303  |
|  SP Plus Corp. (a)  | 13740  | 479389  |
|  Stericycle, Inc. (a)  | 51587  | 2689230  |
|  Tetra Tech, Inc.  | 29837  | 4612502  |
|  TOMI Environmental Solutions, Inc. (a)(b)  | 8765  | 5960  |
|  Virco Manufacturing Co. (a)  | 950  | 3990  |
|  VSE Corp.  | 7604  | 372900  |
|  |  | 63663509  |
| Construction & Engineering - 0.1%  |  |  |
|  Bowman Consulting Group Ltd. (a)  | 2968  | 58292  |
|  Capitalworks Emerging Markets Acquisition Corp. (a)  | 2441  | 25045  |
|  Concrete Pumping Holdings, Inc. (a)  | 28584  | 201803  |
|  Construction Partners, Inc. Class A (a)  | 27784  | 794622  |
|  Great Lakes Dredge & Dock Corp. (a)  | 35442  | 259435  |
|  IES Holdings, Inc. (a)  | 12297  | 415885  |
|  iSun, Inc. (a)(b)  | 10234  | 16988  |
|  Limbach Holdings, Inc. (a)  | 6648  | 79377  |
|  Matrix Service Co. (a)  | 12262  | 62781  |
|  MYR Group, Inc. (a)  | 9722  | 928743  |
|  Northwest Pipe Co. (a)  | 7033  | 263456  |
|  NV5 Global, Inc. (a)  | 8747  | 1264029  |
|  Orbital Infrastructure Group I (a)(b)  | 34811  | 6468  |
|  Primoris Services Corp.  | 31414  | 670689  |
|  QualTek Services, Inc. Class A (a)(b)  | 22514  | 17923  |
|  SG Blocks, Inc. (a)(b)  | 5721  | 7208  |
|  Sterling Construction Co., Inc. (a)  | 17918  | 586815  |
|  Willscot Mobile Mini Holdings (a)  | 124008  | 5978426  |
|  |  | 11637985  |
| Electrical Equipment - 0.2%  |  |  |
|  ADS-TEC Energy PLC (a)(b)  | 14709  | 75310  |
|  Advent Technologies Holdings, Inc. Class A (a)(b)  | 25238  | 56028  |
|  Allied Motion Technologies, Inc.  | 8863  | 314105  |
|  American Superconductor Corp. (a)  | 23972  | 90135  |
|  Array Technologies, Inc. (a)  | 87239  | 1826785  |
|  Asia Pacific Wire & Cable Corp. Ltd. (a)(b)  | 107599  | 151715  |
|  Ballard Power Systems, Inc. (a)(b)  | 164663  | 1004444  |
|  Beam Global (a)(b)  | 6808  | 130373  |
|  Blink Charging Co. (a)(b)  | 27952  | 387974  |
|  Broadwind, Inc. (a)  | 9566  | 16645  |
|  Capstone Turbine Corp. (a)(b)  | 5108  | 8786  |
|  CBAK Energy Technology, Inc. (a)(b)  | 60126  | 70347  |
|  Chardan NexTech Acquisition 2 Corp. (a)(b)  | 8643  | 72774  |
|  Encore Wire Corp. (b)  | 11489  | 1678658  |
|  Energous Corp. (a)(b)  | 89434  | 90328  |
|  Energy Focus, Inc. (a)(b)  | 4115  | 1476  |
|  Enovix Corp. (a)(b)  | 87094  | 1136577  |
|  Fluence Energy, Inc. (a)(b)  | 60162  | 1033583  |
|  Flux Power Holdings, Inc. (a)(b)  | 15492  | 73587  |
|  FTC Solar, Inc. (a)(b)  | 38990  | 82659  |
|  FuelCell Energy, Inc. (a)(b)  | 225259  | 779396  |
|  Fusion Fuel Green PLC Class A (a)(b)  | 4794  | 33079  |
|  Ideal Power, Inc. (a)(b)  | 6424  | 77602  |
|  LSI Industries, Inc.  | 17145  | 203511  |
|  NeoVolta, Inc. (a)(b)  | 4318  | 15243  |
|  Nuvve Holding Corp. (a)(b)  | 16407  | 10172  |
|  Orion Energy Systems, Inc. (a)  | 14347  | 30416  |
|  Pineapple Energy, Inc. (a)(b)  | 1083  | 2751  |
|  Pineapple Energy, Inc. rights (a)(c)  | 1083  | 0  |
|  Pioneer Power Solutions, Inc. (a)(b)  | 9793  | 29673  |
|  Plug Power, Inc. (a)(b)  | 334467  | 5338093  |
|  Polar Power, Inc. (a)(b)  | 8285  | 18393  |
|  Powell Industries, Inc.  | 6368  | 167606  |
|  Preformed Line Products Co.  | 3095  | 291982  |
|  Shoals Technologies Group, Inc. (a)  | 65301  | 1891770  |
|  SKYX Platforms Corp. (b)  | 68476  | 164342  |
|  SunPower Corp. (a)(b)  | 97348  | 2360689  |
|  Sunrun, Inc. (a)  | 120249  | 3917712  |
|  Sunworks, Inc. (a)(b)  | 14202  | 34511  |
|  TPI Composites, Inc. (a)  | 21435  | 258935  |
|  Tritium DCFC Ltd. (a)(b)  | 101080  | 161728  |
|  Ultralife Corp. (a)  | 11042  | 46156  |
|  Vicor Corp. (a)  | 18628  | 1005726  |
|  |  | 25141775  |
| Industrial Conglomerates - 0.9%  |  |  |
|  Gaucho Group Holdings, Inc. (a)(b)  | 832  | 1240  |
|  Honeywell International, Inc.  | 385339  | 84601177  |
|  Icahn Enterprises LP  | 184109  | 9422699  |
|  |  | 94025116  |
| Machinery - 0.5%  |  |  |
|  Agrify Corp. (a)(b)  | 1129  | 1174  |
|  Altra Industrial Motion Corp.  | 35733  | 2094668  |
|  Astec Industries, Inc.  | 13267  | 586932  |
|  Atlis Motor Vehicles, Inc. (a)(b)  | 6484  | 60690  |
|  Berkshire Grey, Inc. Class A (a)(b)  | 92621  | 87925  |
|  Blue Bird Corp. (a)  | 16718  | 197440  |
|  Columbus McKinnon Corp. (NY Shares)  | 16265  | 524221  |
|  Commercial Vehicle Group, Inc. (a)(b)  | 21200  | 146280  |
|  Eastern Co. (b)  | 4547  | 104581  |
|  Energy Recovery, Inc. (a)  | 35074  | 813015  |
|  Fast Radius, Inc. Class A (a)(b)  | 28548  | 3429  |
|  Franklin Electric Co., Inc.  | 25745  | 2144559  |
|  FreightCar America, Inc. (a)(b)  | 32845  | 127110  |
|  Greenland Technologies Holding Corp. (a)(b)  | 5467  | 12246  |
|  GreenPower Motor Co., Inc. (a)  | 11083  | 24881  |
|  Hillman Solutions Corp. Class A (a)  | 118272  | 941445  |
|  Hurco Companies, Inc.  | 4416  | 110135  |
|  Hydrofarm Holdings Group, Inc. (a)  | 45713  | 114740  |
|  Hyzon Motors, Inc. Class A (a)(b)  | 134771  | 218329  |
|  Ideanomics, Inc. (a)(b)  | 232089  | 51060  |
|  JE Cleantech Holdings Ltd. (b)  | 7504  | 6529  |
|  Kornit Digital Ltd. (a)  | 23765  | 609335  |
|  L.B. Foster Co. Class A (a)  | 5419  | 51047  |
|  Lincoln Electric Holdings, Inc.  | 32427  | 4795305  |
|  LiqTech International, Inc. (a)(b)  | 14828  | 5902  |
|  Manitex International, Inc. (a)  | 14236  | 67479  |
|  Microvast Holdings, Inc. (a)(b)  | 170830  | 374118  |
|  Middleby Corp. (a)  | 29825  | 4300467  |
|  Nauticus Robotics, Inc. (a)(b)  | 6031  | 22857  |
|  Nikola Corp. (a)(b)  | 200219  | 524574  |
|  NN, Inc. (a)(b)  | 23071  | 44066  |
|  Nordson Corp.  | 32070  | 7584234  |
|  Omega Flex, Inc. (b)  | 6379  | 613086  |
|  PACCAR, Inc.  | 195459  | 20701063  |
|  Park-Ohio Holdings Corp.  | 7033  | 93891  |
|  Perma-Pipe International Holdings, Inc. (a)  | 5390  | 52606  |
|  Proterra, Inc. Class A (a)(b)  | 125619  | 695929  |
|  Sarcos Technology and Robotics Corp. Class A (a)  | 75604  | 88079  |
|  Shyft Group, Inc. (The)  | 20942  | 513707  |
|  Symbotic, Inc. (a)(b)  | 35622  | 393623  |
|  Taylor Devices, Inc. (a)  | 1759  | 23606  |
|  Twin Disc, Inc. (a)  | 9749  | 104022  |
|  Urban-Gro, Inc. (a)(b)  | 1561  | 7727  |
|  Vicinity Motor Corp. (a)(b)  | 64732  | 58265  |
|  voxeljet AG ADR (a)  | 2769  | 7421  |
|  Westport Fuel Systems, Inc. (a)  | 72395  | 69492  |
|  Xos, Inc. Class A (a)(b)  | 97889  | 62649  |
|  |  | 50235939  |
| Marine - 0.0%  |  |  |
|  Capital Product Partners LP  | 6724  | 94943  |
|  Castor Maritime, Inc. (a)(b)  | 49703  | 81513  |
|  Eagle Bulk Shipping, Inc. (b)  | 8764  | 450908  |
|  EuroDry Ltd. (a)(b)  | 3499  | 56159  |
|  Euroseas Ltd. (b)  | 5072  | 103317  |
|  Golden Ocean Group Ltd. (b)  | 114916  | 969891  |
|  Pangaea Logistics Solutions Ltd. (b)  | 29549  | 151586  |
|  Pyxis Tankers, Inc. (a)(b)  | 10640  | 52774  |
|  Seanergy Martime Holdings Corp. (b)  | 72085  | 37290  |
|  Star Bulk Carriers Corp. (b)  | 58306  | 1122391  |
|  United Maritime Corp. (a)(b)  | 608  | 2207  |
|  |  | 3122979  |
| Professional Services - 0.5%  |  |  |
|  Atlas Technical Consultants, Inc. (a)(b)  | 23333  | 126232  |
|  Barrett Business Services, Inc.  | 3985  | 391845  |
|  China Index Holdings Ltd. ADR (a)(b)  | 30315  | 27284  |
|  CoStar Group, Inc. (a)  | 225597  | 18282381  |
|  CRA International, Inc.  | 4701  | 579445  |
|  DLH Holdings Corp. (a)  | 6805  | 95270  |
|  Exponent, Inc. (b)  | 28889  | 2987411  |
|  First Advantage Corp. (a)  | 83856  | 1115285  |
|  FiscalNote Holdings, Inc. Class A (a)  | 1  | 6  |
|  Forrester Research, Inc. (a)  | 10756  | 378396  |
|  Headhunter Group PLC ADR (c)  | 16914  | 46036  |
|  Heidrick & Struggles International, Inc.  | 10143  | 301247  |
|  Hirequest, Inc. (b)  | 6327  | 110723  |
|  Hudson Global, Inc. (a)  | 1914  | 48807  |
|  Huron Consulting Group, Inc. (a)  | 11971  | 932062  |
|  ICF International, Inc.  | 10225  | 1108083  |
|  Kelly Services, Inc. Class A (non-vtg.)  | 31187  | 529867  |
|  Kforce, Inc.  | 10845  | 640614  |
|  LegalZoom.com, Inc. (a)  | 93817  | 830280  |
|  RCM Technologies, Inc. (a)(b)  | 6964  | 106410  |
|  Recruiter.com Group, Inc. (a)(b)  | 7704  | 4227  |
|  Red Violet, Inc. (a)(b)  | 8743  | 199340  |
|  Resources Connection, Inc.  | 22136  | 427225  |
|  ShiftPixy, Inc. (a)(b)  | 5720  | 92492  |
|  Sterling Check Corp. (a)(b)  | 57207  | 831790  |
|  Sunrise New Energy Co. Ltd. (a)(b)  | 8860  | 36149  |
|  Upwork, Inc. (a)  | 70469  | 863245  |
|  Verisk Analytics, Inc.  | 88436  | 16246578  |
|  Where Food Comes From, Inc. (a)(b)  | 2480  | 35935  |
|  Willdan Group, Inc. (a)  | 8506  | 149195  |
|  |  | 47523860  |
| Road & Rail - 1.0%  |  |  |
|  AMERCO (b)  | 10958  | 693641  |
|  AMERCO (non-vtg.)  | 98622  | 6229952  |
|  ArcBest Corp.  | 13918  | 1151993  |
|  Avis Budget Group, Inc. (a)  | 27519  | 6153248  |
|  Covenant Transport Group, Inc. Class A (b)  | 6293  | 241588  |
|  CSX Corp.  | 1225747  | 40069669  |
|  Daseke, Inc. (a)  | 34313  | 200045  |
|  Ezgo Technologies Ltd. (a)(b)  | 2944  | 1148  |
|  FTAI Infrastructure LLC  | 32535  | 92725  |
|  Grab Holdings Ltd. (a)(b)  | 2113068  | 6381465  |
|  Heartland Express, Inc.  | 44050  | 737397  |
|  Helbiz, Inc. (a)(b)  | 4659  | 1013  |
|  Hertz Global Holdings, Inc. (b)  | 190100  | 3269720  |
|  HyreCar, Inc. (a)(b)  | 10990  | 6589  |
|  J.B. Hunt Transport Services, Inc.  | 57881  | 10643737  |
|  Landstar System, Inc.  | 20130  | 3482087  |
|  Marten Transport Ltd.  | 47473  | 1011650  |
|  MingZhu Logistics Holdings Ltd. (a)(b)  | 2711  | 6588  |
|  Old Dominion Freight Lines, Inc.  | 64070  | 19388223  |
|  P.A.M. Transportation Services, Inc.  | 14004  | 392532  |
|  Patriot Transportation Holding, Inc. (a)  | 1759  | 14635  |
|  Saia, Inc. (a)  | 15481  | 3771017  |
|  Swvl Holdings Corp. Class A (a)(b)  | 147664  | 54636  |
|  Td Holdings, Inc. (a)  | 2626  | 3230  |
|  TuSimple Holdings, Inc. (a)  | 21274  | 47867  |
|  Universal Logistics Holdings, Inc.  | 17590  | 667892  |
|  Werner Enterprises, Inc.  | 37001  | 1627304  |
|  Yellow Corp. (a)(b)  | 25553  | 81770  |
|  |  | 106423361  |
| Trading Companies & Distributors - 0.3%  |  |  |
|  Beacon Roofing Supply, Inc. (a)  | 38797  | 2265357  |
|  Code Chain New Continent Ltd. (a)(b)  | 590  | 1528  |
|  Distribution Solutions Group I (a)  | 12223  | 433305  |
|  DXP Enterprises, Inc. (a)  | 11146  | 287901  |
|  Euro Tech Holdings Co. Ltd. (a)  | 4600  | 6808  |
|  Fastenal Co.  | 328356  | 16913618  |
|  FTAI Aviation Ltd. (b)  | 60222  | 1055089  |
|  H&E Equipment Services, Inc.  | 19766  | 828788  |
|  Hudson Technologies, Inc. (a)  | 26274  | 296633  |
|  Karat Packaging, Inc.  | 10117  | 139817  |
|  McGrath RentCorp.  | 12871  | 1262903  |
|  Rush Enterprises, Inc.:  |  |  |
|  Class A  | 27065  | 1394659  |
|  Class B (b)  | 6706  | 355351  |
|  Titan Machinery, Inc. (a)  | 11661  | 513434  |
|  Transcat, Inc. (a)  | 4527  | 362296  |
|  Willis Lease Finance Corp. (a)  | 3418  | 164064  |
|  |  | 26281551  |
| Transportation Infrastructure - 0.0%  |  |  |
|  Grupo Aeroportuario Norte S.A.B. de CV ADR (b)  | 3405  | 236716  |
|  Singularity Future Technology Ltd. (a)  | 11251  | 8356  |
|  |  | 245072  |
|  TOTAL INDUSTRIALS  |  | 507573746  |
| INFORMATION TECHNOLOGY - 44.3%  |  |  |
| Communications Equipment - 1.3%  |  |  |
|  ADTRAN Holdings, Inc. (b)  | 42564  | 862772  |
|  Applied Optoelectronics, Inc. (a)(b)  | 20141  | 44310  |
|  AudioCodes Ltd.  | 17081  | 327955  |
|  Aviat Networks, Inc. (a)  | 6448  | 202854  |
|  CalAmp Corp. (a)  | 18255  | 65901  |
|  Cambium Networks Corp. (a)  | 14493  | 308556  |
|  Casa Systems, Inc. (a)(b)  | 21937  | 60107  |
|  Ceragon Networks Ltd. (a)(b)  | 40973  | 80307  |
|  Cisco Systems, Inc.  | 2358227  | 117251046  |
|  Clearfield, Inc. (a)  | 8422  | 1108504  |
|  ClearOne, Inc. (a)  | 10289  | 7870  |
|  CommScope Holding Co., Inc. (a)  | 117050  | 1039404  |
|  COMSovereign Holding Corp. (a)(b)  | 20231  | 1847  |
|  Comtech Telecommunications Corp.  | 12600  | 147042  |
|  Digi International, Inc. (a)  | 19090  | 810752  |
|  DZS, Inc. (a)(b)  | 36894  | 436087  |
|  EMCORE Corp. (a)  | 20355  | 28904  |
|  Ericsson (B Shares) sponsored ADR  | 200476  | 1277032  |
|  Extreme Networks, Inc. (a)  | 71064  | 1490212  |
|  F5, Inc. (a)  | 33582  | 5192113  |
|  Franklin Wireless Corp. (a)  | 9420  | 32122  |
|  Genasys, Inc. (a)(b)  | 20513  | 61744  |
|  Gilat Satellite Networks Ltd. (a)(b)  | 24237  | 149785  |
|  Harmonic, Inc. (a)(b)  | 60290  | 924849  |
|  Infinera Corp. (a)(b)  | 138900  | 937575  |
|  Inseego Corp. (a)(b)  | 52527  | 66709  |
|  Ituran Location & Control Ltd.  | 10985  | 256719  |
|  KVH Industries, Inc. (a)  | 10763  | 122591  |
|  Lantronix, Inc. (a)  | 15008  | 76841  |
|  Lumentum Holdings, Inc. (a)  | 38886  | 2136397  |
|  Minim, Inc. (a)(b)  | 14155  | 2326  |
|  NETGEAR, Inc. (a)  | 18625  | 367471  |
|  NetScout Systems, Inc. (a)  | 41313  | 1540149  |
|  Ondas Holdings, Inc. (a)(b)  | 18652  | 48309  |
|  PC-Tel, Inc.  | 11312  | 51356  |
|  Radware Ltd. (a)  | 27195  | 561033  |
|  Ribbon Communications, Inc. (a)  | 100851  | 255153  |
|  Sierra Wireless, Inc. (a)(b)  | 20687  | 606750  |
|  Silicom Ltd. (a)  | 4848  | 221457  |
|  Siyata Mobile, Inc. (a)(b)  | 19350  | 3433  |
|  Tessco Technologies, Inc. (a)  | 10061  | 49701  |
|  UTStarcom Holdings Corp. (a)  | 12236  | 51391  |
|  ViaSat, Inc. (a)(b)  | 44110  | 1503710  |
|  Viavi Solutions, Inc. (a)  | 125363  | 1420363  |
|  Vislink Technologies, Inc. (a)(b)  | 25373  | 9134  |
|  |  | 142200643  |
| Electronic Equipment & Components - 0.7%  |  |  |
|  908 Devices, Inc. (a)(b)  | 25319  | 270913  |
|  Advanced Energy Industries, Inc.  | 21207  | 1964616  |
|  AEye, Inc. Class A (a)(b)  | 56554  | 50333  |
|  Airgain, Inc. (a)  | 4073  | 32055  |
|  Akoustis Technologies, Inc. (a)(b)  | 42555  | 161709  |
|  Alpine 4 Holdings, Inc. (a)(b)  | 99302  | 60574  |
|  Arbe Robotics Ltd. (a)(b)  | 27724  | 110342  |
|  Avnet, Inc.  | 55211  | 2493881  |
|  Bel Fuse, Inc.:  |  |  |
|  Class A  | 1125  | 37519  |
|  Class B (non-vtg.)  | 5258  | 181086  |
|  Bonso Electronic International, Inc. (a)(b)  | 5325  | 17945  |
|  CDW Corp.  | 77569  | 14632616  |
|  Cemtrex, Inc. (a)(b)  | 30161  | 4826  |
|  Cepton, Inc. (a)(b)  | 71459  | 97184  |
|  ClearSign Combustion Corp. (a)(b)  | 16057  | 11020  |
|  Climb Global Solutions, Inc.  | 3243  | 106922  |
|  Coda Octopus Group, Inc. (a)(b)  | 4103  | 26300  |
|  Cognex Corp.  | 101872  | 5071188  |
|  Coherent Corp. (a)  | 72398  | 2654835  |
|  CPS Technologies Corp. (a)(b)  | 4893  | 15511  |
|  Daktronics, Inc. (a)  | 31984  | 110345  |
|  Data I/O Corp. (a)  | 15054  | 63528  |
|  Deswell Industries, Inc.  | 1758  | 5432  |
|  Digital Ally, Inc. (a)(b)  | 23185  | 7364  |
|  ePlus, Inc. (a)  | 14180  | 704179  |
|  Evolv Technologies Holdings, Inc. (a)(b)  | 82187  | 286833  |
|  FARO Technologies, Inc. (a)  | 11137  | 333219  |
|  Flex Ltd. (a)  | 255671  | 5619649  |
|  Focus Universal, Inc. (a)(b)  | 25043  | 275223  |
|  Frequency Electronics, Inc. (a)  | 5274  | 30906  |
|  Hollysys Automation Technologies Ltd.  | 35132  | 600757  |
|  Identiv, Inc. (a)  | 10328  | 86239  |
|  IDEX Biometrics ASA ADR (a)  | 440  | 3700  |
|  Innoviz Technologies Ltd. (a)(b)  | 78745  | 422861  |
|  Insight Enterprises, Inc. (a)  | 19371  | 2012841  |
|  Integrated Media Technology Ltd. (a)(b)  | 3824  | 2543  |
|  Interlink Electronics, Inc. (a)(b)  | 2544  | 23125  |
|  IPG Photonics Corp. (a)  | 27700  | 2521531  |
|  Iteris, Inc. (a)  | 22008  | 69325  |
|  Itron, Inc. (a)  | 24868  | 1322480  |
|  KEY Tronic Corp. (a)  | 6057  | 29316  |
|  Kimball Electronics, Inc. (a)  | 15945  | 368170  |
|  LightPath Technologies, Inc. Class A (a)(b)  | 12016  | 14660  |
|  Lightwave Logic, Inc. (a)(b)  | 60149  | 476982  |
|  Littelfuse, Inc.  | 13952  | 3439168  |
|  Luna Innovations, Inc. (a)(b)  | 21826  | 147544  |
|  MicroVision, Inc. (a)(b)  | 87687  | 265692  |
|  MICT, Inc. (a)(b)  | 91949  | 89310  |
|  Napco Security Technologies, Inc.  | 23668  | 624362  |
|  National Instruments Corp. (b)  | 72866  | 2988963  |
|  Nayax Ltd. (a)  | 18600  | 387810  |
|  Neonode, Inc. (a)(b)  | 4962  | 20344  |
|  nLIGHT, Inc. (a)  | 37379  | 405936  |
|  Novanta, Inc. (a)  | 19813  | 3125501  |
|  OSI Systems, Inc. (a)  | 9960  | 881261  |
|  PC Connection, Inc.  | 15743  | 874524  |
|  Plexus Corp. (a)  | 16563  | 1825574  |
|  Powerfleet, Inc. (a)  | 19674  | 55481  |
|  Red Cat Holdings, Inc. (a)(b)  | 30119  | 35540  |
|  Research Frontiers, Inc. (a)(b)  | 10936  | 25700  |
|  RF Industries Ltd. (a)(b)  | 2448  | 12509  |
|  Richardson Electronics Ltd.  | 7825  | 199068  |
|  Sanmina Corp. (a)  | 34858  | 2303765  |
|  ScanSource, Inc. (a)  | 12803  | 382298  |
|  Senstar Technologies Ltd. (a)  | 12188  | 17490  |
|  Sono-Tek Corp. (a)  | 2629  | 14722  |
|  Supercom Ltd. (a)(b)  | 893  | 1893  |
|  Trimble, Inc. (a)  | 140006  | 8365359  |
|  TROOPS, Inc. (a)(b)  | 52367  | 98450  |
|  TTM Technologies, Inc. (a)  | 56839  | 913403  |
|  Velodyne Lidar, Inc. (a)  | 178421  | 175655  |
|  Ventoux CCM Acquisition Corp. (a)(b)  | 11540  | 23657  |
|  Wrap Technologies, Inc. (a)(b)  | 38058  | 78399  |
|  Zebra Technologies Corp. Class A (a)  | 29398  | 7945691  |
|  |  | 79117652  |
| IT Services - 2.8%  |  |  |
|  Affirm Holdings, Inc. (a)(b)  | 110911  | 1543881  |
|  AgileThought, Inc. Class A (a)(b)  | 21017  | 85119  |
|  Akamai Technologies, Inc. (a)  | 89317  | 8472611  |
|  Alithya Group, Inc. (a)  | 36580  | 64015  |
|  Amdocs Ltd.  | 67525  | 6000272  |
|  American Virtual Cloud Technologies, Inc. (a)(b)  | 2981  | 3339  |
|  Automatic Data Processing, Inc.  | 237552  | 62746985  |
|  AvidXchange Holdings, Inc. (a)  | 108324  | 933753  |
|  Backblaze, Inc. Class A (b)  | 1817  | 8122  |
|  BigCommerce Holdings, Inc. (a)  | 8309  | 71790  |
|  Brightcove, Inc. (a)  | 26601  | 147104  |
|  Cantaloupe, Inc. (a)  | 40019  | 145269  |
|  Cass Information Systems, Inc.  | 9021  | 392233  |
|  Cerberus Cyber Sentinel Corp. (b)  | 82667  | 253788  |
|  Chindata Group Holdings Ltd. ADR (a)(b)  | 68215  | 488419  |
|  CLPS, Inc. (a)  | 5050  | 5303  |
|  Cognizant Technology Solutions Corp. Class A  | 292910  | 18221931  |
|  Computer Task Group, Inc. (a)  | 17316  | 130909  |
|  Concentrix Corp.  | 29329  | 3589283  |
|  Conduent, Inc. (a)  | 123383  | 498467  |
|  Crexendo, Inc. (b)  | 12457  | 26035  |
|  CSG Systems International, Inc.  | 17738  | 1096918  |
|  CSP, Inc. (b)  | 2765  | 24304  |
|  Cyxtera Technologies, Inc. Class A (a)  | 67929  | 133141  |
|  Data Storage Corp. (a)(b)  | 23206  | 42003  |
|  Dlocal Ltd. (a)(b)  | 90228  | 1317329  |
|  Edgio, Inc. (a)  | 115599  | 166463  |
|  Euronet Worldwide, Inc. (a)  | 28258  | 2626581  |
|  EVO Payments, Inc. Class A (a)  | 27260  | 918935  |
|  Exela Technologies, Inc. (a)(b)  | 5224  | 925  |
|  ExlService Holdings, Inc. (a)  | 18501  | 3463387  |
|  Fiserv, Inc. (a)  | 363587  | 37943939  |
|  Flywire Corp. (a)  | 66557  | 1443621  |
|  Formula Systems (1985) Ltd. ADR (a)(b)  | 193  | 16550  |
|  GDS Holdings Ltd. ADR (a)(b)  | 46140  | 733626  |
|  Getnet Adquirencia e Servicos Para Meios de Pagamento SA ADR (b)  | 24013  | 41062  |
|  GreenBox POS (a)(b)  | 21290  | 15542  |
|  Grid Dynamics Holdings, Inc. (a)  | 61814  | 787510  |
|  Hackett Group, Inc.  | 16264  | 375698  |
|  i3 Verticals, Inc. Class A (a)  | 11916  | 313272  |
|  IBEX Ltd. (a)  | 11244  | 290208  |
|  Information Services Group, Inc.  | 25958  | 139135  |
|  Innodata, Inc. (a)(b)  | 13207  | 41074  |
|  Inpixon (a)  | 689  | 1791  |
|  International Money Express, Inc. (a)  | 46524  | 1010501  |
|  Jack Henry & Associates, Inc. (b)  | 40700  | 7706545  |
|  Kingsoft Cloud Holdings Ltd. ADR (a)(b)  | 81831  | 247130  |
|  Lesaka Technologies, Inc. (a)(b)  | 31755  | 126702  |
|  Marqeta, Inc. Class A (a)  | 268368  | 1795382  |
|  MoneyGram International, Inc. (a)  | 51548  | 562904  |
|  MongoDB, Inc. Class A (a)  | 39285  | 5998427  |
|  Nuvei Corp. (a)(b)(d)  | 31120  | 958807  |
|  Okta, Inc. (a)  | 79522  | 4240113  |
|  Paya Holdings, Inc. (a)  | 72210  | 672275  |
|  Paychex, Inc.  | 205512  | 25489653  |
|  Payoneer Global, Inc. (a)  | 187374  | 1011820  |
|  PayPal Holdings, Inc. (a)  | 660202  | 51766439  |
|  Paysign, Inc. (a)  | 29027  | 86500  |
|  Perficient, Inc. (a)  | 20170  | 1433079  |
|  PFSweb, Inc. (a)(b)  | 12193  | 136196  |
|  Priority Technology Holdings, Inc. (a)  | 38686  | 230569  |
|  Rackspace Technology, Inc. (a)(b)  | 141850  | 692228  |
|  Remitly Global, Inc. (a)(b)  | 104107  | 1088959  |
|  Repay Holdings Corp. (a)  | 27786  | 246184  |
|  Research Solutions, Inc. (a)  | 4834  | 10393  |
|  Sabre Corp. (a)  | 179819  | 1098694  |
|  SS&C Technologies Holdings, Inc.  | 148674  | 7992714  |
|  Steel Connect, Inc. (a)  | 32364  | 36571  |
|  StoneCo Ltd. Class A (a)  | 160026  | 1869104  |
|  Taoping, Inc. (a)(b)  | 3739  | 2553  |
|  TaskUs, Inc. (a)  | 14716  | 289464  |
|  The Glimpse Group, Inc. (a)(b)  | 3147  | 14571  |
|  The OLB Group, Inc. (a)(b)  | 1982  | 1642  |
|  Thoughtworks Holding, Inc. (a)  | 200491  | 1828478  |
|  Ttec Holdings, Inc.  | 26494  | 1270387  |
|  Tucows, Inc. (a)  | 6556  | 201269  |
|  Usio, Inc. (a)(b)  | 12705  | 31763  |
|  VeriSign, Inc. (a)  | 61415  | 12271331  |
|  Verra Mobility Corp. (a)  | 88691  | 1405752  |
|  Vnet Group, Inc. ADR (a)(b)  | 71009  | 355755  |
|  WaveDancer, Inc. (a)  | 2165  | 1277  |
|  WeTrade Group, Inc. (b)  | 88233  | 76763  |
|  Wix.com Ltd. (a)  | 32253  | 2918574  |
|  |  | 292939110  |
| Semiconductors & Semiconductor Equipment - 11.1%  |  |  |
|  ACM Research, Inc.  | 28563  | 258781  |
|  Advanced Micro Devices, Inc. (a)  | 919260  | 71362154  |
|  AEHR Test Systems (a)  | 13393  | 349156  |
|  Allegro MicroSystems LLC (a)  | 104788  | 3263098  |
|  Alpha & Omega Semiconductor Ltd. (a)  | 14105  | 494803  |
|  Ambarella, Inc. (a)  | 23986  | 1779761  |
|  Amkor Technology, Inc.  | 135545  | 3797971  |
|  Amtech Systems, Inc. (a)  | 9588  | 104893  |
|  Analog Devices, Inc.  | 290932  | 50014120  |
|  Applied Materials, Inc.  | 492596  | 53988522  |
|  Ascent Solar Technologies, Inc. (a)(b)  | 22041  | 66123  |
|  ASML Holding NV  | 49115  | 29867814  |
|  Atomera, Inc. (a)(b)  | 13904  | 118601  |
|  Axcelis Technologies, Inc. (a)  | 19430  | 1551680  |
|  AXT, Inc. (a)  | 21623  | 114818  |
|  Broadcom, Inc.  | 230466  | 126993680  |
|  Camtek Ltd. (a)(b)  | 23975  | 584750  |
|  Canadian Solar, Inc. (a)(b)  | 35996  | 1290457  |
|  CEVA, Inc. (a)  | 12199  | 331447  |
|  ChipMOS TECHNOLOGIES, Inc. sponsored ADR (b)  | 3922  | 87461  |
|  Cirrus Logic, Inc. (a)  | 32816  | 2451683  |
|  Cohu, Inc. (a)  | 26895  | 963379  |
|  Credo Technology Group Holding Ltd. (b)  | 84458  | 1176500  |
|  CVD Equipment Corp. (a)  | 4263  | 22807  |
|  Diodes, Inc. (a)  | 25728  | 2372893  |
|  Enphase Energy, Inc. (a)  | 77129  | 24726786  |
|  Entegris, Inc.  | 86350  | 6673992  |
|  Everspin Technologies, Inc. (a)  | 13033  | 88103  |
|  First Solar, Inc. (a)  | 60699  | 10472398  |
|  FormFactor, Inc. (a)  | 42470  | 979783  |
|  GlobalFoundries, Inc. (a)(b)  | 308432  | 19847599  |
|  GSI Technology, Inc. (a)  | 15609  | 37618  |
|  Himax Technologies, Inc. sponsored ADR (b)  | 59577  | 439082  |
|  Ichor Holdings Ltd. (a)  | 15188  | 452299  |
|  Impinj, Inc. (a)  | 13887  | 1771287  |
|  indie Semiconductor, Inc. (a)(b)  | 78627  | 645528  |
|  Intel Corp.  | 2340077  | 70366115  |
|  KLA Corp.  | 81493  | 32038973  |
|  Kopin Corp. (a)  | 49279  | 79832  |
|  Kulicke & Soffa Industries, Inc.  | 33199  | 1591892  |
|  Lam Research Corp.  | 77697  | 36702509  |
|  Lattice Semiconductor Corp. (a)  | 80486  | 5861795  |
|  MACOM Technology Solutions Holdings, Inc. (a)  | 38228  | 2625881  |
|  Marvell Technology, Inc.  | 489406  | 22767167  |
|  Maxeon Solar Technologies Ltd. (a)(b)  | 27787  | 639657  |
|  MaxLinear, Inc. Class A (a)  | 42983  | 1573178  |
|  Meta Materials, Inc. (a)(b)  | 151939  | 288684  |
|  Microchip Technology, Inc.  | 310121  | 24558482  |
|  Micron Technology, Inc.  | 625208  | 36043241  |
|  MKS Instruments, Inc.  | 39259  | 3292260  |
|  Monolithic Power Systems, Inc.  | 26156  | 9990546  |
|  Navitas Semiconductor Corp. (a)(b)  | 100637  | 479032  |
|  Nova Ltd. (a)(b)  | 15784  | 1350637  |
|  NVE Corp.  | 2373  | 151184  |
|  NVIDIA Corp.  | 1418182  | 239998940  |
|  NXP Semiconductors NV  | 150082  | 26390419  |
|  O2Micro International Ltd. sponsored ADR (a)  | 16202  | 70803  |
|  onsemi (a)  | 247119  | 18583349  |
|  PDF Solutions, Inc. (a)  | 23680  | 742842  |
|  Peraso, Inc. (a)(b)  | 20260  | 22894  |
|  Photronics, Inc. (a)  | 36838  | 692554  |
|  Pixelworks, Inc. (a)  | 37111  | 53811  |
|  Power Integrations, Inc. (b)  | 33245  | 2675558  |
|  Qorvo, Inc. (a)  | 59460  | 5901405  |
|  Qualcomm, Inc.  | 639793  | 80927417  |
|  QuickLogic Corp. (a)(b)  | 2338  | 14355  |
|  Rambus, Inc. (a)  | 63437  | 2434712  |
|  Rigetti Computing, Inc. Class A (a)  | 72424  | 94151  |
|  Rubicon Technology, Inc. (a)  | 332  | 631  |
|  SemiLEDs Corp. (a)(b)  | 4500  | 11925  |
|  Semtech Corp. (a)  | 36094  | 1109530  |
|  Silicon Laboratories, Inc. (a)  | 20841  | 3031115  |
|  Silicon Motion Tech Corp. sponsored ADR  | 19713  | 1243890  |
|  SiTime Corp. (a)  | 11247  | 1186109  |
|  SkyWater Technology, Inc. (a)(b)  | 21008  | 207349  |
|  Skyworks Solutions, Inc.  | 89365  | 8545081  |
|  SMART Global Holdings, Inc. (a)(b)  | 25906  | 438070  |
|  SolarEdge Technologies, Inc. (a)  | 31789  | 9500461  |
|  SPI Energy Co. Ltd. sponsored ADR (a)  | 11554  | 16753  |
|  Synaptics, Inc. (a)  | 20715  | 2195169  |
|  Teradyne, Inc.  | 89661  | 8378820  |
|  Texas Instruments, Inc.  | 521580  | 94124327  |
|  Tower Semiconductor Ltd. (a)  | 61304  | 2732319  |
|  Transphorm, Inc. (a)  | 7137  | 41038  |
|  Ultra Clean Holdings, Inc. (a)  | 25361  | 903612  |
|  Universal Display Corp.  | 25639  | 2887464  |
|  Veeco Instruments, Inc. (a)(b)  | 28870  | 573936  |
|  WiSA Technologies, Inc. (a)(b)  | 50912  | 5794  |
|  WISeKey International Holding Ltd. ADR (a)(b)  | 695  | 1188  |
|  |  | 1185680683  |
| Software - 15.4%  |  |  |
|  Absolute Software Corp.  | 25866  | 250642  |
|  ACI Worldwide, Inc. (a)  | 65286  | 1364477  |
|  Adeia, Inc.  | 60469  | 668182  |
|  Adobe, Inc. (a)  | 266877  | 92053884  |
|  Agilysys, Inc. (a)  | 14089  | 935510  |
|  Agora, Inc. ADR (a)  | 56495  | 177394  |
|  Alarm.com Holdings, Inc. (a)  | 28485  | 1421402  |
|  Alkami Technology, Inc. (a)  | 54588  | 686171  |
|  Allot Ltd. (a)(b)  | 21262  | 78882  |
|  Altair Engineering, Inc. Class A (a)(b)  | 28825  | 1414443  |
|  American Software, Inc. Class A  | 20292  | 300525  |
|  Amplitude, Inc. (a)(b)  | 45925  | 657646  |
|  ANSYS, Inc. (a)  | 50237  | 12775269  |
|  AppFolio, Inc. (a)  | 11991  | 1368053  |
|  Appian Corp. Class A (a)(b)  | 24732  | 940558  |
|  Applied Digital Corp. (b)  | 89800  | 175110  |
|  AppLovin Corp. (a)(b)  | 154182  | 2221763  |
|  Argo Blockchain PLC ADR (a)(b)  | 2693  | 2006  |
|  Arqit Quantum, Inc. (a)(b)  | 67275  | 513308  |
|  Arteris, Inc. (a)  | 17296  | 85615  |
|  Aspen Technology, Inc. (a)  | 36856  | 8495308  |
|  Asure Software, Inc. (a)(b)  | 12380  | 97183  |
|  Atlassian Corp. PLC (a)  | 83095  | 10931147  |
|  Auddia, Inc. (a)(b)  | 4309  | 4675  |
|  AudioEye, Inc. (a)(b)  | 8256  | 38473  |
|  Aurora Mobile Ltd. ADR (a)(b)  | 47465  | 41484  |
|  Authid, Inc. (a)(b)  | 12623  | 14012  |
|  Autodesk, Inc. (a)  | 123479  | 24936584  |
|  AvePoint, Inc. (a)(b)  | 117943  | 556691  |
|  Aware, Inc. (a)  | 13849  | 27006  |
|  Benefitfocus, Inc. (a)  | 12461  | 129221  |
|  Bentley Systems, Inc. Class B (b)  | 154645  | 6125488  |
|  Bio-Key International, Inc. (a)(b)  | 10259  | 9541  |
|  Bit Digital, Inc. (a)(b)  | 5626  | 5168  |
|  Bit Origin Ltd. (a)(b)  | 30160  | 6822  |
|  Bitfarms Ltd. (a)(b)  | 218197  | 127209  |
|  Blackbaud, Inc. (a)  | 30083  | 1783019  |
|  BlackLine, Inc. (a)  | 35625  | 2411456  |
|  Braze, Inc.  | 27817  | 714897  |
|  Bridgeline Digital, Inc. (a)  | 2527  | 3487  |
|  BSQUARE Corp. (a)(b)  | 7925  | 8638  |
|  BTCS, Inc.  | 2315  | 2384  |
|  BTRS Holdings, Inc. (a)  | 87606  | 829629  |
|  Cadence Design Systems, Inc. (a)  | 154207  | 26529772  |
|  Cellebrite DI Ltd. (a)(b)  | 106708  | 482320  |
|  Cerence, Inc. (a)  | 27954  | 573337  |
|  Check Point Software Technologies Ltd. (a)  | 72033  | 9568143  |
|  Cipher Mining, Inc. (a)(b)  | 155211  | 121313  |
|  Cleanspark, Inc. (a)(b)  | 6833  | 15374  |
|  Cognyte Software Ltd. (a)  | 61289  | 180803  |
|  Color Star Technology Co. Ltd. (a)(b)  | 1380  | 1111  |
|  CommVault Systems, Inc. (a)  | 24432  | 1612512  |
|  Confluent, Inc. (a)(b)  | 84849  | 1954072  |
|  Consensus Cloud Solutions, Inc. (a)  | 11285  | 640875  |
|  Couchbase, Inc. (a)(b)  | 23156  | 314922  |
|  Coupa Software, Inc. (a)  | 39085  | 2471735  |
|  Crowdstrike Holdings, Inc. (a)  | 122704  | 14436126  |
|  Cvent Holding Corp. (a)  | 238766  | 1337090  |
|  CyberArk Software Ltd. (a)  | 22061  | 3288633  |
|  Cyngn, Inc. (a)(b)  | 11100  | 8658  |
|  Cyren Ltd. (a)  | 1797  | 1599  |
|  Datadog, Inc. Class A (a)  | 167083  | 12661550  |
|  Datasea, Inc. (a)(b)  | 16136  | 22268  |
|  DatChat, Inc. (a)(b)  | 11224  | 5320  |
|  Descartes Systems Group, Inc. (a)  | 47707  | 3313251  |
|  Digimarc Corp. (a)(b)  | 15142  | 337364  |
|  Digital Turbine, Inc. (a)  | 45318  | 827507  |
|  Docebo, Inc. (a)(b)  | 18504  | 590278  |
|  DocuSign, Inc. (a)  | 116559  | 5486432  |
|  Domo, Inc. Class B (a)  | 23964  | 342685  |
|  Dropbox, Inc. Class A (a)  | 159854  | 3766160  |
|  Duck Creek Technologies, Inc. (a)(b)  | 74702  | 835915  |
|  Ebix, Inc. (b)  | 17007  | 322963  |
|  eGain Communications Corp. (a)  | 24943  | 219498  |
|  Embark Technology, Inc. (a)(b)  | 7450  | 30694  |
|  Everbridge, Inc. (a)  | 25015  | 816490  |
|  EverCommerce, Inc. (a)  | 111483  | 743592  |
|  Expensify, Inc. (b)  | 37779  | 361545  |
|  Five9, Inc. (a)  | 39358  | 2523241  |
|  Fortinet, Inc. (a)  | 449228  | 23880960  |
|  Freshworks, Inc. (a)(b)  | 89881  | 1328441  |
|  GitLab, Inc. (a)(b)  | 49563  | 1960217  |
|  Gorilla Technology Group, Inc. (a)(b)  | 39553  | 379709  |
|  Greenidge Generation Holdings, Inc. (a)(b)  | 6418  | 4106  |
|  HashiCorp, Inc. (b)  | 44894  | 1225606  |
|  HIVE Blockchain Technologies Ltd. (a)(b)  | 2040  | 4304  |
|  Hut 8 Mining Corp. (a)(b)  | 143401  | 170647  |
|  Infobird Co. Ltd. (a)(b)  | 2317  | 1738  |
|  Intapp, Inc. (a)  | 34418  | 795400  |
|  Intellicheck, Inc. (a)(b)  | 10166  | 22162  |
|  InterDigital, Inc.  | 17923  | 899197  |
|  Intrusion, Inc. (a)(b)  | 13441  | 41264  |
|  Intuit, Inc.  | 160915  | 65587345  |
|  Iris Energy Ltd. (b)  | 30475  | 45408  |
|  Jamf Holding Corp. (a)  | 67210  | 1430229  |
|  JFrog Ltd. (a)  | 49834  | 1095351  |
|  Kaltura, Inc. (a)(b)  | 70000  | 133700  |
|  Karooooo Ltd. (b)  | 15941  | 405539  |
|  Kaspien Holdings, Inc. (a)(b)  | 939  | 782  |
|  KnowBe4, Inc. (a)  | 44669  | 1102878  |
|  LivePerson, Inc. (a)  | 50042  | 587493  |
|  Livevox Holdings, Inc. (a)(b)  | 69123  | 156218  |
|  Magic Software Enterprises Ltd.  | 31025  | 536733  |
|  Manhattan Associates, Inc. (a)  | 35415  | 4460165  |
|  Marathon Digital Holdings, Inc. (a)(b)  | 69576  | 439720  |
|  Marin Software, Inc. (a)(b)  | 14390  | 15973  |
|  Materialise NV ADR (a)  | 14271  | 137715  |
|  Matterport, Inc. (a)(b)  | 194000  | 611100  |
|  Mawson Infrastructure Group, Inc. (a)(b)  | 35300  | 12002  |
|  Mercurity Fintech Holding, Inc. sponsored ADR (a)(b)  | 11191  | 9400  |
|  Microsoft Corp.  | 4246449  | 1083438998  |
|  MicroStrategy, Inc. Class A (a)(b)  | 5348  | 1059385  |
|  Mitek Systems, Inc. (a)  | 28300  | 289509  |
|  MMTEC, Inc. (a)(b)  | 2683  | 2924  |
|  Momentive Global, Inc. (a)  | 80549  | 638754  |
|  Monday.com Ltd. (a)(b)  | 26486  | 2847245  |
|  My Size, Inc. (a)(b)  | 86590  | 13889  |
|  nCino, Inc. (a)(b)  | 64312  | 1679829  |
|  NetSol Technologies, Inc. (a)  | 6495  | 20005  |
|  Nextnav, Inc. (a)(b)  | 54893  | 180598  |
|  NICE Ltd. sponsored ADR (a)  | 29012  | 5633260  |
|  Nisun International Enterprise (a)  | 11226  | 5950  |
|  NortonLifeLock, Inc.  | 325508  | 7473664  |
|  Nutanix, Inc. Class A (a)  | 131081  | 3704349  |
|  Oblong, Inc. (a)(b)  | 25309  | 4553  |
|  Onespan, Inc. (a)  | 27480  | 345424  |
|  Open Text Corp.  | 153133  | 4499048  |
|  Opera Ltd. ADR (a)  | 20330  | 107342  |
|  Otonomo Technologies Ltd. (a)(b)  | 42044  | 16607  |
|  Pagaya Technologies Ltd. Class A (a)(b)  | 223820  | 223820  |
|  Palo Alto Networks, Inc. (a)  | 170154  | 28909165  |
|  Park City Group, Inc. (b)  | 11886  | 61569  |
|  Paycor HCM, Inc. (a)(b)  | 97696  | 2825368  |
|  Paylocity Holding Corp. (a)  | 30781  | 6705025  |
|  Pegasystems, Inc.  | 50927  | 1846104  |
|  Phunware, Inc. (a)(b)  | 56490  | 60444  |
|  Powerbridge Technologies Co. Ltd. (a)(b)  | 44173  | 6008  |
|  Progress Software Corp.  | 24678  | 1315831  |
|  PTC, Inc. (a)  | 65301  | 8306940  |
|  Qualtrics International, Inc. (a)  | 106588  | 1093593  |
|  Qualys, Inc. (a)  | 22000  | 2713040  |
|  Quantum Computing, Inc. (a)(b)  | 20196  | 44633  |
|  Qumu Corp. (a)(b)  | 16919  | 8798  |
|  Radcom Ltd. (a)(b)  | 13668  | 143514  |
|  Rapid7, Inc. (a)  | 31413  | 923542  |
|  RealNetworks, Inc. (a)  | 22292  | 16117  |
|  Rekor Systems, Inc. (a)(b)  | 22727  | 22388  |
|  Rimini Street, Inc. (a)  | 102912  | 432230  |
|  Riot Blockchain, Inc. (a)(b)  | 107353  | 499191  |
|  Safe-T Group Ltd. ADR (a)(b)  | 2487  | 8307  |
|  SAI.TECH Global Corp. Class A (a)(b)  | 7507  | 19969  |
|  Sapiens International Corp. NV  | 29953  | 582885  |
|  SeaChange International, Inc. (a)  | 14506  | 6549  |
|  SecureWorks Corp. (a)  | 11955  | 85837  |
|  Semantix, Inc. (a)(b)  | 4113  | 4360  |
|  ShotSpotter, Inc. (a)  | 9121  | 305827  |
|  SilverSun Technologies, Inc. (A Shares) (a)  | 910  | 3267  |
|  Smith Micro Software, Inc. (a)(b)  | 26575  | 59794  |
|  Soluna Holdings, Inc. (a)(b)  | 5272  | 4198  |
|  SoundHound AI, Inc. (a)(b)  | 87055  | 111430  |
|  Sphere 3D Corp. (a)  | 22706  | 7452  |
|  Splunk, Inc. (a)  | 93578  | 7269139  |
|  SpringBig Holdings, Inc. (a)(b)  | 23342  | 19084  |
|  Sprout Social, Inc. (a)  | 29231  | 1733398  |
|  SPS Commerce, Inc. (a)  | 19954  | 2838656  |
|  SRAX, Inc. (a)(b)  | 9776  | 17597  |
|  Stronghold Digital Mining, Inc. Class A (a)(b)  | 10185  | 7435  |
|  Sumo Logic, Inc. (a)  | 69094  | 525114  |
|  Synchronoss Technologies, Inc. (a)(b)  | 64975  | 60427  |
|  Synopsys, Inc. (a)  | 87068  | 29563069  |
|  Telos Corp. (a)  | 4181  | 17142  |
|  Tenable Holdings, Inc. (a)  | 62120  | 2371742  |
|  TeraWulf, Inc. (a)  | 52778  | 43806  |
|  TeraWulf, Inc. rights (a)(c)  | 946  | 0  |
|  Upland Software, Inc. (a)  | 21178  | 159682  |
|  Varonis Systems, Inc. (a)  | 63549  | 1349781  |
|  Verb Technology Co., Inc. (a)(b)  | 61842  | 10093  |
|  Verint Systems, Inc. (a)  | 35965  | 1414503  |
|  Veritone, Inc. (a)(b)  | 18574  | 125189  |
|  Vertex, Inc. Class A (a)(b)  | 29998  | 515366  |
|  Viant Technology, Inc. (a)  | 11166  | 42654  |
|  WalkMe Ltd. (a)  | 49858  | 436258  |
|  Workday, Inc. Class A (a)  | 114005  | 19141440  |
|  Xunlei Ltd. sponsored ADR (a)  | 24768  | 46564  |
|  Zenvia, Inc. (a)(b)  | 1673  | 2459  |
|  ZeroFox Holdings, Inc. (a)(b)  | 6028  | 27126  |
|  Zoom Video Communications, Inc. Class A (a)  | 144143  | 10872706  |
|  Zscaler, Inc. (a)  | 81406  | 10863631  |
|  |  | 1638409601  |
| Technology Hardware, Storage & Peripherals - 13.0%  |  |  |
|  Apple, Inc.  | 9150800  | 1354592902  |
|  Astro-Med, Inc. (a)  | 3663  | 43040  |
|  Avid Technology, Inc. (a)  | 25039  | 703095  |
|  Borqs Technologies, Inc. (a)(b)  | 7860  | 4009  |
|  Boxlight Corp. (a)(b)  | 32673  | 13239  |
|  Canaan, Inc. ADR (a)(b)  | 92287  | 239946  |
|  CompoSecure, Inc. (a)(b)  | 50906  | 255039  |
|  Corsair Gaming, Inc. (a)(b)  | 59540  | 1004440  |
|  CPI Card Group (a)  | 4378  | 105072  |
|  Ebang International Holdings, Inc. Class A (a)(b)  | 1980  | 9722  |
|  Immersion Corp. (b)  | 18807  | 136539  |
|  Intevac, Inc. (a)  | 22851  | 131165  |
|  Logitech International SA (b)  | 92848  | 5621018  |
|  Movano, Inc. (a)(b)  | 16621  | 31081  |
|  Nano Dimension Ltd. ADR (a)(b)  | 155866  | 384989  |
|  NetApp, Inc.  | 125582  | 8490599  |
|  NWTN, Inc. (a)(b)  | 10409  | 92536  |
|  One Stop Systems, Inc. (a)(b)  | 8505  | 26706  |
|  Quantum Corp. (a)  | 29791  | 37835  |
|  Seagate Technology Holdings PLC  | 122827  | 6506146  |
|  Socket Mobile, Inc. (a)(b)  | 1296  | 2631  |
|  Sonim Technologies, Inc. (a)  | 7078  | 2923  |
|  Stratasys Ltd. (a)  | 34957  | 490447  |
|  Super Micro Computer, Inc. (a)  | 29455  | 2657725  |
|  Transact Technologies, Inc. (a)(b)  | 6575  | 41751  |
|  Turtle Beach Corp. (a)  | 8432  | 80526  |
|  Western Digital Corp. (a)  | 175864  | 6463002  |
|  Xerox Holdings Corp.  | 89618  | 1461670  |
|  |  | 1389629793  |
|  TOTAL INFORMATION TECHNOLOGY  |  | 4727977482  |
| MATERIALS - 0.4%  |  |  |
| Chemicals - 0.1%  |  |  |
|  Advanced Emissions Solutions, Inc. (a)  | 9725  | 27133  |
|  AgroFresh Solutions, Inc. (a)  | 34342  | 101309  |
|  Amyris, Inc. (a)(b)  | 166033  | 287237  |
|  Balchem Corp.  | 17562  | 2472730  |
|  Bioceres Crop Solutions Corp. (a)(b)  | 26868  | 371047  |
|  Bon Natural Life Ltd. (a)  | 4398  | 4336  |
|  CN Energy Group, Inc. (a)(b)  | 8671  | 7067  |
|  Crown ElectroKinetics Corp. (a)(b)  | 5276  | 1082  |
|  Diversey Holdings Ltd. (a)  | 193314  | 993634  |
|  Fuwei Films Holdings Co. Ltd. (a)(b)  | 3842  | 30160  |
|  Gulf Resources, Inc. (a)  | 8302  | 29804  |
|  Hawkins, Inc.  | 11982  | 498451  |
|  Innospec, Inc.  | 14671  | 1626867  |
|  Loop Industries, Inc. (a)(b)  | 23631  | 66167  |
|  Methanex Corp. (b)  | 40908  | 1595821  |
|  Northern Technologies International Corp. (b)  | 5689  | 73957  |
|  Origin Materials, Inc. Class A (a)(b)  | 78046  | 434716  |
|  PureCycle Technologies, Inc. (a)(b)  | 96800  | 671792  |
|  Save Foods, Inc. (a)(b)  | 6151  | 7566  |
|  |  | 9300876  |
| Construction Materials - 0.0%  |  |  |
|  ReTo Eco-Solutions, Inc. (a)(b)  | 22427  | 9307  |
|  Smith-Midland Corp. (a)  | 2305  | 52554  |
|  United States Lime & Minerals, Inc.  | 3255  | 452380  |
|  |  | 514241  |
| Containers & Packaging - 0.0%  |  |  |
|  Cryptyde, Inc. (a)  | 7424  | 2190  |
|  Pactiv Evergreen, Inc.  | 102760  | 1196126  |
|  TriMas Corp.  | 23430  | 640811  |
|  |  | 1839127  |
| Metals & Mining - 0.3%  |  |  |
|  5E Advanced Materials, Inc. (a)(b)  | 24267  | 271790  |
|  Algoma Steel Group, Inc. (b)  | 58301  | 385953  |
|  Ascent Industries Co. (a)  | 7726  | 82127  |
|  Century Aluminum Co. (a)  | 47905  | 431624  |
|  China Natural Resources, Inc. (a)  | 12136  | 4612  |
|  Ferroglobe PLC (a)  | 108224  | 501077  |
|  Haynes International, Inc.  | 8044  | 401878  |
|  Huadi International Group Co. Ltd. (a)(b)  | 7169  | 57352  |
|  Hycroft Mining Holding Corp. (a)  | 125396  | 90323  |
|  Kaiser Aluminum Corp. (b)  | 9418  | 851387  |
|  Largo, Inc. (a)(b)  | 32652  | 182198  |
|  Olympic Steel, Inc.  | 7458  | 261701  |
|  Pan American Silver Corp. (b)  | 118840  | 1947788  |
|  Perpetua Resources Corp. (a)  | 28542  | 59938  |
|  Piedmont Lithium, Inc. (a)(b)  | 9153  | 527762  |
|  Ramaco Resources, Inc. (b)  | 27313  | 312734  |
|  Royal Gold, Inc.  | 36746  | 4127678  |
|  Schnitzer Steel Industries, Inc. Class A (b)  | 15466  | 530948  |
|  Sigma Lithium Corp. (a)(b)  | 58171  | 1995265  |
|  Snow Lake Resources Ltd. (b)  | 4113  | 12956  |
|  SSR Mining, Inc. (b)  | 119238  | 1807648  |
|  Steel Dynamics, Inc.  | 105172  | 10930526  |
|  TMC the metals Co., Inc. (a)(b)  | 115145  | 98449  |
|  U.S. Gold Corp. (a)  | 1706  | 7233  |
|  Universal Stainless & Alloy Products, Inc. (a)  | 7722  | 57297  |
|  |  | 25938244  |
| Paper & Forest Products - 0.0%  |  |  |
|  Mercer International, Inc. (SBI) (b)  | 38360  | 529368  |
|  TOTAL MATERIALS  |  | 38121856  |
| REAL ESTATE - 1.0%  |  |  |
| Equity Real Estate Investment Trusts (REITs) - 0.9%  |  |  |
|  Creative Media & Community Trust Corp.  | 12011  | 72426  |
|  Diversified Healthcare Trust (SBI)  | 142959  | 141529  |
|  Equinix, Inc.  | 52158  | 36022923  |
|  Gaming & Leisure Properties  | 146131  | 7687952  |
|  Gladstone Commercial Corp.  | 18518  | 351657  |
|  Gladstone Land Corp.  | 24626  | 505818  |
|  Global Self Storage, Inc.  | 5948  | 30335  |
|  Host Hotels & Resorts, Inc.  | 401032  | 7595546  |
|  Indus Realty Trust, Inc. (b)  | 3882  | 248448  |
|  Lamar Advertising Co. Class A  | 48162  | 4822943  |
|  Medalist Diversified (REIT), Inc.  | 12929  | 10214  |
|  Necessity Retail (REIT), Inc./The  | 86334  | 576711  |
|  Office Properties Income Trust  | 35609  | 544462  |
|  Phillips Edison & Co., Inc.  | 65268  | 2103588  |
|  Potlatch Corp. (b)  | 49080  | 2345533  |
|  Presidio Property Trust, Inc.:  |  |  |
|  Class A (b)  | 6016  | 6618  |
|  Class A warrants 1/24/27 (a)  | 6016  | 470  |
|  Regency Centers Corp.  | 95220  | 6325465  |
|  Retail Opportunity Investments Corp.  | 70063  | 1068461  |
|  Sabra Health Care REIT, Inc.  | 132435  | 1709736  |
|  SBA Communications Corp. Class A  | 61984  | 18551811  |
|  Service Properties Trust  | 89889  | 705629  |
|  Sotherly Hotels, Inc. (a)  | 4274  | 8292  |
|  Uniti Group, Inc.  | 129373  | 985822  |
|  Wheeler REIT, Inc. (a)  | 15634  | 28141  |
|  |  | 92450530  |
| Real Estate Management & Development - 0.1%  |  |  |
|  Alset, Inc. (a)(b)  | 43381  | 11006  |
|  Altisource Portfolio Solutions SA (a)  | 12106  | 182680  |
|  Avalon GloboCare Corp. (a)(b)  | 48932  | 20248  |
|  Colliers International Group, Inc. (b)  | 27875  | 2638926  |
|  Comstock Holding Companies, Inc. (a)  | 4017  | 17353  |
|  eXp World Holdings, Inc. (b)  | 93210  | 1218255  |
|  Fathom Holdings, Inc. (a)(b)  | 7329  | 35839  |
|  FirstService Corp.  | 27548  | 3563885  |
|  Flj Group Ltd. ADR (a)  | 4737  | 6158  |
|  FRP Holdings, Inc. (a)  | 6217  | 378615  |
|  Green Giant, Inc. (a)(b)  | 20468  | 59562  |
|  Gyrodyne LLC (a)  | 1080  | 10228  |
|  InterGroup Corp. (a)  | 986  | 45040  |
|  MDJM Ltd. (a)(b)  | 4594  | 7810  |
|  Newmark Group, Inc.  | 100225  | 849908  |
|  Opendoor Technologies, Inc. (a)  | 23032  | 42609  |
|  Redfin Corp. (a)(b)  | 21073  | 112951  |
|  Stratus Properties, Inc.  | 5346  | 129908  |
|  The Real Brokerage, Inc. (a)  | 43591  | 54925  |
|  The RMR Group, Inc.  | 7911  | 228707  |
|  Ucommune International Ltd. (a)(b)  | 2354  | 3719  |
|  Zillow Group, Inc.:  |  |  |
|  Class A (a)  | 9051  | 338507  |
|  Class C (a)(b)  | 122377  | 4647878  |
|  |  | 14604717  |
|  TOTAL REAL ESTATE  |  | 107055247  |
| UTILITIES - 1.0%  |  |  |
| Electric Utilities - 1.0%  |  |  |
|  Alliant Energy Corp.  | 139857  | 7873949  |
|  American Electric Power Co., Inc.  | 297563  | 28804098  |
|  Constellation Energy Corp.  | 183909  | 17677333  |
|  Exelon Corp.  | 565747  | 23404953  |
|  MGE Energy, Inc.  | 19112  | 1376255  |
|  Otter Tail Corp.  | 23594  | 1406910  |
|  Via Renewables, Inc. Class A, (b)  | 7308  | 47210  |
|  Xcel Energy, Inc.  | 312776  | 21963131  |
|  |  | 102553839  |
| Gas Utilities - 0.0%  |  |  |
|  RGC Resources, Inc. (b)  | 5446  | 132229  |
| Independent Power and Renewable Electricity Producers - 0.0%  |  |  |
|  Atlantica Sustainable Infrastructure PLC (b)  | 70020  | 1953558  |
|  Eco Wave Power Global AB ADR (a)(b)  | 1986  | 8738  |
|  Montauk Renewables, Inc. (a)(b)  | 85373  | 1030452  |
|  ReNew Energy Global PLC (a)(b)  | 161158  | 978229  |
|  VivoPower International PLC (a)(b)  | 27588  | 9636  |
|  |  | 3980613  |
| Multi-Utilities - 0.0%  |  |  |
|  NorthWestern Energy Corp.  | 28847  | 1684953  |
| Water Utilities - 0.0%  |  |  |
|  Artesian Resources Corp. Class A  | 6205  | 338545  |
|  Cadiz, Inc. (a)(b)  | 30070  | 63748  |
|  Consolidated Water Co., Inc.  | 10783  | 157000  |
|  Global Water Resources, Inc.  | 13586  | 173629  |
|  Middlesex Water Co.  | 10525  | 983561  |
|  Pure Cycle Corp. (a)  | 13933  | 147829  |
|  York Water Co.  | 8284  | 378496  |
|  |  | 2242808  |
|  TOTAL UTILITIES  |  | 110594442  |
| <br> **TOTAL COMMON STOCKS** <br> (Cost $5,687,945,051)  |  | <br> **10631715397**  |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp; **Nonconvertible Preferred Stocks - 0.0%**  | &nbsp;&nbsp; **Nonconvertible Preferred Stocks - 0.0%**  | &nbsp;&nbsp; **Nonconvertible Preferred Stocks - 0.0%**  |
|  | Shares  | Value ($) <br>|
| CONSUMER DISCRETIONARY - 0.0%  |  |  |
| Hotels, Restaurants & Leisure - 0.0%  |  |  |
|  FAT Brands, Inc.  | 1005  | 18110  |
| ENERGY - 0.0%  |  |  |
| Oil, Gas & Consumable Fuels - 0.0%  |  |  |
|  Imperial Petroleum, Inc.  | 816  | 15888  |
| INFORMATION TECHNOLOGY - 0.0%  |  |  |
| Semiconductors & Semiconductor Equipment - 0.0%  |  |  |
|  Meta Materials, Inc. (a)  | 84218  | 688061  |
| Software - 0.0%  |  |  |
|  SRAX, Inc. (a)(c)  | 9776  | 489  |
|  TOTAL INFORMATION TECHNOLOGY  |  | 688550  |
| <br> **TOTAL NONCONVERTIBLE PREFERRED STOCKS** <br> (Cost $51,446)  |  | <br> **722548**  |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp; **U.S. Treasury Obligations - 0.0%**  | &nbsp;&nbsp; **U.S. Treasury Obligations - 0.0%**  | &nbsp;&nbsp; **U.S. Treasury Obligations - 0.0%**  |
|  | Principal <br> Amount (f) <br>| Value ($) <br>|
|  U.S. Treasury Bills, yield at date of purchase 1.15% 1/26/23 (g) <br>(Cost $4,991,137) <br>| 5000000  | **4968461**  |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp; **Money Market Funds - 4.6%**  | &nbsp;&nbsp; **Money Market Funds - 4.6%**  | &nbsp;&nbsp; **Money Market Funds - 4.6%**  |
|  | Shares  | Value ($) <br>|
|  Fidelity Cash Central Fund 3.86% (h)  | 19030181  | 19033988  |
|  Fidelity Securities Lending Cash Central Fund 3.86% (h)(i)  | 468542952  | 468589806  |
| <br> **TOTAL MONEY MARKET FUNDS** <br> (Cost $487,623,794)  |  | **487623794**  |

---

---

| | |
|:---|:---|
| <br> **TOTAL INVESTMENT IN SECURITIES - 104.3%** <br> (Cost $6,180,611,428) <br>| <br>**11125030200**  |
| **NET OTHER ASSETS (LIABILITIES) - (4.3)%**  | **(462234021)**  |
| **NET ASSETS - 100.0%**  | **10662796179**  |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp; **Futures Contracts**  | &nbsp;&nbsp; **Futures Contracts**  | &nbsp;&nbsp; **Futures Contracts**  | &nbsp;&nbsp; **Futures Contracts**  | &nbsp;&nbsp; **Futures Contracts**  | &nbsp;&nbsp; **Futures Contracts**  |
|  | Number <br> of contracts  | Expiration <br> Date  | Notional <br> Amount ($) <br>| Value ($) <br>| Unrealized <br> Appreciation/ <br> (Depreciation) ($) <br>|
| Purchased  |  |  |  |  |  |
| Equity Index Contracts  |  |  |  |  |  |
| CME E-mini NASDAQ 100 Index Contracts (United States)  | 142  | Dec 2022  | 34199990  | 2555575  | 2555575  |
| The notional amount of futures purchased as a percentage of Net Assets is 0.3%  | The notional amount of futures purchased as a percentage of Net Assets is 0.3%  | The notional amount of futures purchased as a percentage of Net Assets is 0.3%  | The notional amount of futures purchased as a percentage of Net Assets is 0.3%  | The notional amount of futures purchased as a percentage of Net Assets is 0.3%  | The notional amount of futures purchased as a percentage of Net Assets is 0.3%  |

---

**Legend**

(a) Non-income producing

(b) Security or a portion of the security is on loan at period end.

(c) Level 3 security

(d) Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $969,048 or 0.0% of net assets.

(e) Affiliated company

(f) Amount is stated in United States dollars unless otherwise noted.

(g) Security or a portion of the security was pledged to cover margin requirements for futures contracts. At period end, the value of securities pledged amounted to $2,275,555.

(h) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements, which are not covered by the Fund's Report of Independent Registered Public Accounting Firm, are available on the SEC's website or upon request.

(i) Investment made with cash collateral received from securities on loan.

**Affiliated Central Funds**

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| Affiliate  | Value, <br> beginning <br> of period ($)  | Purchases ($)  | Sales <br> Proceeds ($)  | Dividend <br> Income ($)  | Realized <br> Gain (loss) ($)  | Change in <br> Unrealized <br> appreciation <br> (depreciation) ($)  | Value, <br> end <br> of period ($)  | % ownership, <br> end <br> of period  |
|  Fidelity Cash Central Fund 3.86%  | 87722770  | 992512269  | 1061201051  | 703385  | -  | -  | 19033988  | 0.0%  |
|  Fidelity Securities Lending Cash Central Fund 3.86%  | 518835135  | 1825703813  | 1875949142  | 24644232  | -  | -  | 468589806  | 1.4%  |
| Total  | 606557905  | 2818216082  | 2937150193  | 25347617  | -  | -  | 487623794  |  |

---

Amounts in the income column in the above table include any capital gain distributions from underlying funds, which are presented in the corresponding line item in the Statement of Operations, if applicable.

Amount for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities.

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

**Other Affiliated Issuers**

An affiliated company is a company in which the Fund has ownership of at least 5% of the voting securities. Fiscal year to date transactions with companies which are or were affiliates are as follows:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| Affiliate  | Value, <br> beginning <br> of period ($)  | Purchases ($)  | Sales <br> Proceeds ($)  | Dividend <br> Income ($)  | Realized <br> Gain (loss) ($)  | Change in <br> Unrealized <br> appreciation <br> (depreciation) ($)  | Value, <br> end <br> of period ($)  |
|  Quoin Pharmaceuticals Ltd. ADR  | 32579  | 8571  | -  | 2  | -  | (39228)  | 1922  |
|  Stran & Co., Inc.  | -  | 9297  | -  | -  | -  | (7193)  | -  |
| Total  | 32579  | 17868  | -  | 2  | -  | (46421)  | 1922  |

---

Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.

**Investment Valuation**

The following is a summary of the inputs used, as of November 30, 2022, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. For more information on valuation inputs, and their aggregation into the levels used below, please refer to the Investment Valuation section in the accompanying Notes to Financial Statements.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Valuation Inputs at Reporting Date:**  | **Valuation Inputs at Reporting Date:**  | **Valuation Inputs at Reporting Date:**  | **Valuation Inputs at Reporting Date:**  | **Valuation Inputs at Reporting Date:**  |
| **Description**  | **Total ($)**  | **Level 1 ($)**  | **Level 2 ($)**  | **Level 3 ($)**  |
| **<u>Investments in Securities:</u>**  |  |  |  |  |
|  **Equities:**  |  |  |  |  |
| Communication Services  | 1429492431  | 1428842280  | -  | 650151  |
| Consumer Discretionary  | 1531087242  | 1530979995  | -  | 107247  |
| Consumer Staples  | 519785466  | 519783674  | -  | 1792  |
| Energy  | 91391870  | 91391870  | -  | -  |
| Financials  | 543802919  | 543802790  | -  | 129  |
| Health Care  | 1024866694  | 1024611286  | 13  | 255395  |
| Industrials  | 507573746  | 507527686  | -  | 46060  |
| Information Technology  | 4728666032  | 4728665543  | -  | 489  |
| Materials  | 38121856  | 38121856  | -  | -  |
| Real Estate  | 107055247  | 107055247  | -  | -  |
| Utilities  | 110594442  | 110594442  | -  | -  |
|  U.S. Government and Government Agency Obligations  | 4968461  | -  | 4968461  | -  |
|  Money Market Funds  | 487623794  | 487623794  | -  | -  |
| **Total Investments in Securities:**  | 11125030200  | 11119000463  | 4968474  | 1061263  |
| **<u>Derivative Instruments:</u>**  |  |  |  |  |
|  **Assets**  |  |  |  |  |
| Futures Contracts  | 2555575  | 2555575  | -  | -  |
| Total Assets  | 2555575  | 2555575  | -  | -  |
| **Total Derivative Instruments:**  | 2555575  | 2555575  | -  | -  |

---

**Value of Derivative Instruments**

The following table is a summary of the Fund's value of derivative instruments by primary risk exposure as of November 30, 2022. For additional information on derivative instruments, please refer to the Derivative Instruments section in the accompanying Notes to Financial Statements.

---

| | | |
|:---|:---|:---|
| **Primary Risk Exposure / Derivative Type** <br>| **Value**  | **Value**  |
|  | **Asset ($)**  | **Liability ($)**  |
| **Equity Risk**  |  |  |
| Futures Contracts (a)  | 2555575  | 0  |
| **Total Equity Risk**  | 2555575  | 0  |
| **Total Value of Derivatives**  | 2555575  | 0  |

---

(a)Reflects gross cumulative appreciation (depreciation) on futures contracts as presented in the Schedule of Investments. In the Statement of Assets and Liabilities, the period end daily variation margin is included in receivable or payable for daily variation margin on futures contracts, and the net cumulative appreciation (depreciation) is included in Total accumulated earnings (loss).

**Financial Statements**

---

| | | |
|:---|:---|:---|
| **Statement of Assets and Liabilities**  | **Statement of Assets and Liabilities**  | **Statement of Assets and Liabilities**  |
|  |  | **November 30, 2022**  |
| **Assets**  |  |  |
| Investment in securities, at value (including securities loaned of $462,999,520) - See accompanying schedule:  |  |  |
|  Unaffiliated issuers (cost $5,692,785,898)  | $10637404484  |  |
|  Fidelity Central Funds (cost $487,623,794)  | 487623794  |  |
|  Other affiliated issuers (cost $201,736)  | 1922  |  |
|  Total Investment in Securities (cost $6,180,611,428)  |  | $11125030200  |
|  Cash  |  | 460356  |
|  Foreign currency held at value (cost $299)  |  | 302  |
| Receivable for investments sold  |  | 212727  |
|  Receivable for fund shares sold  |  | 2744013  |
|  Dividends receivable  |  | 9942384  |
|  Distributions receivable from Fidelity Central Funds  |  | 1543596  |
|  Receivable for daily variation margin on futures contracts  |  | 1438778  |
|  Prepaid expenses  |  | 14341  |
|  Receivable from investment adviser for expense reductions  |  | 457136  |
| Other receivables  |  | 7591  |
| **Total assets**  |  | 11141851424  |
| **Liabilities**  |  |  |
|  Payable for fund shares redeemed  | $7611062  |  |
|  Accrued management fee  | 2036906  |  |
|  Other affiliated payables  | 857044  |  |
|  Other payables and accrued expenses  | 36060  |  |
|  Collateral on securities loaned  | 468514173  |  |
| **Total Liabilities**  |  | 479055245  |
| **Net Assets**  |  | $10662796179  |
|  Net Assets consist of:  |  |  |
|  Paid in capital  |  | $5750818217  |
|  Total accumulated earnings (loss)  |  | 4911977962  |
|  **Net Assets**  |  | $10662796179  |
|  **Net Asset Value** , offering price and redemption price per share ($10,662,796,179 ÷ 73,168,089 shares)  |  | $145.73  |

---

---

| | | |
|:---|:---|:---|
| **Statement of Operations**  | **Statement of Operations**  | **Statement of Operations**  |
|  |  | **Year ended** <br> **November 30, 2022**  |
|  **Investment Income**  |  |  |
| Dividends (including $2 earned from affiliated issuers)  |  | $94274858  |
| Interest  |  | 39937  |
| Income from Fidelity Central Funds (including $24,644,232 from security lending)  |  | 25347617  |
| **Total Income**  |  | 119662412  |
|  **Expenses**  |  |  |
| Management fee  | $27702501  |  |
| Transfer agent fees  | 11542709  |  |
| Accounting fees  | 100000  |  |
| Custodian fees and expenses  | 149850  |  |
| Independent trustees' fees and expenses  | 45213  |  |
| Registration fees  | 185585  |  |
| Audit  | 80618  |  |
| Legal  | 2239914  |  |
| Interest  | 95  |  |
| Miscellaneous  | 52098  |  |
| Total expenses before reductions  | 42098583  |  |
| Expense reductions  | (6345463)  |  |
| Total expenses after reductions  |  | 35753120  |
| **Net Investment income (loss)**  |  | 83909292  |
| **Realized and Unrealized Gain (Loss)**  |  |  |
| Net realized gain (loss) on:  |  |  |
| Investment Securities:  |  |  |
| Unaffiliated issuers  | (39129792)  |  |
| Foreign currency transactions  | 2086  |  |
| Futures contracts  | (33240676)  |  |
| Total net realized gain (loss)  |  | (72368382)  |
| Change in net unrealized appreciation (depreciation) on:  |  |  |
| Investment Securities:  |  |  |
| Unaffiliated issuers  | (3628064717)  |  |
| Affiliated issuers  | (46421)  |  |
| Assets and liabilities in foreign currencies  | 20  |  |
| Futures contracts  | 1814732  |  |
| Total change in net unrealized appreciation (depreciation)  |  | (3626296386)  |
| **Net gain (loss)**  |  | (3698664768)  |
| **Net increase (decrease) in net assets resulting from operations**  |  | $(3614755476)  |

---

---

| | | |
|:---|:---|:---|
| **Statement of Changes in Net Assets**  | **Statement of Changes in Net Assets**  | **Statement of Changes in Net Assets**  |
|  | **Year ended** <br> **November 30, 2022**  | **Year ended** <br> **November 30, 2021**  |
| **Increase (Decrease) in Net Assets**  |  |  |
| Operations  |  |  |
| &nbsp;&nbsp; Net investment income (loss)  | $83909292  | $69667550  |
| &nbsp;&nbsp; Net realized gain (loss)  | (72368382) <br>| 8014845 <br>|
| &nbsp;&nbsp; Change in net unrealized appreciation (depreciation)  | (3626296386)  | 2899218781 <br>|
| &nbsp;&nbsp; **Net increase (decrease) in net assets resulting from operations**  | (3614755476) <br>| 2976901176 <br>|
| Distributions to shareholders  | (66552817) <br>| (72649348) <br>|
| Share transactions  |  |  |
| &nbsp;&nbsp; Proceeds from sales of shares  | 2272549827  | 3087419105  |
| Reinvestment of distributions  | 61977740 <br>| 68602714 <br>|
| &nbsp;&nbsp; Cost of shares redeemed  | (2068342097)  | (2148253665)  |
| **Net increase (decrease) in net assets resulting from share transactions**  | 266185470 <br>| 1007768154 <br>|
| &nbsp;&nbsp; **Total increase (decrease) in net assets**  | (3415122823) <br>| 3912019982 <br>|
| **Net Assets**  |  |  |
| &nbsp;&nbsp; Beginning of period  | 14077919002  | 10165899020 <br>|
| &nbsp;&nbsp; End of period  | $10662796179  | $14077919002  |
| **Other Information**  |  |  |
| Shares  |  |  |
| &nbsp;&nbsp; Sold  | 13957177  | 17656843  |
| Issued in reinvestment of distributions  | 312168 <br>| 425312 <br>|
| &nbsp;&nbsp; Redeemed  | (12859134)  | (12297115)  |
| &nbsp;&nbsp; Net increase (decrease)  | 1410211  | 5785040  |

---

**Financial Highlights** 

 **Fidelity® Nasdaq Composite Index® Fund** <br>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Years ended November 30,**  | **2022**  | **2021**  | **2020**  | **2019**  | **2018**  |
| **Selected Per-Share Data**  |  |  |  |  |  |
| Net asset value, beginning of period  | $196.19  | $154.09  | $113.58  | $96.86  | $90.92  |
| Income from Investment Operations  |  |  |  |  |  |
| Net investment income (loss) <sup>A,B</sup>  | 1.16  | 1.00  | 1.04  | 1.12  | .89  |
| Net realized and unrealized gain (loss)  | (50.70)  | 42.19  | 44.44  | 17.26  | 5.71  |
| Total from investment operations  | (49.54)  | 43.19  | 45.48  | 18.38  | 6.60  |
| Distributions from net investment income  | (.92)  | (1.09)  | (1.11) <sup>C</sup>  | (.81)  | (.64)  |
| Distributions from net realized gain  | -  | -  | (3.86) <sup>C</sup>  | (.85)  | (.02)  |
| Total distributions  | (.92)  | (1.09)  | (4.97)  | (1.66)  | (.66)  |
| Net asset value, end of period  | $145.73  | $196.19  | $154.09  | $113.58  | $96.86  |
| **Total Return** <sup>D</sup>  | (25.37)%  | 28.18%  | 41.63%  | 19.55%  | 7.30%  |
| **Ratios to Average Net Assets** <sup>B,E,F</sup>  |  |  |  |  |  |
| Expenses before reductions  | .36%  | .35%  | .35%  | .35%  | .40%  |
| Expenses net of fee waivers, if any  | .31%  | .29%  | .29%  | .29%  | .29%  |
| Expenses net of all reductions  | .31%  | .29%  | .29%  | .29%  | .29%  |
| Net investment income (loss)  | .73%  | .56%  | .84%  | 1.10%  | .90%  |
| **Supplemental Data**  |  |  |  |  |  |
| Net assets, end of period (000 omitted)  | $10662796  | $14077919  | $10165899  | $7154288  | $6002333  |
| Portfolio turnover rate <sup>G</sup>  | 4%  | 7%  | 17%  | 6%  | 15%  |

---

<sup>A</sup> *Calculated based on average shares outstanding during the period.*

<sup>B</sup> *Net investment income (loss) is affected by the timing of the declaration of dividends by any underlying mutual funds or exchange-traded funds (ETFs). Net investment income (loss) of any mutual funds or ETFs is not included in the Fund's net investment income (loss) ratio.*

<sup>C</sup> *The amount shown reflects reclassifications related to book to tax differences that were made in the year shown.*

<sup>D</sup> *Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.*

<sup>E</sup> *Fees and expenses of any underlying mutual funds or exchange-traded funds (ETFs) are not included in the Fund's expense ratio. The Fund indirectly bears its proportionate share of these expenses. For additional expense information related to investments in Fidelity Central Funds, please refer to the "Investments in Fidelity Central Funds" note found in the Notes to Financial Statements section of the most recent Annual or Semi-Annual report.*

<sup>F</sup> *Expense ratios reflect operating expenses of the class. Expenses before reductions do not reflect amounts reimbursed, waived, or reduced through arrangements with the investment adviser, brokerage services, or other offset arrangements, if applicable, and do not represent the amount paid by the class during periods when reimbursements, waivers or reductions occur.*

<sup>G</sup> *Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).*

**Notes to Financial Statements**

For the period ended November 30, 2022

**1. Organization.**

Fidelity Nasdaq Composite Index Fund (the Fund) is a fund of Fidelity Concord Street Trust (the Trust) and is authorized to issue an unlimited number of shares. Share transactions on the Statement of Changes in Net Assets may contain exchanges between affiliated funds. The Trust is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Massachusetts business trust. The Fund may operate as a non-diversified fund, as defined under the 1940 Act, to the approximate extent the Index is non-diversified.

**2. Investments in Fidelity Central Funds.**

Funds may invest in Fidelity Central Funds, which are open-end investment companies generally available only to other investment companies and accounts managed by the investment adviser and its affiliates. The Schedule of Investments lists any Fidelity Central Funds held as an investment as of period end, but does not include the underlying holdings of each Fidelity Central Fund. An investing fund indirectly bears its proportionate share of the expenses of the underlying Fidelity Central Funds.

Based on its investment objective, each Fidelity Central Fund may invest or participate in various investment vehicles or strategies that are similar to those of the investing fund. These strategies are consistent with the investment objectives of the investing fund and may involve certain economic risks which may cause a decline in value of each of the Fidelity Central Funds and thus a decline in the value of the investing fund.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Fidelity Central Fund**  | **Investment Manager**  | **Investment Objective**  | **Investment Practices**  | **Expense Ratio** <sup>A</sup>  |
| Fidelity Money Market Central Funds  | Fidelity Management & Research Company LLC (FMR)  | Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity.  | Short-term Investments  | Less than .005%  |

---

<sup>A</sup> *Expenses expressed as a percentage of average net assets and are as of each underlying Central Fund's most recent annual or semi-annual shareholder report.* 

A complete unaudited list of holdings for each Fidelity Central Fund is available upon request or at the Securities and Exchange Commission website at www.sec.gov. In addition, the financial statements of the Fidelity Central Funds which contain the significant accounting policies (including investment valuation policies) of those funds, and are not covered by the Report of Independent Registered Public Accounting Firm, are available on the Securities and Exchange Commission website or upon request.

**3. Significant Accounting Policies.**

The Fund is an investment company and applies the accounting and reporting guidance of the Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946 *Financial Services - Investment Companies* . The financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP), which require management to make certain estimates and assumptions at the date of the financial statements. Actual results could differ from those estimates. Subsequent events, if any, through the date that the financial statements were issued have been evaluated in the preparation of the financial statements. The Fund's Schedule of Investments lists any underlying mutual funds or exchange-traded funds (ETFs) but does not include the underlying holdings of these funds. The following summarizes the significant accounting policies of the Fund:

**Investment Valuation.** Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. The Board of Trustees (the Board) has designated the Fund's investment adviser as the valuation designee responsible for the fair valuation function and performing fair value determinations as needed. The investment adviser has established a Fair Value Committee (the Committee) to carry out the day-to-day fair valuation responsibilities and has adopted policies and procedures to govern the fair valuation process and the activities of the Committee. In accordance with these fair valuation policies and procedures, which have been approved by the Board, the Fund attempts to obtain prices from one or more third party pricing services or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with the policies and procedures. Factors used in determining fair value vary by investment type and may include market or investment specific events, transaction data, estimated cash flows, and market observations of comparable investments. The frequency that the fair valuation procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee manages the Fund's fair valuation practices and maintains the fair valuation policies and procedures. The Fund's investment adviser reports to the Board information regarding the fair valuation process and related material matters.

The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels as shown below:

Level 1 - unadjusted quoted prices in active markets for identical investments

Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)

Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)

Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing service on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, ETFs and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.

Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing services or from brokers who make markets in such securities. U.S. government and government agency obligations are valued by pricing services who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker-supplied prices. When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing services. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.

Futures contracts are valued at the settlement price established each day by the board of trade or exchange on which they are traded and are categorized as Level 1 in the hierarchy. Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. The aggregate value of investments by input level as of November 30, 2022 is included at the end of the Fund's Schedule of Investments.

**Foreign Currency.** Certain Funds may use foreign currency contracts to facilitate transactions in foreign-denominated securities. Gains and losses from these transactions may arise from changes in the value of the foreign currency or if the counterparties do not perform under the contracts' terms.

Foreign-denominated assets, including investment securities, and liabilities are translated into U.S. dollars at the exchange rates at period end. Purchases and sales of investment securities, income and dividends received, and expenses denominated in foreign currencies are translated into U.S. dollars at the exchange rate in effect on the transaction date.

The effects of exchange rate fluctuations on investments are included with the net realized and unrealized gain (loss) on investment securities. Other foreign currency transactions resulting in realized and unrealized gain (loss) are disclosed separately.

**Investment Transactions and Income.** For financial reporting purposes, the Fund's investment holdings and NAV include trades executed through the end of the last business day of the period. The NAV per share for processing shareholder transactions is calculated as of the close of business of the New York Stock Exchange (NYSE), normally 4:00 p.m. Eastern time and includes trades executed through the end of the prior business day. Gains and losses on securities sold are determined on the basis of identified cost and include proceeds received from litigation. Commissions paid to certain brokers with whom the investment adviser, or its affiliates, places trades on behalf of a fund include an amount in addition to trade execution, which may be rebated back to a fund. Any such rebates are included in net realized gain (loss) on investments in the Statement of Operations. Dividend income is recorded on the ex-dividend date, except for certain dividends from foreign securities where the ex-dividend date may have passed, which are recorded as soon as the Fund is informed of the ex-dividend date. Non-cash dividends included in dividend income, if any, are recorded at the fair market value of the securities received. Income and capital gain distributions from Fidelity Central Funds, if any, are recorded on the ex-dividend date. Certain distributions received by the Fund represent a return of capital or capital gain. The Fund determines the components of these distributions subsequent to the ex-dividend date, based upon receipt of tax filings or other correspondence relating to the underlying investment. These distributions are recorded as a reduction of cost of investments and/or as a realized gain. Interest income is accrued as earned and includes coupon interest and amortization of premium and accretion of discount on debt securities as applicable. Investment income is recorded net of foreign taxes withheld where recovery of such taxes is uncertain. Funds may file withholding tax reclaims in certain jurisdictions to recover a portion of amounts previously withheld. Any withholding tax reclaims income is included in the Statement of Operations in dividends. Any receivables for withholding tax reclaims are included in the Statement of Assets and Liabilities in dividends receivable.

**Expenses.** Expenses directly attributable to a fund are charged to that fund. Expenses attributable to more than one fund are allocated among the respective funds on the basis of relative net assets or other appropriate methods. Expenses included in the accompanying financial statements reflect the expenses of that fund and do not include any expenses associated with any underlying mutual funds or exchange-traded funds. Although not included in a fund's expenses, a fund indirectly bears its proportionate share of these expenses through the net asset value of each underlying mutual fund or exchange-traded fund. Expense estimates are accrued in the period to which they relate and adjustments are made when actual amounts are known.

**Income Tax Information and Distributions to Shareholders.** Each year, the Fund intends to qualify as a regulated investment company under Subchapter M of the Internal Revenue Code, including distributing substantially all of its taxable income and realized gains. As a result, no provision for U.S. Federal income taxes is required. As of November 30, 2022, the Fund did not have any unrecognized tax benefits in the financial statements; nor is the Fund aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. The Fund files a U.S. federal tax return, in addition to state and local tax returns as required. The Fund's federal income tax returns are subject to examination by the Internal Revenue Service (IRS) for a period of three fiscal years after they are filed. State and local tax returns may be subject to examination for an additional fiscal year depending on the jurisdiction. Foreign taxes are provided for based on the Fund's understanding of the tax rules and rates that exist in the foreign markets in which it invests.

Distributions are declared and recorded on the ex-dividend date. Income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP. In addition, the Fund claimed a portion of the payment made to redeeming shareholders as a distribution for income tax purposes.

Capital accounts within the financial statements are adjusted for permanent book-tax differences. These adjustments have no impact on net assets or the results of operations. Capital accounts are not adjusted for temporary book-tax differences which will reverse in a subsequent period.

Book-tax differences are primarily due to futures contracts, foreign currency transactions, passive foreign investment companies (PFIC), partnerships, capital loss carryforwards and losses deferred due to wash sales.

As of period end, the cost and unrealized appreciation (depreciation) in securities, and derivatives if applicable, for federal income tax purposes were as follows:

---

| | |
|:---|:---|
| **Gross unrealized appreciation**  | $5763179041  |
| **Gross unrealized depreciation**  | <u>(834138512)</u>  |
| **Net unrealized appreciation (depreciation)**  | <u>$4929040529</u>  |
| **Tax Cost**  | <u>$6195989671</u>  |

---

The tax-based components of distributable earnings as of period end were as follows:

---

| | |
|:---|:---|
| **Undistributed ordinary income**  | <u>$78078280</u>  |
| **Capital loss carryforward**  | <u>$(93211487)</u>  |
| **Net unrealized appreciation (depreciation) on securities and other investments**  | <u>$4927111170</u>  |

---

Capital loss carryforwards are only available to offset future capital gains of the Fund to the extent provided by regulations and may be limited. The capital loss carryforward information presented below, including any applicable limitation, is estimated as of fiscal period end and is subject to adjustment.

---

| | |
|:---|:---|
| Short-term  | $(91242778)  |
| Long-term  | <u>(1968709)</u>  |
| **Total capital loss carryforward**  | <u>$(93211487)</u>  |

---

The tax character of distributions paid was as follows:

---

| | | |
|:---|:---|:---|
|  | **November 30, 2022**  | **November 30, 2021**  |
| **Ordinary Income**  | $66552817  | $72649348  |

---

**Restricted Securities (including Private Placements).** Funds may invest in securities that are subject to legal or contractual restrictions on resale. These securities generally may be resold in transactions exempt from registration or to the public if the securities are registered. Disposal of these securities may involve time-consuming negotiations and expense, and prompt sale at an acceptable price may be difficult. Information regarding restricted securities held at period end is included at the end of the Schedule of Investments, if applicable.

**4. Derivative Instruments.**

**Risk Exposures and the Use of Derivative Instruments.** The Fund's investment objectives allow for various types of derivative instruments, including futures contracts. Derivatives are investments whose value is primarily derived from underlying assets, indices or reference rates and may be transacted on an exchange or over-the-counter (OTC). Derivatives may involve a future commitment to buy or sell a specified asset based on specified terms, to exchange future cash flows at periodic intervals based on a notional principal amount, or for one party to make one or more payments upon the occurrence of specified events in exchange for periodic payments from the other party.

Derivatives were used to increase returns and to manage exposure to certain risks as defined below. The success of any strategy involving derivatives depends on analysis of numerous economic factors, and if the strategies for investment do not work as intended, the objectives may not be achieved.

Derivatives were used to increase or decrease exposure to the following risk(s):

---

| | |
|:---|:---|
| Equity Risk  | Equity risk relates to the fluctuations in the value of financial instruments as a result of changes in market prices (other than those arising from interest rate risk or foreign exchange risk), whether caused by factors specific to an individual investment, its issuer, or all factors affecting all instruments traded in a market or market segment. <br>|

---

Funds are also exposed to additional risks from investing in derivatives, such as liquidity risk and counterparty credit risk. Liquidity risk is the risk that a fund will be unable to close out the derivative in the open market in a timely manner. Counterparty credit risk is the risk that the counterparty will not be able to fulfill its obligation to a fund. Counterparty credit risk related to exchange-traded contracts may be mitigated by the protection provided by the exchange on which they trade.

Investing in derivatives may involve greater risks than investing in the underlying assets directly and, to varying degrees, may involve risk of loss in excess of any initial investment and collateral received and amounts recognized in the Statement of Assets and Liabilities. In addition, there may be the risk that the change in value of the derivative contract does not correspond to the change in value of the underlying instrument.

**Futures Contracts.** A futures contract is an agreement between two parties to buy or sell a specified underlying instrument for a fixed price at a specified future date. Futures contracts were used to manage exposure to the stock market.

Upon entering into a futures contract, a fund is required to deposit either cash or securities (initial margin) with a clearing broker in an amount equal to a certain percentage of the face value of the contract. Futures contracts are marked-to-market daily and subsequent daily payments are made or received by a fund depending on the daily fluctuations in the value of the futures contracts and are recorded as unrealized appreciation or (depreciation). This receivable and/or payable, if any, is included in daily variation margin on futures contracts in the Statement of Assets and Liabilities. Realized gain or (loss) is recorded upon the expiration or closing of a futures contract. The net realized gain (loss) and change in net unrealized appreciation (depreciation) on futures contracts during the period is presented in the Statement of Operations.

Any open futures contracts at period end are presented in the Schedule of Investments under the caption "Futures Contracts". The notional amount at value reflects each contract's exposure to the underlying instrument or index at period end, and is representative of volume of activity during the period unless an average notional amount is presented. Any securities deposited to meet initial margin requirements are identified in the Schedule of Investments. Any cash deposited to meet initial margin requirements is presented as segregated cash with brokers for derivative instruments in the Statement of Assets and Liabilities.

**5. Purchases and Sales of Investments.**

Purchases and sales of securities, other than short-term securities and in-kind transactions, as applicable, are noted in the table below.

---

| | | |
|:---|:---|:---|
|  | **Purchases ($)**  | **Sales ($)**  |
| **Fidelity Nasdaq Composite Index Fund**  | 903370552  | 452047293  |

---

**6. Fees and Other Transactions with Affiliates.**

**Management Fee.** Fidelity Management & Research Company LLC (the investment adviser) and its affiliates provide the Fund with investment management related services for which the Fund pays a monthly management fee that is based on an annual rate of .24% of the Fund's average net assets.

**Sub-Adviser.** Geode Capital Management, LLC (Geode), serves as sub-adviser for the Fund. Geode provides discretionary investment advisory services to the Fund and is paid by the investment adviser for providing these services.

**Transfer Agent Fees.** Fidelity Investments Institutional Operations Company LLC (FIIOC), an affiliate of the investment adviser, is the Fund's transfer, dividend disbursing and shareholder servicing agent. FIIOC receives an asset-based fee of .10% of the Fund's average net assets. FIIOC pays for typesetting, printing and mailing of shareholder reports, except proxy statements.

**Accounting Fees.** Fidelity Service Company, Inc. (FSC), an affiliate of the investment adviser, maintains the Fund's accounting records. The accounting fee is based on the level of average net assets for each month. For the period, the fees were equivalent to the following annual rates:

---

| | |
|:---|:---|
|  | **% of Average Net Assets**  |
| **Fidelity Nasdaq Composite Index Fund**  | - <sup>A</sup>  |

---

<sup>A</sup> *Amount represents less than .005%* 

**Interfund Lending Program.** Pursuant to an Exemptive Order issued by the Securities and Exchange Commission (the SEC), the Fund, along with other registered investment companies having management contracts with Fidelity Management & Research Company LLC (FMR), or other affiliated entities of FMR, may participate in an interfund lending program. This program provides an alternative credit facility allowing the Fund to borrow from, or lend money to, other participating affiliated funds. At period end, there were no interfund loans outstanding. Activity in this program during the period for which loans were outstanding was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Borrower or Lender**  | **Average Loan Balance**  | **Weighted Average Interest Rate**  | **Interest Expense**  |
| **Fidelity Nasdaq Composite Index Fund**  | Borrower  | $10875000  | .32%  | $95  |

---

**Interfund Trades.** Funds may purchase from or sell securities to other Fidelity Funds under procedures adopted by the Board. The procedures have been designed to ensure these interfund trades are executed in accordance with Rule 17a-7 of the 1940 Act. Any interfund trades are included within the respective purchases and sales amounts shown in the Purchases and Sales of Investments note. During the period, there were no interfund trades.

**Other.** During the period, the investment adviser reimbursed the Fund for certain losses as follows:

---

| | |
|:---|:---|
|  | **Amount**  |
| **Fidelity Nasdaq Composite Index Fund**  | $2347  |

---

**7. Committed Line of Credit.**

Certain Funds participate with other funds managed by the investment adviser or an affiliate in a $4.25 billion credit facility (the "line of credit") to be utilized for temporary or emergency purposes to fund shareholder redemptions or for other short-term liquidity purposes. The participating funds have agreed to pay commitment fees on their pro-rata portion of the line of credit, which are reflected in Miscellaneous expenses on the Statement of Operations, and are listed below. During the period, there were no borrowings on this line of credit.

---

| | |
|:---|:---|
|  | **Amount**  |
| **Fidelity Nasdaq Composite Index Fund**  | $20523  |

---

**8. Security Lending.** 

Funds lend portfolio securities from time to time in order to earn additional income. Lending agents are used, including National Financial Services (NFS), an affiliate of the investment adviser. Pursuant to a securities lending agreement, NFS will receive a fee, which is capped at 9.9% of a fund's daily lending revenue, for its services as lending agent. A fund may lend securities to certain qualified borrowers, including NFS. On the settlement date of the loan, a fund receives collateral (in the form of U.S. Treasury obligations, letters of credit and/or cash) against the loaned securities and maintains collateral in an amount not less than 100% of the market value of the loaned securities during the period of the loan. The market value of the loaned securities is determined at the close of business of a fund and any additional required collateral is delivered to a fund on the next business day. A fund or borrower may terminate the loan at any time, and if the borrower defaults on its obligation to return the securities loaned because of insolvency or other reasons, a fund may apply collateral received from the borrower against the obligation. A fund may experience delays and costs in recovering the securities loaned. Any cash collateral received is invested in the Fidelity Securities Lending Cash Central Fund. Any loaned securities are identified as such in the Schedule of Investments, and the value of loaned securities and cash collateral at period end, as applicable, are presented in the Statement of Assets and Liabilities. Security lending income represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities. Security lending income is presented in the Statement of Operations as a component of income from Fidelity Central Funds. Affiliated security lending activity, if any, was as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **Total Security Lending Fees Paid to NFS**  | **Security Lending Income From Securities Loaned to NFS**  | **Value of Securities Loaned to NFS at Period End**  |
| **Fidelity Nasdaq Composite Index Fund**  | $2573105  | $730639  | $4987171  |

---

**9. Expense Reductions.** 

The investment adviser contractually agreed to reimburse the Fund to the extent annual operating expenses exceeded .29% of average net assets. This reimbursement will remain in place through March 31, 2024. Some expenses, for example the compensation of the independent Trustees, and certain miscellaneous expenses such as proxy and shareholder meeting expenses, are excluded from this reimbursement. During the period this reimbursement reduced the Fund's expenses by $6,343,024.

Through arrangements with the Fund's custodian, credits realized as a result of certain uninvested cash balances were used to reduce the Fund's expenses by $2,439.

**10. Other.**

A fund's organizational documents provide former and current trustees and officers with a limited indemnification against liabilities arising in connection with the performance of their duties to the fund. In the normal course of business, a fund may also enter into contracts that provide general indemnifications. A fund's maximum exposure under these arrangements is unknown as this would be dependent on future claims that may be made against a fund. The risk of material loss from such claims is considered remote.

**11. Risk and Uncertainties.**

Many factors affect a fund's performance. Developments that disrupt global economies and financial markets, such as pandemics, epidemics, outbreaks of infectious diseases, war, terrorism, and environmental disasters, may significantly affect a fund's investment performance. The effects of these developments to a fund will be impacted by the types of securities in which a fund invests, the financial condition, industry, economic sector, and geographic location of an issuer, and a fund's level of investment in the securities of that issuer.

**Report of Independent Registered Public Accounting Firm**

To the Board of Trustees of Fidelity Concord Street Trust and the Shareholders of Fidelity Nasdaq Composite Index Fund

**Opinion on the Financial Statements and Financial Highlights**

We have audited the accompanying statement of assets and liabilities of Fidelity Nasdaq Composite Index Fund (the "Fund"), a fund of Fidelity Concord Street Trust, including the schedule of investments, as of November 30, 2022, the related statement of operations for the year then ended, the statement of changes in net assets for each of the two years in the period then ended, the financial highlights for each of the five years in the period then ended, and the related notes. In our opinion, the financial statements and financial highlights present fairly, in all material respects, the financial position of the Fund as of November 30, 2022, and the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period then ended, and the financial highlights for each of the five years in the period then ended in conformity with accounting principles generally accepted in the United States of America.

**Basis for Opinion**

These financial statements and financial highlights are the responsibility of the Fund's management. Our responsibility is to express an opinion on the Fund's financial statements and financial highlights based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement, whether due to error or fraud. The Fund is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements and financial highlights, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements and financial highlights. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements and financial highlights. Our procedures included confirmation of securities owned as of November 30, 2022, by correspondence with the custodian and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.

/s/ Deloitte & Touche LLP

Boston, Massachusetts

January 13, 2023

We have served as the auditor of one or more of the Fidelity investment companies since 1999.

**Trustees and Officers**

**<u>TRUSTEES AND OFFICERS</u>**

The Trustees, Members of the Advisory Board (if any), and officers of the trust and fund, as applicable, are listed below. The Board of Trustees governs the fund and is responsible for protecting the interests of shareholders. The Trustees are experienced executives who meet periodically throughout the year to oversee the fund's activities, review contractual arrangements with companies that provide services to the fund, oversee management of the risks associated with such activities and contractual arrangements, and review the fund's performance. Except for Jonathan Chiel, each of the Trustees oversees 318 funds. Mr. Chiel oversees 186 funds.

The Trustees hold office without limit in time except that (a) any Trustee may resign; (b) any Trustee may be removed by written instrument, signed by at least two-thirds of the number of Trustees prior to such removal; (c) any Trustee who requests to be retired or who has become incapacitated by illness or injury may be retired by written instrument signed by a majority of the other Trustees; and (d) any Trustee may be removed at any special meeting of shareholders by a two-thirds vote of the outstanding voting securities of the trust. Each Trustee who is not an interested person (as defined in the 1940 Act) of the trust and the fund is referred to herein as an Independent Trustee. Each Independent Trustee shall retire not later than the last day of the calendar year in which his or her 75th birthday occurs. The Independent Trustees may waive this mandatory retirement age policy with respect to individual Trustees. Officers and Advisory Board Members hold office without limit in time, except that any officer or Advisory Board Member may resign or may be removed by a vote of a majority of the Trustees at any regular meeting or any special meeting of the Trustees. Except as indicated, each individual has held the office shown or other offices in the same company for the past five years.

The fund's Statement of Additional Information (SAI) includes more information about the Trustees. To request a free copy, call Fidelity at 1-800-544-8544.

<u>Experience, Skills, Attributes, and Qualifications of the Trustees.</u> The Governance and Nominating Committee has adopted a statement of policy that describes the experience, qualifications, attributes, and skills that are necessary and desirable for potential Independent Trustee candidates (Statement of Policy). The Board believes that each Trustee satisfied at the time he or she was initially elected or appointed a Trustee, and continues to satisfy, the standards contemplated by the Statement of Policy. The Governance and Nominating Committee also engages professional search firms to help identify potential Independent Trustee candidates who have the experience, qualifications, attributes, and skills consistent with the Statement of Policy. From time to time, additional criteria based on the composition and skills of the current Independent Trustees, as well as experience or skills that may be appropriate in light of future changes to board composition, business conditions, and regulatory or other developments, have also been considered by the professional search firms and the Governance and Nominating Committee. In addition, the Board takes into account the Trustees' commitment and participation in Board and committee meetings, as well as their leadership of standing and ad hoc committees throughout their tenure.

In determining that a particular Trustee was and continues to be qualified to serve as a Trustee, the Board has considered a variety of criteria, none of which, in isolation, was controlling. The Board believes that, collectively, the Trustees have balanced and diverse experience, qualifications, attributes, and skills, which allow the Board to operate effectively in governing the fund and protecting the interests of shareholders. Information about the specific experience, skills, attributes, and qualifications of each Trustee, which in each case led to the Board's conclusion that the Trustee should serve (or continue to serve) as a trustee of the fund, is provided below.

<u>Board Structure and Oversight Function.</u> Robert A. Lawrence is an interested person and currently serves as Chair. The Trustees have determined that an interested Chair is appropriate and benefits shareholders because an interested Chair has a personal and professional stake in the quality and continuity of services provided to the fund. Independent Trustees exercise their informed business judgment to appoint an individual of their choosing to serve as Chair, regardless of whether the Trustee happens to be independent or a member of management. The Independent Trustees have determined that they can act independently and effectively without having an Independent Trustee serve as Chair and that a key structural component for assuring that they are in a position to do so is for the Independent Trustees to constitute a substantial majority for the Board. The Independent Trustees also regularly meet in executive session. David M. Thomas serves as Lead Independent Trustee and as such (i) acts as a liaison between the Independent Trustees and management with respect to matters important to the Independent Trustees and (ii) with management prepares agendas for Board meetings.

Fidelity <sup>®</sup> funds are overseen by different Boards of Trustees. The fund's Board oversees Fidelity's high income and certain equity funds, and other Boards oversee Fidelity's investment-grade bond, money market, asset allocation, and other equity funds. The asset allocation funds may invest in Fidelity <sup>®</sup> funds overseen by the fund's Board. The use of separate Boards, each with its own committee structure, allows the Trustees of each group of Fidelity **®** funds to focus on the unique issues of the funds they oversee, including common research, investment, and operational issues. On occasion, the separate Boards establish joint committees to address issues of overlapping consequences for the Fidelity <sup>®</sup> funds overseen by each Board.

The Trustees operate using a system of committees to facilitate the timely and efficient consideration of all matters of importance to the Trustees, the fund, and fund shareholders and to facilitate compliance with legal and regulatory requirements and oversight of the fund's activities and associated risks. The Board, acting through its committees, has charged FMR and its affiliates with (i) identifying events or circumstances the occurrence of which could have demonstrably adverse effects on the fund's business and/or reputation; (ii) implementing processes and controls to lessen the possibility that such events or circumstances occur or to mitigate the effects of such events or circumstances if they do occur; and (iii) creating and maintaining a system designed to evaluate continuously business and market conditions in order to facilitate the identification and implementation processes described in (i) and (ii) above. Because the day-to-day operations and activities of the fund are carried out by or through FMR, its affiliates, and other service providers, the fund's exposure to risks is mitigated but not eliminated by the processes overseen by the Trustees. While each of the Board's committees has responsibility for overseeing different aspects of the fund's activities, oversight is exercised primarily through the Operations, Audit, and Compliance Committees. Appropriate personnel, including but not limited to the fund's Chief Compliance Officer (CCO), FMR's internal auditor, the independent accountants, the fund's Treasurer and portfolio management personnel, make periodic reports to the Board's committees, as appropriate, including an annual review of Fidelity's risk management program for the Fidelity <sup>®</sup> funds. The responsibilities of each standing committee, including their oversight responsibilities, are described further under "Standing Committees of the Trustees."

<u>Interested Trustees\*:</u>

Correspondence intended for a Trustee who is an interested person may be sent to Fidelity Investments, 245 Summer Street, Boston, Massachusetts 02210.

<u>Name, Year of Birth; Principal Occupations and Other Relevant Experience+</u>

Jonathan Chiel (1957)

Year of Election or Appointment: 2016

Trustee

Mr. Chiel also serves as Trustee of other Fidelity <sup>®</sup> funds. Mr. Chiel is Executive Vice President and General Counsel for FMR LLC (diversified financial services company, 2012-present). Previously, Mr. Chiel served as general counsel (2004-2012) and senior vice president and deputy general counsel (2000-2004) for John Hancock Financial Services; a partner with Choate, Hall & Stewart (1996-2000) (law firm); and an Assistant United States Attorney for the United States Attorney's Office of the District of Massachusetts (1986-95), including Chief of the Criminal Division (1993-1995). Mr. Chiel is a director on the boards of the Boston Bar Foundation and the Maimonides School.

Bettina Doulton (1964)

Year of Election or Appointment: 2021

Trustee

Ms. Doulton also serves as Trustee of other Fidelity <sup>®</sup> funds. Prior to her retirement, Ms. Doulton served in a variety of positions at Fidelity Investments, including as a managing director of research (2006-2007), portfolio manager to certain Fidelity <sup>®</sup> funds (1993-2005), equity analyst and portfolio assistant (1990-1993), and research assistant (1987-1990). Ms. Doulton currently owns and operates Phi Builders + Architects and Cellardoor Winery. Previously, Ms. Doulton served as a member of the Board of Brown Capital Management, LLC (2014-2018).

Robert A. Lawrence (1952)

Year of Election or Appointment: 2020

Trustee

Chair of the Board of Trustees

Mr. Lawrence also serves as Trustee of other funds. Previously, Mr. Lawrence served as a Trustee and Member of the Advisory Board of certain funds. Prior to his retirement in 2008, Mr. Lawrence served as Vice President of certain Fidelity <sup>®</sup> funds (2006-2008), Senior Vice President, Head of High Income Division of Fidelity Management & Research Company (investment adviser firm, 2006-2008), and President of Fidelity Strategic Investments (investment adviser firm, 2002-2005).

\* Determined to be an "Interested Trustee" by virtue of, among other things, his or her affiliation with the trust or various entities under common control with FMR.

+ The information includes the Trustee's principal occupation during the last five years and other information relating to the experience, attributes, and skills relevant to the Trustee's qualifications to serve as a Trustee, which led to the conclusion that the Trustee should serve as a Trustee for the fund.

<u>Independent Trustees:</u>

Correspondence intended for an Independent Trustee may be sent to Fidelity Investments, P.O. Box 55235, Boston, Massachusetts 02205-5235.

<u>Name, Year of Birth; Principal Occupations and Other Relevant Experience+</u>

Thomas P. Bostick (1956)

Year of Election or Appointment: 2021

Trustee

Lieutenant General Bostick also serves as Trustee of other Fidelity <sup>®</sup> funds. Prior to his retirement, General Bostick (United States Army, Retired) held a variety of positions within the U.S. Army, including Commanding General and Chief of Engineers, U.S. Army Corps of Engineers (2012-2016) and Deputy Chief of Staff and Director of Human Resources, U.S. Army (2009-2012). General Bostick currently serves as a member of the Board and Finance and Governance Committees of CSX Corporation (transportation, 2020-present) and a member of the Board and Corporate Governance and Nominating Committee of Perma-Fix Environmental Services, Inc. (nuclear waste management, 2020-present). General Bostick serves as Chief Executive Officer of Bostick Global Strategies, LLC (consulting, 2016-present) and as a member of the Board of HireVue, Inc. (video interview and assessment, 2020-present). Previously, General Bostick served as a Member of the Advisory Board of certain Fidelity® funds (2021), President, Intrexon Bioengineering (2018-2020) and Chief Operating Officer (2017-2020) and Senior Vice President of the Environment Sector (2016-2017) of Intrexon Corporation (biopharmaceutical company).

Dennis J. Dirks (1948)

Year of Election or Appointment: 2005

Trustee

Mr. Dirks also serves as Trustee of other Fidelity <sup>®</sup> funds. Prior to his retirement in May 2003, Mr. Dirks served as Chief Operating Officer and as a member of the Board of The Depository Trust & Clearing Corporation (financial markets infrastructure), President, Chief Operating Officer and a member of the Board of The Depository Trust Company (DTC), President and a member of the Board of the National Securities Clearing Corporation (NSCC), Chief Executive Officer and a member of the Board of the Government Securities Clearing Corporation and Chief Executive Officer and a member of the Board of the Mortgage-Backed Securities Clearing Corporation. Mr. Dirks currently serves as a member of the Finance Committee (2016-present) and Board (2017-present) and is Treasurer (2018-present) of the Asolo Repertory Theatre.

Donald F. Donahue (1950)

Year of Election or Appointment: 2018

Trustee

Mr. Donahue also serves as Trustee of other Fidelity <sup>®</sup> funds. Mr. Donahue serves as President and Chief Executive Officer of Miranda Partners, LLC (risk consulting for the financial services industry, 2012-present). Previously, Mr. Donahue served as Chief Executive Officer (2006-2012), Chief Operating Officer (2003-2006) and Managing Director, Customer Marketing and Development (1999-2003) of The Depository Trust & Clearing Corporation (financial markets infrastructure). Mr. Donahue currently serves as a member (2007-present) and Co-Chairman (2016-present) of the Board of United Way of New York and a member of the Board of The Leadership Academy (previously NYC Leadership Academy) (2012-present). Mr. Donahue previously served as a member of the Advisory Board of certain Fidelity® funds (2015-2018).

Vicki L. Fuller (1957)

Year of Election or Appointment: 2020

Trustee

Ms. Fuller also serves as Trustee of other Fidelity <sup>®</sup> funds. Previously, Ms. Fuller served as a member of the Advisory Board of certain Fidelity <sup>®</sup> funds (2018-2020), Chief Investment Officer of the New York State Common Retirement Fund (2012-2018) and held a variety of positions at AllianceBernstein L.P. (global asset management, 1985-2012), including Managing Director (2006-2012) and Senior Vice President and Senior Portfolio Manager (2001-2006). Ms. Fuller currently serves as a member of the Board, Audit Committee and Nominating and Governance Committee of two Blackstone business development companies (2020-present), as a member of the Board of Treliant, LLC (consulting, 2019-present), as a member of the Advisory Board of Ariel Alternatives, LLC (private equity, 2021-present) and as a member of the Board and Chair of the Audit Committee of Gusto, Inc. (software, 2021-present). In addition, Ms. Fuller currently serves as a member of the Board of Roosevelt University (2019-present) and as a member of the Executive Board of New York University's Stern School of Business. Ms. Fuller previously served as a member of the Board, Audit Committee and Nominating and Governance Committee of The Williams Companies, Inc. (natural gas infrastructure, 2018-2021).

Patricia L. Kampling (1959)

Year of Election or Appointment: 2020

Trustee

Ms. Kampling also serves as Trustee of other Fidelity <sup>®</sup> funds. Prior to her retirement, Ms. Kampling served as Chairman of the Board and Chief Executive Officer (2012-2019), President and Chief Operating Officer (2011-2012) and Executive Vice President and Chief Financial Officer (2010-2011) of Alliant Energy Corporation. Ms. Kampling currently serves as a member of the Board, Finance Committee and Governance, Compensation and Nominating Committee of Xcel Energy Inc. (utilities company, 2020-present) and as a member of the Board, Audit, Finance and Risk Committee and Safety, Environmental, Technology and Operations Committee and Chair of the Executive Development and Compensation Committee of American Water Works Company, Inc. (utilities company, 2019-present). In addition, Ms. Kampling currently serves as a member of the Board of the Nature Conservancy, Wisconsin Chapter (2019-present). Previously, Ms. Kampling served as a Member of the Advisory Board of certain Fidelity® funds (2020), a member of the Board, Compensation Committee and Executive Committee and Chair of the Audit Committee of Briggs & Stratton Corporation (manufacturing, 2011-2021), a member of the Board of Interstate Power and Light Company (2012-2019) and Wisconsin Power and Light Company (2012-2019) (each a subsidiary of Alliant Energy Corporation) and as a member of the Board and Workforce Development Committee of the Business Roundtable (2018-2019).

Thomas A. Kennedy (1955)

Year of Election or Appointment: 2021

Trustee

Mr. Kennedy also serves as Trustee of other Fidelity <sup>®</sup> funds. Previously, Mr. Kennedy served as a Member of the Advisory Board of certain Fidelity <sup>®</sup> funds (2020) and held a variety of positions at Raytheon Company (aerospace and defense, 1983-2020), including Chairman and Chief Executive Officer (2014-2020) and Executive Vice President and Chief Operating Officer (2013-2014). Mr. Kennedy currently serves as Executive Chairman of the Board of Directors of Raytheon Technologies Corporation (aerospace and defense, 2020-present). He is also a member of the Rutgers School of Engineering Industry Advisory Board (2011-present) and a member of the UCLA Engineering Dean's Executive Board (2016-present).

Oscar Munoz (1959)

Year of Election or Appointment: 2021

Trustee

Mr. Munoz also serves as Trustee of other Fidelity <sup>®</sup> funds. Prior to his retirement, Mr. Munoz served as Executive Chairman (2020-2021), Chief Executive Officer (2015-2020), President (2015-2016) and a member of the Board (2010-2021) of United Airlines Holdings, Inc. Mr. Munoz currently serves as a member of the Board of CBRE Group, Inc. (commercial real estate, 2020-present), a member of the Board of Univision Communications, Inc. (Hispanic media, 2020-present) and a member of the Advisory Board of Salesforce.com, Inc. (cloud-based software, 2020-present). Previously, Mr. Munoz served as a Member of the Advisory Board of certain Fidelity <sup>®</sup> funds (2021).

David M. Thomas (1949)

Year of Election or Appointment: 2008

Trustee

Lead Independent Trustee

Mr. Thomas also serves as Trustee of other Fidelity <sup>®</sup> funds. Previously, Mr. Thomas served as Executive Chairman (2005-2006) and Chairman and Chief Executive Officer (2000-2005) of IMS Health, Inc. (pharmaceutical and healthcare information solutions). Mr. Thomas currently serves as a member of the Board of Fortune Brands Home and Security (home and security products, 2004-present) and as Director (2013-present) and Non-Executive Chairman of the Board (2022-present) of Interpublic Group of Companies, Inc. (marketing communication).

Susan Tomasky (1953)

Year of Election or Appointment: 2020

Trustee

Ms. Tomasky also serves as Trustee of other Fidelity <sup>®</sup> funds. Prior to her retirement, Ms. Tomasky served in various executive officer positions at American Electric Power Company, Inc. (1998-2011), including most recently as President of AEP Transmission (2007-2011). Ms. Tomasky currently serves as a member of the Board and Sustainability Committee and as Chair of the Audit Committee of Marathon Petroleum Corporation (2018-present) and as a member of the Board, Executive Committee, Corporate Governance Committee and Organization and Compensation Committee and as Chair of the Audit Committee of Public Service Enterprise Group, Inc. (utilities company, 2012-present) and as a member of the Board of its subsidiary company, Public Service Electric and Gas Co. (2021-present). In addition, Ms. Tomasky currently serves as a member (2009-present) and President (2020-present) of the Board of the Royal Shakespeare Company - America (2009-present), as a member of the Board of the Columbus Association for the Performing Arts (2011-present) and as a member of the Board and Kenyon in the World Committee of Kenyon College (2016-present). Previously, Ms. Tomasky served as a Member of the Advisory Board of certain Fidelity <sup>®</sup> funds (2020), as a member of the Board of the Columbus Regional Airport Authority (2007-2020), as a member of the Board (2011-2018) and Lead Independent Director (2015-2018) of Andeavor Corporation (previously Tesoro Corporation) (independent oil refiner and marketer) and as a member of the Board of Summit Midstream Partners LP (energy, 2012-2018).

Michael E. Wiley (1950)

Year of Election or Appointment: 2020

Trustee

Mr. Wiley also serves as Trustee of other Fidelity <sup>®</sup> funds. Previously, Mr. Wiley served as a member of the Advisory Board of certain Fidelity <sup>®</sup> funds (2018-2020), Chairman, President and CEO of Baker Hughes, Inc. (oilfield services, 2000-2004). Mr. Wiley also previously served as a member of the Board of Andeavor Corporation (independent oil refiner and marketer, 2005-2018), a member of the Board of Andeavor Logistics LP (natural resources logistics, 2015-2018) and a member of the Board of High Point Resources (exploration and production, 2005-2020).

+ The information includes the Trustee's principal occupation during the last five years and other information relating to the experience, attributes, and skills relevant to the Trustee's qualifications to serve as a Trustee, which led to the conclusion that the Trustee should serve as a Trustee for the fund.

<u>Advisory Board Members and Officers:</u>

Correspondence intended for a Member of the Advisory Board (if any) may be sent to Fidelity Investments, P.O. Box 55235, Boston, Massachusetts 02205-5235. Correspondence intended for an officer or Peter S. Lynch may be sent to Fidelity Investments, 245 Summer Street, Boston, Massachusetts 02210. Officers appear below in alphabetical order.

<u>Name, Year of Birth; Principal Occupation</u>

Peter S. Lynch (1944)

Year of Election or Appointment: 2003

Member of the Advisory Board

Mr. Lynch also serves as a Member of the Advisory Board of other Fidelity <sup>®</sup> funds. Mr. Lynch is Vice Chairman and a Director of Fidelity Management & Research Company LLC (investment adviser firm). In addition, Mr. Lynch serves as a Trustee of Boston College and as the Chairman of the Inner-City Scholarship Fund. Previously, Mr. Lynch served as Vice Chairman and a Director of FMR Co., Inc. (investment adviser firm) and on the Special Olympics International Board of Directors (1997-2006).

Craig S. Brown (1977)

Year of Election or Appointment: 2022

Deputy Treasurer

Mr. Brown also serves as an officer of other funds. Mr. Brown serves as Assistant Treasurer of FIMM, LLC (2021-present) and is an employee of Fidelity Investments (2013-present). Previously, Mr. Brown served as Assistant Treasurer of certain Fidelity <sup>®</sup> funds (2019-2022).

John J. Burke III (1964)

Year of Election or Appointment: 2018

Chief Financial Officer

Mr. Burke also serves as Chief Financial Officer of other funds. Mr. Burke serves as Head of Investment Operations for Fidelity Fund and Investment Operations (2018-present) and is an employee of Fidelity Investments (1998-present). Previously Mr. Burke served as head of Asset Management Investment Operations (2012-2018).

William C. Coffey (1969)

Year of Election or Appointment: 2019

Assistant Secretary

Mr. Coffey also serves as Assistant Secretary of other funds. He is Senior Vice President and Deputy General Counsel of FMR LLC (diversified financial services company, 2010-present), and is an employee of Fidelity Investments. Previously, Mr. Coffey served as Secretary and CLO of certain funds (2018-2019); CLO, Secretary, and Senior Vice President of Fidelity Management & Research Company and FMR Co., Inc. (investment adviser firms, 2018-2019); Secretary of Fidelity SelectCo, LLC and Fidelity Investments Money Management, Inc. (investment adviser firms, 2018-2019); CLO of Fidelity Management & Research (Hong Kong) Limited, FMR Investment Management (UK) Limited, and Fidelity Management & Research (Japan) Limited (investment adviser firms, 2018-2019); and Assistant Secretary of certain funds (2009-2018).

Timothy M. Cohen (1969)

Year of Election or Appointment: 2018

Vice President

Mr. Cohen also serves as Vice President of other funds. Mr. Cohen serves as Co-Head of Equity (2018-present), a Director of Fidelity Management & Research (Japan) Limited (investment adviser firm, 2016-present), and is an employee of Fidelity Investments. Previously, Mr. Cohen served as Executive Vice President of Fidelity SelectCo, LLC (2019), Head of Global Equity Research (2016-2018), Chief Investment Officer - Equity and a Director of Fidelity Management & Research (U.K.) Inc. (investment adviser firm, 2013-2015) and as a Director of Fidelity Management & Research (Hong Kong) Limited (investment adviser firm, 2017).

Jonathan Davis (1968)

Year of Election or Appointment: 2010

Assistant Treasurer

Mr. Davis also serves as an officer of other funds. Mr. Davis serves as Assistant Treasurer of FIMM, LLC (2021-present), FMR Capital, Inc. (2017-present), FD Funds GP LLC (2021-present), FD Funds Holding LLC (2021-present), and FD Funds Management LLC (2021-present); and is an employee of Fidelity Investments. Previously, Mr. Davis served as Vice President and Associate General Counsel of FMR LLC (diversified financial services company, 2003-2010).

Laura M. Del Prato (1964)

Year of Election or Appointment: 2018

Assistant Treasurer

Ms. Del Prato also serves as an officer of other funds. Ms. Del Prato serves as Assistant Treasurer of FIMM, LLC (2021-present) and is an employee of Fidelity Investments (2017-present). Previously, Ms. Del Prato served as President and Treasurer of The North Carolina Capital Management Trust: Cash Portfolio and Term Portfolio (2018-2020). Prior to joining Fidelity Investments, Ms. Del Prato served as a Managing Director and Treasurer of the JPMorgan Mutual Funds (2014-2017). Prior to JPMorgan, Ms. Del Prato served as a partner at Cohen Fund Audit Services (accounting firm, 2012-2013) and KPMG LLP (accounting firm, 2004-2012).

Colm A. Hogan (1973)

Year of Election or Appointment: 2020

Assistant Treasurer

Mr. Hogan also serves as an officer of other funds. Mr. Hogan serves as Assistant Treasurer of FIMM, LLC (2021-present) and FMR Capital, Inc. (2017-present) and is an employee of Fidelity Investments (2005-present). Previously, Mr. Hogan served as Deputy Treasurer of certain Fidelity <sup>®</sup> funds (2016-2020) and Assistant Treasurer of certain Fidelity <sup>®</sup> funds (2016-2018).

Pamela R. Holding (1964)

Year of Election or Appointment: 2018

Vice President

Ms. Holding also serves as Vice President of other funds. Ms. Holding serves as Co-Head of Equity (2018-present) and is an employee of Fidelity Investments (2013-present). Previously, Ms. Holding served as Executive Vice President of Fidelity SelectCo, LLC (2019) and as Chief Investment Officer of Fidelity Institutional Asset Management (2013-2018).

Cynthia Lo Bessette (1969)

Year of Election or Appointment: 2019

Secretary and Chief Legal Officer (CLO)

Ms. Lo Bessette also serves as an officer of other funds. Ms. Lo Bessette serves as CLO, Secretary, and Senior Vice President of Fidelity Management & Research Company LLC (investment adviser firm, 2019-present); CLO of Fidelity Management & Research (Hong Kong) Limited, FMR Investment Management (UK) Limited, and Fidelity Management & Research (Japan) Limited (investment adviser firms, 2019-present); Secretary of FD Funds GP LLC (2021-present), FD Funds Holding LLC (2021-present), FD Funds Management LLC (2021-present), and Fidelity Diversifying Solutions LLC (investment adviser firm, 2022-present); and Assistant Secretary of FIMM, LLC (2019-present). She is a Senior Vice President and Deputy General Counsel of FMR LLC (diversified financial services company, 2019-present), and is an employee of Fidelity Investments. Previously, Ms. Lo Bessette served as CLO, Secretary, and Senior Vice President of FMR Co., Inc. (investment adviser firm, 2019); Secretary of Fidelity SelectCo, LLC and Fidelity Investments Money Management, Inc. (investment adviser firms, 2019). Prior to joining Fidelity Investments, Ms. Lo Bessette was Executive Vice President, General Counsel (2016-2019) and Senior Vice President, Deputy General Counsel (2015-2016) of OppenheimerFunds (investment management company) and Deputy Chief Legal Officer (2013-2015) of Jennison Associates LLC (investment adviser firm).

Chris Maher (1972)

Year of Election or Appointment: 2020

Deputy Treasurer

Mr. Maher also serves as an officer of other funds. Mr. Maher serves as Assistant Treasurer of FIMM, LLC (2021-present) and FMR Capital, Inc. (2017-present), and is an employee of Fidelity Investments (2008-present). Previously, Mr. Maher served as Assistant Treasurer of certain funds (2013-2020); Vice President of Asset Management Compliance (2013), Vice President of the Program Management Group of FMR (investment adviser firm, 2010-2013), and Vice President of Valuation Oversight (2008-2010).

Jason P. Pogorelec (1975)

Year of Election or Appointment: 2020

Chief Compliance Officer

Mr. Pogorelec also serves as Chief Compliance Officer of other funds. Mr. Pogorelec is a senior Vice President of Asset Management Compliance for Fidelity Investments and is an employee of Fidelity Investments (2006-present). Previously, Mr. Pogorelec served as Vice President, Associate General Counsel for Fidelity Investments (2010-2020) and Assistant Secretary of certain Fidelity <sup>®</sup> funds (2015-2020).

Brett Segaloff (1972)

Year of Election or Appointment: 2021

Anti-Money Laundering (AML) Officer

Mr. Segaloff also serves as an AML Officer of other funds and other related entities. He is Director, Anti-Money Laundering (2007-present) of FMR LLC (diversified financial services company) and is an employee of Fidelity Investments (1996-present).

Stacie M. Smith (1974)

Year of Election or Appointment: 2016

President and Treasurer

Ms. Smith also serves as an officer of other funds. Ms. Smith serves as Assistant Treasurer of FIMM, LLC (2021-present) and FMR Capital, Inc. (2017-present), is an employee of Fidelity Investments (2009-present), and has served in other fund officer roles. Prior to joining Fidelity Investments, Ms. Smith served as Senior Audit Manager of Ernst & Young LLP (accounting firm, 1996-2009). Previously, Ms. Smith served as Assistant Treasurer (2013-2019) and Deputy Treasurer (2013-2016) of certain Fidelity <sup>®</sup> funds.

Jim Wegmann (1979)

Year of Election or Appointment: 2019

Assistant Treasurer

Mr. Wegmann also serves as an officer of other funds. Mr. Wegmann serves as Assistant Treasurer of FIMM, LLC (2021-present) and is an employee of Fidelity Investments (2011-present). Previously, Mr. Wegmann served as Assistant Treasurer of certain Fidelity <sup>®</sup> funds (2019-2021).

**Shareholder Expense Example**

As a shareholder, you incur two types of costs: (1) transaction costs, which may include sales charges (loads) on purchase payments or redemption proceeds, as applicable and (2) ongoing costs, which generally include management fees, distribution and/or service (12b-1) fees and other Fund expenses. This Example is intended to help you understand your ongoing costs (in dollars) of investing in a fund and to compare these costs with the ongoing costs of investing in other mutual funds.

The Example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period (June 1, 2022 to November 30, 2022). <br>

***Actual Expenses***

The first line of the accompanying table provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000.00 (for example, an $8,600 account value divided by $1,000.00 = 8.6), then multiply the result by the number in the first line for a class/Fund under the heading entitled "Expenses Paid During Period" to estimate the expenses you paid on your account during this period. If any fund is a shareholder of any underlying mutual funds or exchange-traded funds (ETFs) (the Underlying Funds), such fund indirectly bears its proportional share of the expenses of the Underlying Funds in addition to the direct expenses incurred presented in the table. These fees and expenses are not included in the annualized expense ratio used to calculate the expense estimate in the table below.

***Hypothetical Example for Comparison Purposes***

The second line of the accompanying table provides information about hypothetical account values and hypothetical expenses based on the actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds. If any fund is a shareholder of any Underlying Funds, such fund indirectly bears its proportional share of the expenses of the Underlying Funds in addition to the direct expenses as presented in the table. These fees and expenses are not included in the annualized expense ratio used to calculate the expense estimate in the table below.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transaction costs. Therefore, the second line of the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Annualized Expense Ratio-** <sup>A</sup>  | **Beginning Account Value June 1, 2022**  | **Ending Account Value November 30, 2022**  | **Expenses Paid During Period-** <sup>C</sup> **June 1, 2022 to November 30, 2022**  |
| **Fidelity® Nasdaq Composite Index® Fund**  | .31%  |  |  |  |
| **Actual**  |  | $1000  | $955.20  | $1.52  |
| **Hypothetical-** <sup>B</sup>  |  | $1000  | $1023.51  | $1.57  |

---

*A Annualized expense ratio reflects expenses net of applicable fee waivers.*

*B 5% return per year before expenses*

*C Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 183/ 365 (to reflect the one-half year period). The fees and expenses of any Underlying Funds are not included in each annualized expense ratio.*

**Distributions** **(Unaudited)**

The dividend and capital gains distributions for the fund(s) are available on *Fidelity.com* or *Institutional.Fidelity.com* .

A total of 0.03% of the dividends distributed during the fiscal year was derived from interest on U.S. Government securities which is generally exempt from state income tax.

The fund designates 100% of the dividends distributed during the fiscal year as qualifying for the dividends-received deduction for corporate shareholders.

The fund designates 100% of the dividends distributed during the fiscal year as amounts which may be taken into account as a dividend for the purposes of the maximum rate under section 1(h)(11) of the Internal Revenue Code.

The fund will notify shareholders in January 2023 of amounts for use in preparing 2022 income tax returns.

**Board Approval of Investment Advisory Contracts and Management Fees**

**F idelity Nasdaq Composite Index Fund** 

At its September 2022 meeting, the Board of Trustees, including a majority of the Independent Trustees (together, the Board), voted to approve an amended and restated sub-advisory agreement with Geode Capital Management, LLC (Geode) for the fund (the Amended Contract) to decrease the sub-advisory fee rate paid by Fidelity Management & Research Company LLC (FMR), the fund's investment adviser, to Geode on behalf of the fund by 0.10 basis points, effective October 1, 2022. The Board, assisted by the advice of fund counsel and Independent Trustees' counsel, considered a broad range of information.

**Nature, Extent, and Quality of Services Provided.** The Board previously received and considered materials relating to the nature, extent and quality of services provided by FMR and Geode to the fund, including the resources dedicated to investment management and support services, shareholder and administrative services, the benefits to shareholders of investment in a large fund family and the investment performance of the fund in connection with the annual renewal of the fund's current management contract and sub-advisory agreement (Advisory Contracts). At its May 2022 meeting, the Board concluded that the nature, extent and quality of the services provided to the fund under the existing Advisory Contracts should continue to benefit the fund's shareholders. The Board noted that approval of the Amended Contract would not change the fund's portfolio manager, the investment processes, the level or nature of services provided, the resources and personnel allocated or trading and compliance operations. The Board concluded that the nature, extent, and quality of services to be provided to the fund under the Amended Contract should continue to benefit the fund's shareholders.

**Competitiveness of Management Fee and Total Expense Ratio** . The Board noted that the Amended Contract would result in no change in the fund's management fee and total expense ratio and considered that it received and reviewed information regarding the fund's current management fee and total expense ratio compared to "mapped groups" of competitive funds and classes in connection with the annual renewal of the Advisory Contracts. Based on its review, the Board concluded at its May 2022 and September 2022 meetings that the fund's management fee is fair and reasonable in light of the services that the fund receives and the other factors considered and that the fund's total expense ratio was reasonable in light of the services that the fund and its shareholders receive and the other factors considered.

**Costs of the Services and Profitability** . The Board previously reviewed information regarding the revenues earned and the expenses incurred by Fidelity in providing services to the fund and the level of Fidelity's profitability. At its May 2022 meeting, the Board concluded that it was satisfied that Fidelity's profitability in connection with the operation of the fund was not excessive. At the September 2022 meeting, the Board concluded that the Amended Contract would not have a meaningful effect on Fidelity's profitability.

**Economies of Scale.** The Board has previously received and reviewed information regarding whether there have been economies of scale in respect of the management of the Fidelity funds, whether the Fidelity funds (including the fund) have appropriately benefited from any such economies of scale, and whether there is potential for realization of any further economies of scale and that it concluded, at its May 2022 meeting, that economies of scale, if any, are being appropriately shared between fund shareholders and Fidelity. At the September 2022 meeting, the Board concluded that the Amended Contract would not have a meaningful effect on any potential economies of scale.

Based on its evaluation of all of the conclusions noted above, and after considering all factors it believed relevant, the Board concluded that the sub-advisory fee arrangement is fair and reasonable, and that the fund's Amended Contract should be approved.

![](img87682_2.jpg) <br>

1.795539.119 EIF-ANN-0123

Item 2.

<u>Code of Ethics</u>

As of the end of the period, November 30, 2022, Fidelity Concord Street Trust (the trust) has adopted a code of ethics, as defined in Item 2 of Form N-CSR, that applies to its President and Treasurer and its Chief Financial Officer. A copy of the code of ethics is filed as an exhibit to this Form N-CSR.

Item 3.

<u>Audit Committee Financial Expert</u>

The Board of Trustees of the trust has determined that Donald F. Donahue is an audit committee financial expert, as defined in Item 3 of Form N-CSR. Mr. Donahue is independent for purposes of Item 3 of Form N-CSR.

Item 4.

<u>Principal Accountant Fees and Services</u>

<u>Fees and Services</u>

The following table presents fees billed by Deloitte & Touche LLP, the member firms of Deloitte Touche Tohmatsu, and their respective affiliates (collectively, "Deloitte Entities") in each of the last two fiscal years for services rendered to Fidelity Nasdaq Composite Index Fund (the "Fund"):

**<u>Services Billed by Deloitte Entities</u>**

**<u>November 30, 2022 Fees</u><sup>A</sup>**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Audit Fees** | **Audit-Related Fees** | **Tax Fees** | **All Other Fees** |
| Fidelity Nasdaq Composite Index Fund | $62100  | $- | $9300  | $1400 |

---

**<u>November 30, 2021 Fees</u><sup>A</sup>**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Audit Fees** | **Audit-Related Fees** | **Tax Fees** | **All Other Fees** |
| Fidelity Nasdaq Composite Index Fund | $60000  | $- | $9400  | $1400 |

---

<sup>A</sup> Amounts may reflect rounding.

The following table(s) present(s) fees billed by Deloitte Entities that were required to be approved by the Audit Committee for services that relate directly to the operations and financial reporting of the Fund(s) and that are rendered on behalf of Fidelity Management

& Research Company LLC ("FMR") and entities controlling, controlled by, or under common control with FMR (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser) that provide ongoing services to the Fund(s) ("Fund Service Providers"):

**<u>Services Billed by Deloitte Entities</u>**

---

| | | |
|:---|:---|:---|
|  | **<u>November 30, 2022</u><sup>A</sup>** | **<u>November 30, 2021</u><sup>A</sup>** |
| Audit-Related Fees | $-  | $-  |
| Tax Fees | $- | $- |
| All Other Fees | $- | $- |

---

<sup>A</sup> Amounts may reflect rounding.

"Audit-Related Fees" represent fees billed for assurance and related services that are reasonably related to the performance of the fund audit or the review of the fund's financial statements and that are not reported under Audit Fees.

"Tax Fees" represent fees billed for tax compliance, tax advice or tax planning that relate directly to the operations and financial reporting of the fund.

"All Other Fees" represent fees billed for services provided to the fund or Fund Service Provider, a significant portion of which are assurance related, that relate directly to the operations and financial reporting of the fund, excluding those services that are reported under Audit Fees, Audit-Related Fees or Tax Fees.

Assurance services must be performed by an independent public accountant.

\* \* \*

The aggregate non-audit fees billed by Deloitte Entities for services rendered to the Fund(s), FMR (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser), and any Fund Service Provider for each of the last two fiscal years of the Fund(s) are as follows:

---

| | | |
|:---|:---|:---|
| **<u>Billed By</u>** | **<u>November 30, 2022</u><sup>A</sup>** | **<u>November 30, 2021</u><sup>A</sup>** |
| Deloitte Entities | $468300  | $532400  |

---

<sup>A</sup> Amounts may reflect rounding.

The trust's Audit Committee has considered non-audit services that were not pre-approved that were provided by Deloitte Entities to Fund Service Providers to be compatible with maintaining the independence of Deloitte Entities in its(their) audit of the Fund(s), taking into account representations from Deloitte Entities, in accordance with Public Company Accounting Oversight Board rules, regarding its independence from the Fund(s) and its(their) related entities and FMR's review of the appropriateness and permissibility under applicable law of such non-audit services prior to their provision to the Fund(s) Service Providers.

<u>Audit Committee Pre-Approval Policies and Procedures</u>

The trust's Audit Committee must pre-approve all audit and non-audit services provided by a fund's independent registered public accounting firm relating to the operations or financial reporting of the fund. Prior to the commencement of any audit or non-audit services to a fund, the Audit Committee reviews the services to determine whether they are appropriate and permissible under applicable law.

The Audit Committee has adopted policies and procedures to, among other purposes, provide a framework for the Committee's consideration of non-audit services by the audit firms that audit the Fidelity funds. The policies and procedures require that any non-audit service provided by a fund audit firm to a Fidelity fund and any non-audit service provided by a fund auditor to a Fund Service Provider that relates directly to the operations and financial reporting of a Fidelity fund ("Covered Service") are subject to approval by the Audit Committee before such service is provided.

All Covered Services must be approved in advance of provision of the service either: (i) by formal resolution of the Audit Committee, or (ii) by oral or written approval of the service by the Chair of the Audit Committee (or if the Chair is unavailable, such other member of the Audit Committee as may be designated by the Chair to act in the Chair's absence). The approval contemplated by (ii) above is permitted where the Treasurer determines that action on such an engagement is necessary before the next meeting of the Audit Committee.

Non-audit services provided by a fund audit firm to a Fund Service Provider that do not relate directly to the operations and financial reporting of a Fidelity fund are reported to the Audit Committee periodically.

<u>Non-Audit Services Approved Pursuant to Rule 2-01(c)(7)(i)(C) and (ii) of Regulation S-X ("De Minimis Exception")</u>

There were no non-audit services approved or required to be approved by the Audit Committee pursuant to the De Minimis Exception during the Fund's(s') last two fiscal years relating to services provided to (i) the Fund(s) or (ii) any Fund Service Provider that relate directly to the operations and financial reporting of the Fund(s).

Item 5.

<u>Audit Committee of Listed Registrants</u>

Not applicable.

Item 6.

<u>Investments</u>

(a) Not applicable.

(b) Not applicable.

Item 7.

<u>Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies</u>

Not applicable.

Item 8.

<u>Portfolio Managers of Closed-End Management Investment Companies</u>

Not applicable.

Item 9.

<u>Purchase of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers</u>

Not applicable.

Item 10.

<u>Submission of Matters to a Vote of Security Holders</u>

There were no material changes to the procedures by which shareholders may recommend nominees to the trust's Board of Trustees.

Item 11.

<u>Controls and Procedures</u>

(a)(i) The President and Treasurer and the Chief Financial Officer have concluded that the trust's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act) provide reasonable assurances that material information relating to the trust is made known to them by the appropriate persons, based on their evaluation of these controls and procedures as of a date within 90 days of the filing date of this report.

(a)(ii) There was no change in the trust's internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the trust's internal control over financial reporting.

Item 12.

<u>Disclosure of Securities Lending Activities for Closed-End Management</u>

<u>Investment Companies</u>

Not applicable.

Item 13.

<u>Exhibits</u>

(a) (1) [Code of Ethics pursuant to Item 2 of Form N-CSR is filed and attached hereto as EX-99.CODE ETH](code.htm) .

(a) (2) [Certification pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) is filed and attached hereto as Exhibit 99.CERT](ex99cert.htm) .

(a) (3) Not applicable.

(b) [Certification pursuant to Rule 30a-2(b) under the Investment Company Act of 1940 (17 CFR 270.30a-2(b)) is furnished and attached hereto as Exhibit 99.906CERT](ex99906cert.htm) .

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Fidelity Concord Street Trust

---

| | |
|:---|:---|
| By: | <u>/s/Stacie M. Smith</u> |
|  | Stacie M. Smith |
|  | President and Treasurer |
| Date: | January 19, 2023 |

---

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

---

| | |
|:---|:---|
| By: | <u>/s/Stacie M. Smith</u> |
|  | Stacie M. Smith |
|  | President and Treasurer |
| Date: | January 19, 2023 |

---

---

| | |
|:---|:---|
| By: | <u>/s/John J. Burke III</u> |
|  | John J. Burke III |
|  | Chief Financial Officer |
| Date: | January 19, 2023 |

---

## Ex-99.Cert

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Exhibit EX-99.CERT</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I, Stacie M. Smith, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I have reviewed this report on Form N-CSR of Fidelity Concord Street Trust;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; b.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; c.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based upon such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; d.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disclosed in this report any change in the registrant 's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant 's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; b.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Date:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; January 19, 2023

---

| |
|:---|
|  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>/s/Stacie M. Smith</u>  |
|  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stacie M. Smith  |
|  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; President and Treasurer  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I, John J. Burke III, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I have reviewed this report on Form N-CSR of Fidelity Concord Street Trust;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; b.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; c.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based upon such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; d.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disclosed in this report any change in the registrant 's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant 's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; b.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Date:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; January 19, 2023

---

| |
|:---|
|  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>/s/John J. Burke III</u>  |
|  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; John J. Burke III  |
|  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chief Financial Officer  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

## Exhibit 99.906

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exhibit EX-99.906CERT

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code)** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In connection with the attached Report of Fidelity Concord Street Trust (the "Trust ") on Form N-CSR to be filed with the Securities and Exchange Commission (the "Report "), each of the undersigned officers of the Trust does hereby certify that, to the best of such officer 's knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Report fully complies with the requirements of 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Trust as of, and for, the periods presented in the Report.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dated: January 19, 2023

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

---

| |
|:---|
|  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>/s/Stacie M. Smith</u>  |
|  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stacie M. Smith  |
|  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; President and Treasurer  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dated: January 19, 2023

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

---

| |
|:---|
|  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>/s/John J. Burke III</u>  |
|  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; John J. Burke III  |
|  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chief Financial Officer  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Trust and will be retained by the Trust and furnished to the Securities and Exchange Commission or its staff upon request.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

## Ex-99.Code

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **EXHIBIT EX-99.CODE ETH** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **FIDELITY FUNDS' CODE OF ETHICS FOR** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **PRESIDENT, TREASURER AND PRINCIPAL ACCOUNTING OFFICER** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **I. Purposes of the Code/Covered Officers** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; This document constitutes the Code of Ethics (Code) adopted by the Fidelity Funds (Funds) pursuant to the provisions of Rule 30b2-1(a) under the Investment Company Act of 1940), which Rule implements Sections 406 of the Sarbanes-Oxley Act of 2002 with respect to registered investment companies. The Code applies to the Fidelity Funds' President and Treasurer, and Chief Financial Officer (Covered Officers). Fidelity's Ethics Office, a part of Corporate Compliance Group within Core Compliance, administers the Code.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The purposes of the Code are to deter wrongdoing and to promote, on the part of the Covered Officers:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; · &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; · &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; full, fair, accurate, timely and understandable disclosure in reports and documents that the Fidelity Funds submit to the Securities and Exchange Commission (SEC), and in other public communications by a Fidelity Fund;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; · &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; compliance with applicable laws and governmental rules and regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; · &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the prompt internal reporting to an appropriate person or persons identified in the Code of violations of the Code; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; · &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; accountability for adherence to the Code.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Each Covered Officer should adhere to a high standard of business ethics and should be sensitive to situations that may give rise to actual as well as apparent conflicts of interest.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **II.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Covered Officers Should Handle Ethically** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Actual and Apparent Conflicts of Interest** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Overview.** A "conflict of interest" occurs when a Covered Officer's private interest interferes with the interests of, or his service to, the Fidelity Funds. For example, a conflict of interest would arise if a Covered Officer, or a member of his family, receives improper personal benefits as a result of his position with the Fidelity Funds.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Certain conflicts of interest arise out of the relationships between Covered Officers and the Fidelity Funds and already are subject to conflict of interest provisions in the Investment Company Act of 1940 (Investment Company Act) and the Investment Advisers Act of 1940 (Investment Advisers Act). For example, Covered Officers may not individually engage in certain transactions (such as the purchase or sale of securities or other property) with a Fidelity Fund because of their status as "affiliated persons" of the Fund. Separate compliance programs and procedures of the Fidelity Funds, Fidelity Management & Research Company (FMR) and the other Fidelity companies are designed to prevent, or identify and correct, violations of these provisions. This Code does not, and is not intended to, repeat or replace these programs and procedures, and such conflicts fall outside of the parameters of this Code.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Although typically not presenting an opportunity for improper personal benefit, conflicts arise from, or as a result of, the contractual relationship between the Fidelity Funds and FMR (or another Fidelity company) of which the Covered Officers are also officers or employees. As a result, this Code recognizes that the Covered Officers will, in the normal course of their duties (whether formally for the Fidelity Funds, FMR or another Fidelity company), be involved in establishing policies and implementing decisions that have different effects on the Fidelity Funds, FMR and other Fidelity companies. The participation of the Covered Officers in such activities is inherent in the contractual relationship between the Fidelity Funds and FMR (or another Fidelity company), and is consistent with the performance by the Covered Officers of their duties as officers of the Fidelity Funds. Thus, if performed in conformity with the provisions of the Investment Company Act and the Investment Advisers Act, such activities will be deemed to have been handled ethically. In addition, it is recognized by the Funds' Board of Trustees (Board) that the Covered Officers also may be officers or employees of one or more other Fidelity Funds covered by this Code.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other conflicts of interest are covered by the Code, even if such conflicts of interest are not subject to provisions in the Investment Company Act and the Investment Advisers Act. The following list provides examples of conflicts of interest under the Code, but Covered Officers should keep in mind that these examples are not exhaustive. The overarching principle is that the personal interest of a Covered Officer should not be placed improperly before the interest of a Fidelity Fund.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; \* \* \*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Each Covered Officer must:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; · &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not use his or her personal influence or personal relationships improperly to influence investment decisions or financial reporting by any Fidelity Fund whereby the Covered Officer would benefit personally to the detriment of any Fidelity Fund;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; · &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not cause a Fidelity Fund to take action, or fail to take action, for the individual personal benefit of the Covered Officer rather than the benefit of the Fidelity Fund;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; · &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not engage in any outside business activity, including serving as a director or trustee, that prevents the Covered Officer from devoting appropriate time and attention to the Covered Officer's responsibilities with the Fidelity Funds;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; · &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not have a consulting or employment relationship with any of the Fidelity Funds' service providers that are not affiliated with Fidelity; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; · &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not retaliate against any employee or Covered Officer for reports of actual or potential misconduct, which are made in good faith.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; With respect to other fact patterns, if a Covered Officer is in doubt, other potential conflict of interest situations should be described immediately to the Fidelity Ethics Office for resolution. Similarly, any questions a Covered Officer has generally regarding the application or interpretation of the Code should be directed to the Fidelity Ethics Office immediately.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **III. Disclosure and Compliance** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; · &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Each Covered Officer should familiarize himself with the disclosure requirements generally applicable to the Fidelity Funds.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; · &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Each Covered Officer should not knowingly misrepresent, or cause others to misrepresent, facts about any Fidelity Fund to others, whether within or outside Fidelity, including to the Board and auditors, and to governmental regulators and self-regulatory organizations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; · &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Each Covered Officer should, to the extent appropriate within his area of responsibility, consult with other officers and employees of the Fidelity Funds, FMR and the Fidelity service providers, and with the Board's Compliance Committee, with the goal of promoting full, fair, accurate, timely and understandable disclosure in the reports and documents the Fidelity Funds file with, or submit to, the SEC and in other public communications made by the Fidelity Funds; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; · &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It is the responsibility of each Covered Officer to promote compliance with the standards and restrictions imposed by applicable laws, rules and regulations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **IV. Reporting and Accountability** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Each Covered Officer must:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; · &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; upon receipt of the Code, and annually thereafter, submit to the Fidelity Ethics Office an acknowledgement stating that he or she has received, read, and understands the Code; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; · &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; notify the Fidelity Ethics Office promptly if he or she knows of any violation of the Code. <u>Failure to do so is itself a violation of this Code</u> .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Fidelity Ethics Office shall take all action it considers appropriate to investigate any actual or potential violations reported to it. Upon completion of the investigation, if necessary, the matter will be reviewed with senior management or other appropriate parties, and a determination will be made as to whether any action should be taken as detailed below. The Covered Officer will be informed of any action determined to be appropriate. The Fidelity Ethics Office will inform the Personal Trading Committee of all Code violations and actions taken in response. Without implied limitation, appropriate remedial, disciplinary or preventive action may include a written warning, a letter of censure, suspension, dismissal or, in the event of criminal or other serious violations of law, notification of the SEC or other appropriate law enforcement authorities. Additionally, other legal remedies may be pursued.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The policies and procedures described in the Code do not create any obligations to any person or entity other than the Fidelity Funds. The Code is intended solely for the internal use by the Fidelity Funds and does not constitute a promise, contract or an admission by or on behalf of any Fidelity Fund as to any fact, circumstance, or legal conclusion. The Fidelity Funds, the Fidelity companies and the Fidelity Chief Ethics Officer retain the discretion to decide whether the Code applies to a specific situation, and how it should be interpreted.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **V. Oversight** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Material violations of this Code will be reported promptly by FMR to the Board's Compliance Committee. In addition, at least once each year, FMR will provide a written report to the Board, which describes any issues arising under the Code since the last report to the Board, including, but not limited to, information about material violations of the Code and action taken in response to the material violations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **VI. Other Policies and Procedures** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; This Code shall be the sole code of ethics adopted by the Fidelity Funds for purposes of Section 406 of the Sarbanes-Oxley Act and the rules and forms applicable to registered investment companies thereunder. Other Fidelity policies or procedures that cover the behavior or activities of Covered Officers are separate requirements applying to the Covered Officers (and others), and are not part of this Code.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **VII. Amendments** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Any material amendments or changes to this Code must be approved or ratified by a majority vote of the Board, including a majority of the Trustees who are not interested persons of the Fidelity Funds.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **VIII. Records and Confidentiality** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Records of any violation of the Code and of the actions taken as a result of such violations will be kept by the Fidelity Ethics Office. All reports and records prepared or maintained pursuant to this Code will be considered confidential and shall be maintained and protected accordingly. Except as otherwise required by law or this Code, such matters shall not be disclosed to anyone other than the Fidelity Ethics Office, the Personal Trading Committee, the Board, appropriate personnel at the relevant Fidelity company or companies and the legal counsel of any or all of the foregoing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>